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Abstract.
The in vitro techniques of proton induced x-ray emission (PIXE), Rutherford 
backscattering (RBS), instrumental neutron activation analysis (INAA) and the in vivo 
technique of positron emission tomography (PET) have been employed to examine and 
compare elemental concentrations with metabolic rates within the brain. The element 
analysis study builds upon work previously performed at the University of Sun'ey 
whereby trace element concentrations were compared between ‘normal’ and Alzheimer 
disease (AD) brain states. Additionally to these aspects, differences between 
hemispheres and gender were investigated between the disease states for the frontal, 
occipital and parietal regions. Brain tissue samples used in analysis were obtained from 
the Alzheimer’s Disease Brain Bank, Institute of Psychiatry, London.
In the frontal lobe concentrations of phosphorus and iron were seen to have 
different concentrations between hemispheres with higher values in the right hemisphere 
‘normal’ brain and lower concentrations in the right hemisphere AD brain. 
Concentrations were significantly lower in the right hemisphere of AD subjects although 
these concentrations did decrease between AD and ‘nonual’ states. Chlorine and 
calcium were increased in AD subjects. The differences between hemispheres implies 
that the hemispheres are affected differently with the onset of dementia.
Elements enter the brain by passing through the blood brain barrier (BBB) and 
any change in its structure will alter concentrations along with uptake of glucose and 
hence metabolic rates. PET using the tracer ^^P-fluorodeoxyglucose (^^F-FDG) was 
employed to preliminary investigate region, gender and age variations of metabolism 
within the AD brain. Eighteen main regions of interest were chosen for each hemisphere 
of eighteen subjects, nine male and nine female scanned at the Paul ScheiTer Institute 
(PSI) Villi gen Switzerland. Differences between hemispheres, brain regions and gender 
were observed within the AD subject group. Throughout disease duration metabolic 
rates were found to decrease significantly in the majority of lobes over 2 years in the one
female subject who was followed by taking 3 PET scans at intervals over the period. 
The temporomedial region was one exception to this trend where metabolic rates 
increased over the first year and decreased thereafter; temporomedial vulnerability is 
much quoted in AD.
To compare AD subjects with a baseline a control gi’oup of seventy two subjects 
of age range 22 to 82 years was examined to determine gender, age and sex differences 
in the ‘normal’ brain. Up to the age of 60 years a low steady decline in the regional 
cerebral metabolic rate of glucose (rCMRGlu) was observed but above the age of 60 a 
considerably higher rate of decrease was found. Gender differences were also 
discovered. Between hemispheres significances in rCMRGlu were also observed to vary 
with increased age with the youngest subject group having higher metabolic rates in the 
left hemisphere while this dominance decreased to no significance with the increasing 
age of groups. These results have clear implications with regards subject selection in any 
future group study as subjects must be age and gender matched to as high a degree as 
possible.
The primaiy objective of this work was to deteraiine whether variations in 
elemental concentrations between ‘noimal’ and AD brains could be correlated with 
glucose metabolic rate changes within the same regions. The general change in 
elemental concentrations between disease states was observed to decrease more so in 
female brains than male. Metabolic rates also decreased at a greater rate in female 
subjects, so suggesting a possible relationship.
Statistical techniques of analysing data are also studied with the result that 
different ways of reconstructing data in ternis of glucose metabolic rates resulted in 
different absolute values and significances between brain regions. Two normalisation 
routines also resulted in significantly different absolute metabolic rates. Additionally the 
techniques of hierarchical clustering, statistical parametric mapping (SPM) and 
subprofile scalar modelling (SSM) were used to analyse these absolute values, each with 
its own interpretation of data and so each suggesting unique conclusions. The latter 
method suggests changes in neuronal connectivity between the control and AD brain.
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Regions of the brain. Alzheimer related abbreviations.
CAU Caudate nucleus
CER Cerebellum
CGA Cingulate anterior
CGP Cingulate posterior
FRL Frontolateral cortex
FRM Frontomedial cortex
INS Insula
MOT Motor cortex
OCL Occipitolateral cortex
OCM Occipitomedial cortex
PAR Parietal cortex
PUT Putamen
SMS Somatosensory cortex
TEL Temporolateral cortex
TEM Temporomedial cortex
TEP Temporal pole
THA Thalamus
WHM White matter
Statistical analysis abbreviations.
ANOVA Analysis of variance 
GIS Group invariant subprofile
GMP Group mean profile
GSF Global scaling factor
MR Metabolic ratios
PC Principal component
PROI Planar regions of interest
SPM Statistical parametric mapping
SRP Subject residual profile
SSF Subject scaling factor
SSM Subprofile scalar modelling
ACH
ACHE
ACT
AD
ADRDA
Apo-E
APP
ATP
DN
ERFC
FAD
FDG
i s p - F D G
isF-FDG-6
LPR
MAO
MT
NTT
NINCDS
NT
PHF
rCMRGlu
SAD
SDAT
SNP
SOD
Acetylcholine 
Acetylcholinesterase 
Alpha 1 -antichymotrypsin 
Alzheimer’s Disease 
Alzheimer’s Disease and 
Related Disorders Association 
Apoliproprotem E 
Amyloid precursor protein 
Adenosine triphosphate 
Dystrophic neurites 
Evaluation Rapide des 
Fonctions Cognitives 
Familial Alzheimer’s disease 
Fluorodeoxyglucose 
*^F-fluorodeoxyglucose 
P '^F-fluorodeoxyglucose-6- 
phosphate
Lipoprotein receptor 
Monoamine oxidase 
MetaUothionein 
Neurofibrillary tangles 
National Institute of 
Neurological and 
Communicative Disorders and 
Stroke
Neuropil threads 
Paired Helical Fibres 
Regional cerebral metabolic 
rate of glucose 
Sporadic Alzheimer’s disease 
Senile dementia of the 
Alzheimer type 
Senile neuritic plaques 
Super oxide dimutase
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1. Introduction.
Over 670,000 people in the UK are diagnosed with Alzheimer’s Disease (AD), 1 
in 20 of people over 65 and this increases to 1 in 5 for people over the age of 80 
[MRC93]. Once developing the disease, a patient is only expected to live for a further 8- 
10 years eventually succumbing to secondary effects such as bronchopneumonia. 
Contrary to popular thought AD is not an inevitable outcome of old age as only 5 to 6% 
of people over the age of 65 are affected by the disease but in recent times the incidence 
of AD has been shown to be on the increase [Rut98]. This is possibly due to people 
living longer than before which makes them more susceptible to the disease. 
Researchers tend not to agree on the exact percentage of Alzheimer cases with age, for 
example American studies show a vaiiation from 25% to 47% of the population above 
the age of 65 being affected [Eva90].
Most AD research is centered on familial Alzheimer’s disease (FAD), where a 
strong family history of the disease exists. People who fit this requirement can be 
followed from a pre-AD age to, and past, the time which they may develop AD. People 
who have had both parents develop AD have a 54% chance of developing the disease by 
the age of 80, while a 34% chance exists for those with one paient affected [Sma95]. 
This compares with people who have paients unaffected by AD having a 11% 
probability of developing AD. The causes of FAD are genetic and have been reported to 
be associated with chromosomes 1, 14, 19 and 21, though the genetic mechanisms of 
FAD remain lai’gely unexplained. Research here is centered on Sporadic Alzheimer’s 
disease (SAD) where no family history of AD exists and as such no clear evidence for 
its onset. Many reasons have been given for the onset of SAD such as environmental 
toxins [Whi96], smoking [Ott98], diet [Whi96], diabetes [Mes96] general health 
[Smi98] depression [GeeOO] and bizaiTely even head size [Gra96]. More controversial 
causes recorded are those of educational status [Sma95] and ethnic background where 
minorities (in a US population) are at higher risk [Tan98, DevOO], even though many
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links ai'e suggested the majority are tenuous and as such the exact cause of AD has not 
presently been determined.
Elements in trace amounts are essential for the correct functioning of the human 
brain. They are present in neurotransmitters, receptors and various proteins involved in 
brain function and so it is clear that an imbalance or abnormal concentration of a trace 
element in the brain would result in its abnormal function such as those found in AD. 
Several elements are thought, by their relative lack or abundance, to be involved in the 
cause, effect or treatment of AD as either neurotoxins, an aid to free radical production 
or as antioxidants. A review of literature on the elemental composition of the 
Alzheimer’s and ‘normal’ brain shows great differences between each publication. 
Reasons for this may possibly be due to the failure to separate brain regions and lobes 
which have been determined to have varying elemental concentrations [Ste96]. 
Additionally brain hemispheres, gender and age groups are seldom separated all of 
which again have been observed to display certain degrees of variability in elemental 
concentrations [Heb99]. The differences observed in elemental concentrations may be 
due to different neurotransmitters being required for different paits of the brain which 
perfoim different tasks. Different techniques were also used to determine element 
concentrations which again could account for discrepancies between studies.
For a trace element to enter the brain a biological transport mechanism is 
required, the major one of which is through the blood brain banier (BBB). The BBB 
stops harmful trace elements passing into the brain but it is believed in AD the barrier is 
somehow weakened thus allowing many haimful elements through which change 
elemental concentrations within the brain. This change in the BBB has been attributed to 
alterations to the membrane transport system [Ehm86] which would in turn affect 
metabolism within the brain. A practical way of examining the metabolic rates within 
the brain is the use of positron emission tomography (PET) a review of which shows 
hypometabolism in Alzheimer’s generally in the paiietal, temporal and frontal lobes of 
the cortex with the cerebellum relatively unchanged. Whether, as Ehmann [Ehm86] 
suggested, the observed change in metabolism is due to changes in elemental
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concentrations is hard to say as conversely, metabolism may affect elemental 
concentrations.
The brain itself is one of the most metabolically active organs in the body though 
it only constitutes approximately 2% of the body’s total weight (for an average human). 
The brain requires 20% of the body’s oxygen uptake and 15% of the cardiac output 
[Tho85]. The majority of the metabolic energy is used in supporting electrical activity 
which is necessary for normal brain function, the remaining energy being used in the 
repair and maintenance of neurons. There are two vital components of blood involved in 
brain metabolism, these are oxygen and glucose. The glucose supplies electrons, 
reducing equivalents, which are then consumed by the oxygen in aerobic metabolism 
which in turn maintains the conect level of adenosine triphosphate (ATP), biological 
energy. Unlike other parts of the body the brain cannot substitute other metabolic 
substances such as proteins and carbohydrates, for glucose, or other electron acceptors 
for oxygen. So consequently, any deficiency in either oxygen, glucose or both will cause 
a temporary impairment of neural activity. Any prolonged deficiency possibly due to a 
change in the BBB could result in permanent brain damage the effects of which can be 
seen with PET.
PET enables the acquisition of 3D images of brain function using radioactive 
tracers. It can be used to examine regional cerebral blood flow, regional metabolism or 
neurotransmitter turnover, all of which can change in dementia. In this study glucose 
metabolism data obtained from different patients with AD were examined using the 
tracer attached to fluorodeoxyglucose (^^F-FDG). FDG is chosen due to its Idnetics 
being similar to glucose in the initial stages of metabolism. It passes through the blood 
brain barrier and is then phosphorylised intracellulaiiy. At this point the FDG cannot 
enter the Kiebs cycle of normal glucose metabolism and is trapped. The kinematics of 
the process is modelled using compartmental analysis, a way of quantifying PET 
information.
The primaiy objective of this work is to determine whether variations in 
elemental concentrations between ‘normal’ and AD brains could be correlated with 
glucose metabolic rate changes in the same regions of subjects. Unlike a great deal of
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literature much attention has been paid to variables neglected with regai'ds to brain 
status and composition, these variables being previously described. The trace element 
study of chapter 5 builds on work previously performed at the University of Surrey by 
examining hemispherical differences between an AD and ‘normal’ population along 
with gender variations. Proton induced x-ray emission (PIXE) analysis was used to 
determine concentrations of elements within the frontal lobe while short-lived 
instrumental neutron activation analysis (INAA) was used to determine concentrations 
within the occipital and parietal lobes. Chapters 3 and 4 discuss the analytical and 
experimental techniques involved in both PIXE and INA analyses. Samples were 
obtained from the Alzheimer’s Disease Brain Bank, Institute of Psychiatry, London 
where twenty six ‘normal’ and twenty six AD brain tissue samples were taken from the 
frontal lobe. Ten ‘normal’ and ten AD tissue samples were taken from the occipital lobe 
with the same number extracted from the parietal region.
To determine whether hemispherical and gender differences could be determined 
with respect to glucose metabolism a preliminar y study was performed and presented in 
chapter 6, on metabolic rates in the AD brain. A literature review shows many 
publications discussing different phenotypes of FAD with very few researches 
examining SAD cases. For those who do, as observed in the trace element work, they 
rarely separate hemispheres or the age and gender dependence of rCMRGlu. One 
publication covering all of these aspects was discovered but the study contained just 
‘normal’ subjects [Mur96] and like most publications only examined a few regions. A 
principle objective here is to examine all regions achievable to give an insight into 
metabolic changes across the whole brain rather than a few selected regions. Eighteen 
main regions of interest were chosen for each hemisphere of eighteen subjects, nine 
male and nine female. All subjects were clinically diagnosed with AD using the criteria 
of the National Institute of Neurological and Communicative Disorders and Stroke and 
the Alzheimer’s Disease and Related Disorders Association (NINCDS-ADRDA) 
[Mck84]. The data were provided by the Paul Schener Institute (PSI) Villigen, 
Switzerland where the Rhodes method of analysis [Rho83] was used to quantify PET 
data in teims of the regional cerebral metabolic rate of glucose (rCMRGlu). Subject
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scans were obtained using the CTI Siemens EC AT 933/04-16 scanner (Knoxville,
USA). To compare subject scans all image data were transformed to the standardised 
Talairach space from which regions of interests were determined. Within this chapter 
the effects of AD with respect to disease duration are discussed with reference to a 
female subject who was scanned three times over a two year period. This gives a vital 
insight into the gradual decline dementia has upon a subject.
Once an idea as to which regions of the brain were affected in AD a ‘normal’ 
subject group was obtained to form a baseline to which the AD subjects could be 
compared against. A ‘normal’ subject is defined as a person having no neurological 
problems and no family history of dementia, these subjects are termed controls. The 
control group consists of seventy two subjects of age range 22 to 82 years, an age group 
over which it has been reported by many researches that the metabolic rate of glucose 
within the brain decreases linearly with increasing age [Mur96, Ble97]. Gender again is an added 
variable which has been observed to be significant with increasing age. As such, age 
matching of subjects has to be performed to ensure false significances are not obtained 
when comparing subject groups. A study into the effect ageing has on rCMRGlu is 
reported in chapter 7 and how the relationships vary between brain regions. Differences 
discovered with respect to the normalisation techniques are also touched upon within 
this chapter with an examination of two techniques commonly used.
Finally chapter 8 compares the control and AD subjects using a number of 
different statistical techniques with each technique inferring unique changes. With 
regards to glucose metabolism two methods of data interpretation were used, the Rhodes 
method [Rho83] and the Patlak method [Pat85], The Rhodes method uses a general I
uptake model to interpret data obtained from the scanning routine whereas the Patlak j
method relies on rate constants (section 3.5.2). Many researchers completely neglect to 
publish the method used to reconstruct metabolic images and as such comparisons 
between papers cannot be directly made. It has been shown that absolute rCMRGlu 
values can vary greatly depending on the reconstruction model even if the same data set
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is used due to constraints applied to each model [Rho83]. As in the preceding chapters 
standard statistical t-tests (or Wilcoxon) are peifoimed between brain regions to identify 
significant changes between hemisphere, gender and brain regions. But additionally the 
methods of hierarchical clustering and subprofile scalar modelling are used to determine 
whether the two mental states can be uniquely defined. The latter routine of subprofile 
scaling utilises the technique of principal component analysis to identify possible 
‘neuronal connectivity’ between brain regions which have changed with onset of 
dementia. Unlike hierarchical clustering the subprofile scaling model has been 
developed specifically for metabolic changes within the brain. Similarities in the way in 
which elemental concentrations in regions, hemispheres and gender act with regard to 
metabolic rates are discussed within chapter 8. The implications of such interactions are 
also briefly discussed.
The interaction between elemental concentrations and regional metabolic rates 
within the brain has in general not been touched upon in research. Work here introduces 
this concept and endeavours to determine whether this route is a valid one.
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2. The ‘normal’ and Alzheimer’s brain.
2,1. Trace elements.
There are three groups into which the elemental constituents of a biological 
material can be placed. These are the major, minor and the trace elements. The major and 
minor elements make up 99% of the total constituents of biological matter while the 
remaining 1% are known as the trace elements. The trace elements act primarily as 
catalysts in enzyme systems of cells where they serve a wide range of functions. As 
catalysts of enzymes their roles range from weak ionic effects to highly specific 
associations in the form of metalloenzymes. In metalloenzymes the element is strongly 
identified with the protein and each protein molecule has a fixed number of metal atoms 
which generally cannot be replaced by another metal. Even so, it has been shown that 
cobalt and cadmium can be substituted for the original zinc atoms in several zinc 
enzymes while the enzyme remains active [Val71], Though in general, failure in the 
production of, or activity of an enzyme wiU result in metabolic disorders.
2.1.1. Essential and non-essential trace elements.
There are approximately twenty six out of the ninety naturally occurring elements 
which are known to be essential for animal and human life. Eleven of these are classed as 
major and minor elements, these are carbon, hydrogen, oxygen, nitrogen, sulphur, 
calcium, phosphorous, potassium, sodium, chlorine and magnesium. The remaining 
fifteen are generally accepted as trace elements, these are iron, zinc, copper, manganese, 
nickel, cobalt, molybdenum, selenium, chromium, iodine, fluorine, tin, silicon, vanadium 
and arsenic. Others exist which are less easily described and there function is not fully 
defined [Und77]. The majority of trace elements essential to life He between the atomic 
numbers 23 through 34. The explanation most widely beHeved for this is that of ionic
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radii. Elements of small ionic radii would be able to pass tlii'ough the blood brain barrier 
whereas elements with larger radii could not [Ehm86], the elements with a larger ionic 
radii possibly having toxic effects. It is essential that the concentration of a trace element 
used in the 'normal' functioning of the body remains within a limit whereby no adverse 
effects are caused by that element. If the amount of an essential trace element available to 
a person becomes insufficient, possibly caused by inadequate intake and/or reduction of 
body reserves, the metabolic processes in which it acts will fail and function wiU be 
impaired. If an element is too abundant then an ‘overdose’ can occur which will also 
result in impaired function. The sensitivity of particular metabolic processes to the lack 
of essential elements, and the priority in demand required by them, vary in humans with 
age, sex and the speed at which the deficiency develops. Many definitions have been 
formulated to determine whether elements are essential or not such as Mertz who stated 
that, “An element is to be considered to be essential if its deficiency consistently results 
in impairment of a function from optimal to sub-optimal” [Mer70]. Cotzias [Cot67] also 
gave a comprehensive definition which lists six sets of criteria to determine whether or 
not a trace element is essential. The fifteen trace elements previously mentioned fit the 
criteria as described by Cotzias but there exist between twenty and thirty trace elements 
that do not and their presence may be explained due to environmental factors when 
found in human tissues and fluids.
2.1.2. Toxic trace elements.
As well as the essential and non-essential trace elements there is a further group 
of ‘toxic’ trace elements. The definition of a toxic element is complicated as elements 
which are essential to everyday life can also be deemed toxic when they are either too 
high or too low in concentration. This can change elements such as iron, iodine and 
copper from being essential under normal conditions, into toxic elements and categorise 
them with lead, cadmium and mercury which have potentially toxic properties at even the 
lowest concentrations. Mercury is toxic in its own right as even at relatively low 
concentration it can cause toxic effects and is known to cause dementia [Ted82]. This is
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of prime concern as the amount of mercury fillings used in dentistry is on the increase. 
Other such elements derive from the contamination of the air, water supply and foods 
from our increasing urbanisation leading to poor agricultural and industrial practices and 
increases in the use of oil based transport. These practices have a disastrous effect on the 
long-term welfare of human and animal populations. An example of essential elements 
that are known to have a toxic/detrimental effect at high or low concentrations are, iron, 
iodine and copper. Iron deficiency causes anaemia and iodine is associated with goitre 
[Hey84], Copper deficiency results in Menke’s disease and in turn can lead to the 
degeneration of the axons and lead to multiple sclerosis [Wag99], But it must always be 
remembered that ‘safe’ dietary levels of these potentially toxic trace elements also exist. 
The required concentration of an element for ‘normal’ function can also vary depending 
on the extent to which other elements that affect their absorption and retention are 
present. These considerations apply to all the trace elements to varying degrees but some 
have more affect than others. Copper is particularly affected by the relative intake of 
molybdenum and sulphur, or of zinc and iron, which can lead to signs of either copper 
deficiency, or of copper toxicity [Sut66]. As techniques in trace element analysis improve 
many elements once regarded as only toxic have now been found to have essential roles 
at very low concentrations. Some of these elements being arsenic, lead and cadmium 
[Mer93]. Therefore care has to be taken when the term toxic is used to describe 
particular trace elements. When a trace element is ingested or inhaled at a sufficiently 
high level, above the ‘normal’ level, it can lead to the element having a toxic effect.
Bowen [Bow66] presented this graphically with a dose response curve shown in 
figure 2.1 with the plateau showing the region of homeostatic control of an element. This 
graph can be complicated, as each element cannot be considered on its own but as part 
of a system. This is due to the positive and negative interactions of the elements, i.e. one 
element can increase or decrease the absorption of another, and deficient elements may 
be compensated for by other elements being used in a similar process. Graphically this 
would shift the curve either up or down the scale as indicated or even broaden or narrow 
the curve.
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The characteristic concentrations and functional forms of trace elements must be 
maintained within narrow limits if the functional and structural integrity of the tissues is 
to remain and the growth and health of animals and humans are to remain unimpaired. 
Continued unbalanced intake of a particular* element will lead to changes in function and 
concentration within the body depending on deficiency, toxicity, age and sex.
CO
00
Concentration
Figure 2. 1: Dose response curve. The arrows represent how the curve 
can shift depending on other elements concentrations.
2.2. The blood brain barrier.
The main transfer route for trace elements to enter the brain is through the blood 
brain barrier (BBB). There aie other methods of entry such as through the olfactory 
pathway where inhaled air passes the olfactory bulb which is an area shown to be 
severely affected in AD [Mes98]. Elemental imbalances have also been observed between 
‘normal’ and AD subjects olfactory bulbs [Sam95]. Pathological hallmarks related 
typically to AD are found in the olfactory bulb, these being the senile plaques and 
neurofibrillai-y tangles. The degradation of neurons in this area results in a diminishing 
response to smells in the early stages of AD. The BBB itself, the major route for trace
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elements entering the brain, is formed by the astrocytes, a type of glial cell which prevent 
many substances which are present in the blood from penetrating into the brain. The 
brain is approximately two percent of the total human body weight but receives sixteen 
percent of the blood supply. The brain also receives ten times as much blood as muscle 
tissue so the bander must be inherently strong to prevent many substances from passing 
through in spite of such a rich blood supply.
The blood brain barrier exists because many natural substances are poisonous as 
they interfere with neuron activity even though they may not harm other types of cells. 
The barrier prevents these toxic elements entering the brain [Tho85]. Figure 2.2 shows 
the presumed structure of the BBB [Jul81]. The astrocytes send out processes that form 
‘feet’ on the outside or brain side of the blood vessels and capillaries. These form a 
continuous sheath surrounding all the blood vessels in the brain. The sheath of astrocyte 
contains a fatty material so that any substance that is fat resistant, i.e. not soluble in fat, 
will have difficulty trying to pass through the barrier [Tho85]. Many potentially harmful 
substances are not fat-soluble and are thus prevented from entering the brain but others 
such as organic mercury compounds which are fat soluble can [Lan99].
Blood vessel '  ^
iGHalfootBrain
(neurons)
Brain \ (neurons)
Cells of capillary ivnll
Red blood cells
Figure 2. 2: Schematic diagram of the blood-brain barrier.
(not to scale)
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2.3. Structure and function of the brain.
The brain controls functions in the whole body, thinking, remembering, moving, 
speaking, personality, moods, and the senses. We are able to achieve all these functions 
because of complex chemical processes that take place in the brain. The brain also 
regulates body functions that occur without our knowledge or direction such as 
breathing. The human brain is made up of billions of nerve cells called neurons (figure 
2.3) which share information with one another through a large array of biological and 
chemical signals. Each type of neuron has a cell body, an axon, and dendrites. The 
nucleus controls the cell’s activities and contains deoxyribonucleic acid (DNA). The 
axon, which extends from the cell body, sends messages to other neurons. Dendrites 
receive messages from axons of other nerve cells or from specialised sense organs.
i. Multipolar intemeurons 
-Dendrite
ii. Motor neuron 
Dendrite
Cell bod\
Cell body r.I I
iii. Sensory neuron
^ R e c e p t^
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Myelin
sheaths
terminals Muscle
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Cell body
Central
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direction of impulse 
conduction in
Figure 2. 3: Images of the different types of neuron found in the brain.
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Neurons communicate with other neurons and sense organs by producing and 
releasing chemicals called neurotransmitters. When a nerve impulse reaches the end of 
the neuron the signal triggers the release of a neurotransmitter. Certain amino acids, 
dopamine, serotonin and acetylcholine are well known neurotransmitters, the latter is 
discussed further with respect to histopathologicai hallmarks in AD (section 2.4.3.2). 
These chemicals carry messages from the axons of nerve cells across the synapse (the 
gap between nerve cells) to the dendrites of other neurons. Groups of neurons in the 
brain have certain jobs. For example, the cerebral cortex is a large mass of neurons 
involved in thinking, learning, remembering, and planning.
Nerve cell activities are related to three basic systems, communicating 
infoimation, using energy, and repairing cells and tissues. The first system, 
communication between nerve cells has been described. The loss or absence of any of 
several chemical messengers disrupts cell-to-ceU communication and interferes with 
normal brain function. The second system, metabolism, refers to how cells and molecules 
break down chemicals and nutrients into energy. The metabolism in nerve cells needs 
blood circulation to supply the cells with important nutrients, such as oxygen and 
glucose. Biological energy, adenosine triphosphate, can only be produced in the brain by 
neurons metabolising glucose and so is the only source of energy available. Proteins and 
carbohydrates which aie metabolised by other tissues and in the body cannot take the 
place of glucose in the brain. As such depriving the brain of glucose will result in the 
immediate death of nerve cells. The third system repairs and ‘cleans up’ the nerve cells. 
Unlike most other body cells, neurons live a long time and when neurons die they 
generally cannot be replaced, so neurons constantly maintain themselves. If cell cleanup 
and repair slow down or stop for any reason the cell wül stop functioning properly. 
Damage seen in Alzheimer’s disease involves changes in all three of the aforementioned 
systems [Met88].
The brain itself can be physically divided into three major regions as shown in 
figure 2.4, these are the brain stem, cerebrum and the cerebellum. The cerebrum is by far 
the largest region of the brain. It is separated into two hemispheres (not necessarily of
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equal size) and is made up of grey and white matter and underlying nuclei. The outer 
layer is grey and is composed of neuron cell bodies and makes up the cortex and the 
subcortical nuclei. The inner layer is white and is composed of myelin covered axons 
connecting the regions of grey matter, the colour coming from the myelin sheaths. In the 
centre of the brain is the limbic system, this includes within it the hippocampus. 
Memories, one of the major functions affected by AD, which are not lost in the first few 
seconds are believed to be held in the working memory located in the frontal lobe 
[Swa95]. Figure 2.5 shows the regions of the brain associated with different tasks.
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Figure 2. 4: Major cortical regions of the brain
/Smtsafjo]
/  /  
Feelmgs-  J y X
' 'S p e e u li  S . ^ /  V b ion
hfciurtnx
Balance
Figure 2. 5: Tasks within the brain
It is believed that memories are only transferred to the long term memory, a 
function associated with the cerebellum [Blo95], if they are practised. The region 
believed to be responsible for learning and putting memories into storage is the 
hippocampus [Mos95]. Rolle [Rol95] also states that for visual learning, memories can 
be placed immediately in the long-term storage in the temporal cortex. The temporal lobe 
is primary speech and language area, and the occipital lobe is the primary visual region. 
The cerebellum is involved in sensory-motor co-ordination, the thalamus processes visual 
and somatic sensory information the later coming from the somatosensory region
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[Mim99]. The parietal lobe is connected with verbal working memory [Jon98] 
Interestingly these areas have all been found to be affected to a varying degree in AD.
The two different hemispheres of the brain also perform different functions. The 
right hemisphere being primarily concerned with non-verbal skills, left field of view and 
the left side of the body. The left hemisphere controls verbal skills, right field of view and 
the right side of the body.
2.4. Alzheimer diseased brain.
In 1906 a German neurologist, Alois Alzheimer, reported what was then 
recognised as a new kind of disease [AIz06]. He had noticed a few years earlier that a 
51-year-old woman had become ill with symptoms never seen before. As the illness 
progressed the woman’s symptoms grew resulting in a loss of intellectual function, 
thinking, remembering and reasoning, so severe that it interfered with her daily 
functioning and eventually resulted in her death. At post-mortem the brain was found to 
be atrophic and when sections of the cortex were treated in a silver-based stain solution 
neurons containing tangled strands or fibrils were found. The proteins associated with 
the plaques and tangles react with the silver stain solution reducing it to metallic silver 
which is then deposited in and around the hallmarks. In some cases this method showed 
the neurons had been completely replaced by the tangles. Additionally to the fibril 
tangles, Alzheimer also found deposits of silver-stained masses of an unknown material 
throughout the cortex. The silver-stain technique is stiU used to determine AD today. 
Alzheimer defined AD as referring to pre-senile dementia, i.e. before the age of 65. 
People over 65 with AD ai'e referred to as having senile dementia of the Alzheimer type 
(SDAT). AD patients examined here were of the sporadic form, that is to say no family 
history of AD.
Alzheimer’s disease is characterised by certain behavioural symptoms. These 
include increasing memory impairment, perception disorder, bouts of jealousy, violent 
reactions to everyday events and incontinence. In summaiy three stages of severity have 
been described. Firstly, memory disorder, secondly, more obvious cognitive impairment
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with focal symptoms of apraxia, aphasia and agnosia, finally, the inability of the patient 
to care for themselves. By autopsy the AD brain has been found to be generally 
atrophied with the frontal and temporal lobes showing the most wasting away [Mou98]. 
In AD, communication between nerve cells breaks down and this causes nerve cells to 
stop functioning, lose connections with other nerve cells which ultimately results in their 
death. AD destroys neurons in parts of the brain controlling memory, especially the 
hippocampus wliich helps code memories. As nerve cells in the hippocampus break 
down, short-term memory fails, and often the ability to do familiar tasks begins to decline 
as well. AD also attacks the cerebral cortex (the outer layer of the brain) which controls 
thinking. The greatest damage occurs in areas of the cerebral cortex responsible for 
language and reasoning. In different families, with different mutations of AD, different 
clinical features are seen showing the heterogeneity of the disease [Ken94],
The major histological hallmarks of AD are the senile plaques and neurofibrillary tangles 
while less prominent ones are the dystrophic neurites, neurophil threads and finally 
granulovacuolar degeneration. All of these features are characteristic of the chronic 
degeneration of neurons. These changes are particularly evident in the hippocampus and 
regions of the cerebral cortex already described. The formation of senile neuritic plaques 
and neurofibrillary tangles are the only way of formally diagnosing Alzheimer’s disease 
and as such it can only be accurately identified after death at post-mortem.
2.4.1. Hallmarks of the Alzheimer diseased hrain.
Several elements are thought to be involved in Alzheimer’s disease including Al, 
Cd, Hg and Pb as neurotoxins [Lim98]. Cu, Zn and Mn with reference to their role in the 
superoxide dimutase antioxidants, CuZn-SOD and Mn-SOD. Se, again for its antioxidant 
properties and Fe for leading to excess free radical production. How these elements 
affect the brain is complicated due to the heterogeneity of AD. Sporadic and familial AD 
displaying disease heterogeneity and the latter genetic heterogeneity [Ken94]. In familial 
AD the chromosomes 1, 14, 19, 21 and more recently 12 have been attributed to the 
cause of the dementia although defects in these chromosomes have been detected in
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some sporadic cases also. Chromosome 1 has shown a particular mutation of the STM2 
gene in three families with early onset AD [Man97]. Chromosome 14 is seen to result in 
a mutated S I82 gene develop leading to an onset of AD at between 30 and 55 years 
[Man96]. Chromosome 19 is attributed to the e4 allele of apoUproprotein E (Apo-E). 
Research has shown that e4 allele variations correlate well with risk of Alzheimer’s 
disease. [Lan96]. Chromosome 21 is associated with the amyloid precursor protein 
(APP). People with an abnormal APP gene on this chromosome usually begin to develop 
Alzheimer’s disease between age 40 and 65. Additionally, people with Down syndrome 
have an extra copy of chromosome 21 and so an extra APP gene. This results in Down 
syndrome subjects developing Alzheimer’s disease later on in life. Chromosome 12 is 
associated with late onset familial AD again involving Apo-E [Wu98]. These proteins 
win be discussed in future sections.
Positron emission tomography studies have shown evidence for the disease 
heterogeneity as seen in the chromosomes. Generally in Alzheimer’s, hypometabolism is 
seen to affect the parietal, temporal and frontal lobes of the cortex with the cerebellum, 
motor cortex and basal ganglia relatively unchanged. This pattern was seen to be 
changed when looking at different gene linked AD [Ken94]. One interesting observation 
in Kennedy’s work was the discovery of left hemisphere vulnerability in early onset 
familial Alzheimer cases. Differences have also been discovered between sexes with 
research showing more damage in the female brain than the male [SawOO].
2.4.2. Senile neuritic (amyloid) plaques.
In AD, plaques develop in areas of the brain related to memory. They consist of 
an ill-defined mass of abnormal unmyelinated neuronal processes with degenerating 
dendritic processes, abnormal axon terminals and enlarged synaptic endings. Senile 
plaques are extracellular regions of amyloid protein deposits from 5 to lOOfxm in 
diameter and are associated with cell death. Histochemical methods have shown that 
senile plaques display an increase in the activity of certain enzymes and electron 
microscopic studies have revealed that there is an increase in the numbers of
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mitochondria present. The development of plaques is not confined to neurons that 
respond to specific neuro transmitters, they form in neurons of many types. One notable 
exception to this increase in activity of enzymes is monoamine oxidase (MAO). This is 
intriguing since this is the one enzyme that shows an identifiable increase in the ‘normal’ 
ageing brain [OU92] and emphasises the fact that Alzheimer’s disease is not simply a 
speeded up form of the ‘normal’ ageing process. Although a small number of senile 
neuritic plaques are seen in normal ageing.
2.4.2.I. p-Amyloid.
p-Amyloid is the major component of plaques though researchers do not know 
whether amyloid plaques cause AD or result from it. Plaques are associated with cell 
death and there is evidence to believe that p-amyloid is cytotoxic [Beh92], another idea 
being that p-amyloid causes cell death due to the presence of an excessive amount of free 
radicals, p-amyloid is a protein fragment, produced during metabolism, from the larger 
amyloid precursor protein (APP) where chromosome 21 is known to hold the gene 
responsible for its production. The evidence that changes in APP levels produces a 
variation in brain function and that the amount of APP is high in the brain implies an 
important role for APP.
APP is a member of a larger gene family of proteins that make up cell 
membranes. A cell membrane is a layer that encloses the cell and lets substances go in 
and out of the cell. During metabolism APP moves through the membrane of the nerve 
cell, part inside the cell and part outside, where it is then replaced by new APP molecules 
being made in the cell. While APP is embedded in the ceU membrane, enzymes called 
pro tease’s split APP in two. p-amyloid is made only when the splitting occurs at a certain 
point on APP. It is then known to join with other p-amyloid filaments and fragments of 
dead and dying dendrites to form the dense plaques that are a hallmark of AD. There is 
an added complication with the APP, in that there exist different mutations (phenotypes) 
of this precursor protein, APPvai-iie, APPvai-giy. These mutations involve the substitution in 
APP of valine to isoleucine at codon 717, and valine to glycine respectively. In different
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families these phenotypes have been shown to exliibit different clinical features and so to 
the heterogeneity of AD [Ken94]. It has been suggested that APP mutations lead to 
altered APP metabolism which presumably increase the production of the p-amyloid 
peptide and so increase the number of plaques [Lip99].
The lipoprotein receptor (LPR) is responsible for processing released APP, and it 
is the major Apo-E (section 2.4.2.2) receptor in the central nervous system. Lipoproteins 
are proteins that help carry fats and fat-like substances in the blood. Both Apo-E and its 
receptor LPR are associated with amyloid plaques in AD. The LPR receptor processes at 
least seven different molecules, including Apo-E, that build up in amyloid plaques. 
Because several proteins bind to |3-amyloid including Apo-E and ACT (alpha 1- 
antichymotrypsin), the discovery of the role of these proteins in binding (3-amyloid may 
explain why and how AD develops. Several studies have centred on how (3-amyloid is 
processed and how enzymes break down APP [Lit97]. One form of a protein called 
apolipoprotein-E (Apo-E) may play a role in keeping P-amyloid in solution. Other areas 
of research centre on how p-amyloid affects neurons, one study showed how neurons 
from the hippocampal area of the brain died when P-amyloid was added to the cell 
culture [Sis95], This suggests that p-amyloid breaks into fi-agments releasing free 
radicals that attack neurons. How P-amyloid causes nerve cell death remains unsolved, 
however one idea [Yal98] describes how P-amyloid forms small channels in nerve cell 
membranes, these channels may allow excess calcium to enter the nerve cell which then 
kin the cell. Links between P-amyloid and reduced choline levels in nerve ceUs suggests a 
relation between P-amyloid and acetylcholine. Choline is a major component of the 
neurotransmitter acetylcholine. Finally, head injuries have been shown to lead to p- 
amyloid deposition which researchers believe may be a common response to neuronal 
injury [Rob91]. Some researches have linked head injury to an increased chance of 
developing AD [Gra90, Ged89] although others have found little connection [Sab97].
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2.4.2.2, Apolipoprotein-E (Apo-E).
Apolipoprotein-E is a major phospholipid with the gene responsible for the 
production of Apo-E located on chromosome 19, The main function of Apo-E is to 
redistribute lipids, especially cholesterol, within and between different organs. 
Cholesterol is required for the repair, growth and maintenance of myelin and axonal 
membranes during and after any injury. Apo-E is found in neurons of healthy brains and 
is associated with the plaques and neurofibrillary tangles in AD brains [Nam91]. Every 
person has two Apo-E genes, one inherited from each parent. AD researchers are 
interested in thi'ee versions of this gene, Apo-E2, Apo-E3 and Apo-E4.
The relatively rare Apo-E2 may protect some people against the disease as it 
appears to be associated with a lower risk for AD and an increased age of onset. Apo-E3 
is the most common version found in the general population and at the present time it is 
believed to play a neutral role in AD [Pir96]. Apo-E4, which is produced by the gene 
allele e4, has been found to be up to four times more abundant in Alzheimer diseased 
brains than in ‘normals’ [MRC93]. Although researchers disagree about the exact 
number, some scientists believe that Apo-E4 allele is present in just under one-third of 
adults affected by AD [Gol93]. In addition, people who carry two copies of Apo-E4 are 
more likely to get AD than those with one copy of Apo-E4 [Giu98]. How Apo-E4 
increases a subjects susceptibility to AD is not yet known. Apo-E4 may increase deposits 
of P-amyloid and regulate APP or in some unknown way, Apo-E4 may speed up the AD 
process. Apo-E4 also appears to lower the age of onset of AD. However, the presence 
of Apo-E4 in a blood sample cannot predict AD. A person can have Apo-E4 and not get 
the disease, and a person can develop AD without having Apo-E4, again showing the 
disease’s heterogeneity.
2.4.2.2.a. Alphal-antichymotrypsin (ACT).
ACT is a protein that binds to P-amyloid in the brain and is found in increased 
levels in the blood of AD patients. People who inherit two copies of the ACT gene which 
exists in two forms, ACT-A and ACT-T are more likely to develop AD. People with
D. A. Cutts 20
Investigation into Brain Function: 2. The ‘Normal’ and AD brain:
double copies of Apo-E4 and ACT-T appear to have a slightly lowered risk of 
developing AD supporting the theory that AD results from the interaction of multiple 
genes. Production of ACT can be started by a substance normally found in the brain, 
called interleukin-1, a protein associated with inflammatory processes. Anti-inflammatory 
drugs are often used in the treatment of AD.
2.4.3. Neurofibrillary tangles.
The neurofibrillary tangles (NET) seen in Alzheimer brain tissue are made up of 
many closely packed neurofilaments that displace other cytoplasmic organelles within 
neurons. The severity of the dementia correlates positively with the density of NTT’s in 
the neocortex [Bie95]. The individual neurofilaments are generally tubulai* in structure, 
thick helically wound pairs of fibres formed within nerve cells, and vary from 10 to 20nm 
in diameter. The twisted fibre tangles of neurofilaments inside neurons leads to the 
deterioration of neuron dendrites and hence loss of neurons as shown in figure 2.6. 
Unlike senile plaques, neurofibrillary tangles show a marked lack of enzyme activity so 
suggesting evidence for separate, though unknown, causes of these two hallmarks of 
AD. The chief component of tangles is the tau protein. These tangles are the remains of 
the neurons microtubules, the ceUs internal support structures. In healthy neurons, 
micro tubules are formed as parallel fibres.
Neurons guide nutrients fi‘om the bodies of the ceUs down the ends of the axons 
but in cells affected by AD these structures collapse. The tau protein normally forms the 
ties of the micro tubules but in AD it twists into paired helical filaments as previously 
described. These filaments are the major component of neurofibrillary tangles. No one 
has yet discovered why the microtubules collapse, but one theory suggests that the 
presence of Apo-E4 can contribute to this collapse. The collapse of nerve cell supports 
may result in the breakdown of communication between nerve cells and eventually cause 
neurons to die. A small number of neurofibrillai*y tangles are seen in normal ageing.
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Dendrites
Axon
Cell
Figure 2. 6: Progression of senile changes seen in pyramidal multipolar-type neurons in AD. 
Dendrites are progressively lost and the cell body shrinks.
2.4.3.I. Tau protein.
The tau protein, as described, is present in neurofibrillary tangles and in the 
peripheral and central nervous system within nerve cells and more specifically in axons 
[Bin85]. Tau protein forms a major component of the neurofibrillary tangles [Lee91] and 
may be their only component. The tau protein in AD has a high rate of phosphorylation 
associated with it, which is the mechanism by which cells make energy i.e. metabolism 
[Lee96]. Specific enzymes are thought to be involved in tau processing, which with the 
onslaught of AD become inactive enabling abnormal protein processing residues to build 
up in paired helical filament tau.
Researchers also found that AD patients had increased levels of tau in 
cerebrospinal fluid at the earliest stages of AD when compared to healthy volunteers and 
patients with other neurological disorders [Ara98]. A similar report examined the 
cerebrospinal fluid of 22 AD patients with 19 healthy volunteers for tau levels [Rie96]. 
AD patients had higher tau levels during the early stages of the disease than the healthy 
volunteers. Levels of tau did not increase or decrease as AD patient’s dementia 
worsened suggesting that in AD tau may reach a critical level early in the disease.
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2.4.3.2. Acetylcholine (ACH).
Acetylcholine is the neurotransmitter chemical at the neuromuscular junctions 
between motor neurons and skeletal muscle fibres. It is synthesised by the enzyme 
choline acetyltransferase (CAT). ACH activates the muscle fibre receptors and is in turn 
broken down by an enzyme, 'acetylcholinesterase (ACHE), back into its two simple 
chemical constituents, acetyl and choline. Both enzymes have been found to be reduced 
in AD patients in areas associated with neurofibrillary tangles [Dav76], a link has also 
been suggested with P-amyloid. The nucleus basalis at the base of the forebrain which 
projects to the cerebral cortex and hippocampus, also utilises ACH as a neurotransmitter. 
It has been found that in AD there is a massive loss of cells in the nucleus basalis which 
contains ACH neurons projecting to the cerebral cortex and much lower levels of certain 
chemicals associated with the ACH system. A lack of ACH leads to an impaired memory 
while if ACHE is blocked there will be more ACH. Both acetyl and ACH contain the 
trace element sulphur a decrease in concentration of which may suggest a lack of ACH 
and so memory loss which is associated with AD.
2.4.4. Granulovacuolor degeneration.
In the hippocampus small vacuoles or holes have been observed in the cytoplasm 
of the neuron, an effect which is called granulovacuolar degeneration. The vacuoles are 
up to 5)xm in diameter, each containing a small granule some 0.5-1.5|0.m across.
2.4.5. Dystrophic neurites.
Morphological alterations seen in neuronal processes passing through senile 
neuritic plaques are associated with accumulation of amyloid precursor protein (APP) 
and the accumulation of tau which produces the dystrophic neurites (DNs) [Mas93]. As 
in neurofibrillary tangles, paired helical fibres (PHFs) are the dominant filamentous 
element in DNs. These abnormal neurites are characteristically found with PHFs in AD 
although both are found in the normal aged and AD brain without PHFs [Ter94]. In AD
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the PHFs and are closely correlated with the number of tau immunoreactive DNs. The 
axonal origin of DNs could be due to abnormal growth activity causing abnormal 
development [Mas91] which could lead to failure to establish synapses with other 
neuronal dendrites and consequently degenerate at which point abnormal cytoskeletal 
proteins begin to accumulate [Mas93]. Due to their association with senile neuritic 
plaques the DNs show a distribution similar to plaques in AD. McKee [McK91] reported 
that non-demented, aged individuals do not show tau positive DNs in the neocortical 
neuropil or in senile plaques.
2,4.6. Neuropil threads.
Neuropil threads (NTs) consist of fragmented and twisted fibres and are a 
neuropathological feature associated with AD. NT’s form within axons, presynaptic 
terminals and dendrites. Unlike DNs, NTs are independent of plaques but are often 
associated with NFTs. NTs occur in distinct patches within the cortex that contain NFTs 
but no senile plaques [Sch91]. NTs could be a result of abnormal regenerative responses 
leading to an abnormal growth in neuronal processes as they contain growth associated 
proteins [Mas91]. Immunocytochemical techniques have shown that NTs appear to be 
composed of PHFs which contain tau and ubiquitin [Ter94].
2.4.7. Free radicals.
Free radicals are elements which have one or more unpaired electrons and usually 
appear as by-products from specific processes. Free radicals can cause major damage in 
biological matter. The brain requires a high quantity of oxygen duiing metabolism and so 
any oxygen derived free radicals present can cause major damage within brain tissue. In 
‘normals’ the catalyst which helps convert the oxygen free radical Oa'» to O2 is the 
superoxide dimutase (SOD), the importance of SOD has already been discussed in this 
chapter. Another free radical involved in the same respiration mechanism is 0H«. This is 
toxic due to its role in lipid peroxidation which is more likely to damage cell membranes
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due to the polyunsaturated fatty acid present in them. OH* is also toxic due to its ability 
to produce protein free radicals which lead to protein destruction, this can be eliminated 
in the respiration reaction by the catalysts peroxidase and catalyse. Other antioxidants 
used in the protection from free radicals are vitamin E and C and glutathione-Px which 
contains selenium. The normal ageing process produces an increase in the amount of free 
radicals in the brain but a decrease in the ability to fight against them, this will lead to 
cellulai" damage [Smi95]. Non-steroidal anti-inflammatory drugs such as ibuprofen have 
been found to reduce the risk of developing Alzheimer’s disease [Ste97]. It is believed 
that anti inflammatory drugs my act as antioxidants, eliminating free radicals.
2.4.8. Other risk factors.
It had been noted that smokers have a lower risk of getting AD than non-smokers 
but new research [DolOO, BraOO] shows this is not the case and may even increase risk. 
Similarly another study describes how smoking increases the chance of developing AD 
but after its onset smoking improves the learning skiUs although not memory [Ott98]. 
Amongst the bizarre risk factors which researches claim to have found is that of the head 
size of a person [Gra96]. People with a smaller than average head circumference show a 
rapid deterioration in AD while a larger head size .results in a slower deterioration. A 
more controversial factor is that of educational status [Sma95] whereby people with 
poor mental ability are more prone to develop the disease. Aluminium has been very 
much in the public eye over recent years with scares over its use in the water supply 
though at present no essential role is known for this element in the brain. Work suggests 
that there may be a local increase in Al around plaques and tangles in AD [Tok95] 
although some researches dispute this [Mak98]. More research has to be carried out as it 
is not known if Al is a cause or an effect of AD. One pathway in which Al may get into 
the brain is through the olfactory pathway. Inhaled air will pass straight into the olfactory 
bulb. It is known that olfactory areas are badly damaged by AD and contains a large 
amount of Al and along with a high number of plaques and tangles [Rez87]. Lead is the
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latest metal to be implemented in the onset of AD [KosOO] with research concluding that 
workers exposed to lead have an increase chance of developing AD later on in life.
2.5. Conclusions.
Clearly there are many proposed causes of AD along with many phenotypes of 
the disease due to genetic variation. The number of possible permutations with respect to 
brain function and regions of the brain is almost endless. This is reflected in the fact that 
in the first 4 months of 2000, over eight hundred papers have been published examining 
many different chai*acteristics of AD. With the field of research as large and as varied as 
it is, a definite research path has to be chosen so results do not become confused and 
meaningless. Most research is performed on familial cases of AD which as discussed 
have unique chai*acteristics in terms of onset and cause. In research presented here 
sporadic cases were chosen where ‘sporadic’ is defined as a subject having no family 
history of AD, and/or any other neuro-degenerative disease. It is not known why 
sporadics develop the disease so care has to be taken to eliminate problems caused by the 
genetic variations of familial cases where one or a combination of genes maybe the cause 
of dementia. Familial subjects would ‘contaminate’ data and remove the chance of 
detecting elemental changes associated with sudden onset of AD.
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3. Analytical techniques.
3.1. Proton induced x-ray emission analysis.
3.1.1. Introduction.
Proton induced x-ray emission (FIXE) analysis is a technique employed to 
identify elements which exist in minor or trace amounts within a particular sample. In this 
procedure a high energy ion beam of the order of 2 MeV, impinges on a target material, 
this ejects electrons by excitation from the inner shell of the target material leaving 
behind ‘holes’ in the electron shell configuration. These vacancies are then filled by outer 
shell electrons falling into them by de-excitation. It is during this de-excitation transition, 
fluorescence, of the electron that the x-rays are emitted (figure3.1).
X-ray
Proton
Figure 3 .1 : Schematic of Proton induced x-ray emission (Kai).
The probability that de-excitation will result in the emission of x-rays is termed 
fluorescence yield and the probability that the inner shell will be ionised leaving a 
vacancy is the ionisation cross-section. The calculations for the yield and cross-section
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can become difficult as the effect of Auger and Coster-Kronig transitions need to be 
taken into account. The Auger electron can occur with the de-excitation of the outer 
electron, the same process as in the x-ray emission. The energy of an Auger electron is 
equal to the energy difference between the two electron states minus the binding energy 
of the Auger electron. For shells other than the K-shell, Coster-Kronig transitions can 
also occur, this is due to the transition of electrons between subshells of the same 
principal shell.
Just considering the x-ray transition, the outer electron shell is at a higher energy 
state than that of the inner shell the x-ray will have an energy equal to the difference 
between them. The x-rays from such a transition are called ‘K x-rays’ as the transition 
has filled vacancies in the innermost K-shell. Similarly for the next innermost shell ‘L x- 
rays’. A subscript is added to show which outer shell the electron has fallen from, i.e., K* 
lines represent the L to K shell transition. Alpha and beta transitions are shown in figure
3.2. . The transition shown in figure 3.1 (schematic) is that of Kai,resulting in a K x-ray.
Due to the unique configuration of electrons for different elements it follows that
-N-shell
-M-shell
-L-shell
-K-shell
Figure 3. 2: Electron transitions producing K x-rays
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the x-ray emission for each element will be unique. It is also true that the intensity of the 
x-rays produced are a measure of the concentration of the element being used as a target. 
Hence PIXE analysis allows us to determine the trace elemental composition of materials 
of interest.
FIXE analysis has a number of advantages over its electron excitation 
counterpart the first being demonstrated by Birks [Bir64]. Birks showed that excitation 
due to incoming protons was preferable to that of electrons due to the inherently low 
background produced by the protons. The reason for this being electrons exhibit strong 
inelastic interaction therefore produce an intense continuous background, whilst protons 
exhibit little inelastic interaction the background being mainly due to electronic noise and 
environmental radiation. The inelastic interaction is caused by the electron being 
decelerated by the nuclear chai'ge of the target atom, this effect is called bremsstrahlung 
or braking radiation. As a result of the relatively small breaking radiation of the proton, 
the limit of detection is decreased with the peaks no longer hidden within the background 
allowing a greater number of elements to be detected. The relatively low background 
produced by PIXE gives it superiority over techniques such as radiochemical neutron 
activation analysis which may need chemical separation of the target material for a 
similar standard of result. The process of chemical separation can also provide the added 
risk of contamination that is not seen in PIXE work. The technique also makes it possible 
to obtain data from very small samples which is advantageous in research where, for 
example, biopsies from subjects are used and where only small samples are available. 
Though the technique has a non-destructive nature on a macroscopic scale however, it 
has been shown to have a destructive effect on a microscopic scale [Ars91]. Any damage 
by excessive heating can be removed by making the aperture of the proton beam as large 
as possible and making the samples relatively thin so heat will disperse easily.
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3.1.2. Cross-sections and fluorescence yield.
The probability that an inner shell of an atom will undergo ionisation thereby 
leaving a vacancy is called ionisation cross-section. The probability that an inner shell of 
an atom will undergo ionisation and produce x-ray emission is called x-ray production 
cross-section. These two variables are related by the fluorescence yield such that;
^ x -C ^ k ^ i  (3-1)
Where: = x-ray production cross-section.
(Ok = K-shell fluorescence yield.
Gi = ionisation cross-section.
The technique used to calculate ionisation cross-sections in the work here is 
based on the Plane Wave Bom Approximation (PWBA) [Mez58] modified by Brant 
[BraSl]. This model takes into account velocity change due to the coulomb field along 
with its deflection, energy loss during collision and relativistic effects. The analysis 
package utilised a model based on Brants work compiled by Cohen [Coh85].
The probability that de-excitation will result in the emission of x-rays is called 
fluorescence yield. Calculations for fluorescence yield become more difficult with 
increasing shell number but for the inner K-shell the relation is given by [Joh88]:
— ^  (3.2)
, i=0
Where: (Ok = K-shell fluorescence yield,
Z = atomic number.
B =  coefficients used to calculate fluorescence yield [Joh88].
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For the L-shell the equation is fundamentally the same with cqt replaced with 
07^  (equation 3.3) due to the added complications of foster-|aonig transitions between 
subshells.
_  _ X(L1) + X(L2) + X(L3)(i)^ —
71, + 71, + 71. (3. 3)
Where: X(Lo)
Uo
x-ray yield for Lo shell.
fractional number of vacancies in the oth sub-shell.
X(Li) = 71iO), (3.4)
X (Lj ) = (71, + /i^ni )û>2 (3. 5)
X (Z/3 ) — (713 + f 27, 2^ I f  13 f  I l f 23 ] ^ 1  ) ^ 3  (3* 6)
Where ‘Ho’ is the fraction of vacancies in the sub-shell ‘o’ where the sum over all sub­
shells is equal to 1, and ‘/o / is equal to the Coster-Kronig probability of transfer between 
subs-hells ‘o’ and y .  Figure 3.3 shows fluorescence yields for elements that exist in 
biological systems, which have an atomic mass of the order 20-35, are dominated by K 
shell transitions so simplifying resulting spectra.
1.0
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K Shell 
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Figure 3. 3; K and L shell fluorescence yields with atomic number [Ste96].
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3.1.3. X-ray attenuation and proton stopping power.
For accurate analysis of any sample the attenuation coefficient of the x-rays and 
the stopping power of the protons must be calculated. Protons lose energy in inelastic 
collisions with electrons in the target sample with the amount of energy lost dependant 
on the structure and density of the target sample. The measure for energy loss for the 
proton is the linear stopping power which is defined as the amount of energy lost 
travelling through the sample. The mass stopping power is simply the linear stopping 
power divided by the density of the target sample:
5(£ ) = i f E  (3.7)
p œc
Where: p  = density of sample.
dE  = change in energy over distance dx.
For x-rays, the mass attenuation coefficient is calculated by:
(3. 8)(=1
Where: i = f th  element of the sample matrix.
p  = mass attenuation coefficient.
w  = relative proportion by weight of element.
3.1.4, PIXE Spectra and background radiation.
The resulting spectrum produced by PIXE analysis has two main constituent 
parts shown in figure 3.4. One being the continuous background of the electromagnetic 
radiation and the other, the characteristic x-ray peaks superimposed over it. Once a x-ray
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spectrum has been plotted it is important to know the relative intensities of the individual 
x-ray peaks as the K« lines of one element can be easily confused with the Kp of another. 
Reference information, for example by Scofield [Sco74], giving relative intensities is 
available to help distinguish between ‘hard to resolve’ peaks.
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Figure 3. 4; PIXE spectrum of Bowen’s Kale reference material.
The size of the background determines the range of the detection limits; the 
larger the background is, the smaller the detection limits will be. An important measure 
in FIXE is the minimum detection limit (MDL), this is the smallest amount of the element 
being studied which must be present in that paiticular sample to give a signal significantly 
greater than the background. The detection limit is dependent on a number of factors 
including beam energy atomic number and the structure of the sample. The detection 
limit is simply defined as:
N p ^ y /N t  (3.9)
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Where: N  ~ number of counts in peak and ‘6’ background.
F  = constant where F=I is equivalent to one SD (68% confidence).
To improve sensitivity and so reduce the MDL it can be seen from equation 3.9 that:
(3.10)
Here Wp’ is equal to the smallest number of counts required in a photo peak for its 
detection. As the number of background counts is proportional to the charge build up 
from bremsstrahlung and from equation 3.14 it is seen that concentration is inversely 
proportional to charge, as such it follows that:
C«DL “  -r= L =  (3. 11)^chsigQ
Where ‘ ’ is the minimum concentration detection limit.
Clearly from equation 3.11, increasing the charge collected on the sample will 
lower detection limits and so make the detection of lower concentrations possible. 
Reducing the background of the spectrum will also lead to an increase in the number of 
peaks which can be determined above the MDL. The major contributing factor to the 
background radiation is the bremsstrahlung radiation which is produced by charged 
particles passing through matter. There are two types of bremsstrahlung, primary and 
secondary. Primary bremsstrahlung is produced as the incident proton beam passes 
through the Coulomb field of the nuclei. This produces a continuous background 
distribution which is greater for small energies. Primary bremsstrahlung is the main 
contributor to the background radiation at the high energy range of the x-ray spectra. 
Secondary bremsstrahlung is produced by the slowing down of secondary electrons in 
the target sample, this is the main source of background radiation at low energies. This 
radiation has an anisotropic distribution around an angle of 90° to the incident proton
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beam therefore the background can be minimised if the detector is placed at a backward 
angle usually at 135°. Filters can be fitted to the detectors to reduce low energy 
bremsstrahlung and high intensity x-ray peaks from lower Z elements, this improves the 
detection of the smaller peaks of the generally higher Z trace elements. For more 
localised detection combinations of filters can be added so that only the elements in the 
energy range required are seen.
There are other contributions to the background spectra, Compton scattering of 
both x-rays and gamma rays, environmental radiation, secondary electrons and charge 
build up. The Compton scattering of gamma rays is caused when nuclei gain an excited 
state from the bombardment of protons which then de-excites with the emission of a 
gamma ray. Compton scattering then takes place in the sample adding to the 
background. The process involving the emission of a gamma-ray is used in the technique 
of Particle Induced Gamma-ray Emission (PIGE) analysis. Secondary electrons can be 
suppressed by applying a positive bias to the target plate. Charge build up on samples is 
the major cause for concern especially when biological samples are being analysed as this 
leads to a charge imbalance which will ultimately discharge by emitting bremsstrahlung 
radiation. This is one reason for the samples in PIXE analysis requiring to be electrically 
conducting the other being that PIXE analysis relies on accurate charge measurement. 
The most common method used to eliminate sample charging is the application of a 
conducting element, usually carbon, onto the sample surface. But this can increase the 
risk of the sample becoming contaminated if care is not taken in its application.
3.1.5. PIXE spectrum analysis.
For concentrations to be calculated accurately and absolutely is a difficult task 
which involves many variables. This method is called ‘absolute’ analysis and is difficult 
and time consuming to perform. The x-ray yield for samples which completely stop the 
incident proton beam within its matrix, defined as ‘thick’ samples, is given by:
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Y = Aé?4;r fa,(E)F(E)
dE
S {Ë ) (3. 12)
Where: C
Nav
Q
Q
A
CTv
F(E)
concentration of element ‘Z’.
Avogadro’s number, 
total incident proton charge, 
solid angle, detector to beam spot, 
intrinsic efficiency of the detector, 
mass number of element ‘Z’. 
proton charge.
x-ray production cross-section.
x-ray attenuation in the bulk matrix of the sample.
And F  (E) = exp - F cos#. dEcosdp  i^S{E ) (3.13)
Where: F =  mass attenuation coefficient of x-ray.
6a = incident angle (normal to sample) of the proton beam.
Op = angle of emitted x-ray (normal to target).
S(E) -  mass stopping power for a proton with energy 'E \
Ep = incident proton energy.
The above equations involve many variables and thus increase the difficulty in 
obtaining accurate results. To eliminate these difficulties a ‘comparative’ method can be 
used. In the comparative analysis the x-ray spectra from a standard or reference sample 
(e.g. certified reference material) is compared to that of the unknown sample. This 
removes uncertainties in the calculation of cross sections, attenuation and detector
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efficiency which is encountered in the absolute method. To show the simplicity of the 
comparative equation 3.13 reduces to:
Where ‘C’, T  and 'Q' are the concentration, yield and charge of the ‘sa'mple and 
‘standard respectively. And the integral is given by:
/ ( £ , ) =  |< T , ( £ ) F ( £ ) ^  (3.15)
There are two types of standard which can be used, internal and external. An 
internal standard is mixed homogeneously within the sample and should contain elements 
which will not interfere with the sample. Relative concentrations can then be calculated. 
An external standai'd is separate to the sample. The use of a standard limits enors from 
the uncertainties in cross-sections, detector efficiency and attenuation coefficients. 
Additionally the internal standard removes errors in the current integration and any 
geometric errors if carried out under exactly the same irradiation and counting 
conditions. Choosing which analysis to use depends on the sample being used and the 
elements being detected. Reference materials need to be chosen so that their 
compositions ai*e matched closely to that of the sample analysed. This is so proton and x- 
ray attenuation within the sample are similar and so corrections do not have to be made. 
Though standards can be used for most elements, it is sometimes difficult to detect 
certain elements in reference materials because the element concentration lies outside of 
the detection limit. In this case the absolute method of analysis should be used. In work 
presented here comparative analysis was carried out.
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3.1.6. Computer analysis.
To determine the elemental concentrations within each sample, the PIXE package 
PIXAN was used [Cla86]. PIXAN contains data sets required for calculations of 
elemental concentrations including, *K’ and ‘L’ shell x-ray energies [Sto70] and their 
relative yields [Sal74,Coh86], cross sections [Coh85], fluorescence yields [Kra79]. 
Parameters for the calculation of mass stopping powers [And77] and attenuation 
coefficients [The67] are also included. PIXAN relies upon the x-ray spectra being made 
of Gaussian peaks, an assumption which has been examined by Stedman [Ste96], over 
continuous background spectra. The elements to be searched in the spectra are input into 
PIXAN which then looks for the energy peaks associated with the elements using fixed 
intensity ratios. A number of experimental paiameters have to be input, these are the 
energy calibration, detector resolution, filter thickness and energy range.
The background is fitted using an iterative fit which removes low energy 
curvature due to edge effects and smoothing down the peaks to background continuum 
respectively. The bulk matrix composition of a sample, C, N O in biological material is 
determined by Rutherford backscattering (RBS) analysis. This determines those elements 
which are in greatest abundance within the sample and so have greatest effect on the 
proton stopping power, attenuation and the self attenuation of x-rays. Corrections for 
these factors are then made for each sample. Additionally, PIXAN removes silicon 
escape peaks produced from the Si(Li) detector crystal before peak fitting and 
compensates for sum peaks and low energy peak tailing before peak areas are calculated 
using least square fitting. Finally the x-ray yield is calculated for the thick samples so 
solving the integral in equation 3.14.
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3.2. Rutherford backscattering.
3.2.1. Introduction.
Rutherford BackScattering (RBS) is an analytical technique which is used to 
determine the bulk matrix of a sample, this is an essential requirement for work carried 
out using PIXE. In this procedure a beam of protons impinges on a target material. 
While most of the protons will continue to travel with roughly the same energy and 
direction after passing through the sample, some will be scattered at large angles and 
reduced energy. These protons have been scattered elastically by the coulomb repulsion 
between the nuclei of the target atoms and the protons, these are known as Rutherford 
Backscattered protons (figure 3.5). The detected protons produce an energy spectrum 
characteristic to the target sample and so the spectrum can be used to determine the 
elements in the sample. The method of back scattering is important as the calculations 
used to produce the PIXE spectrum rely on accurate concentrations for the bulk matrix 
elements found using RBS. This is required to make corrections for the loss of energy of 
the protons as they pass through the sample. It also determines the attenuation of the 
characteristic x-rays, this makes the comparator method more accurate in ensuring that 
matrix differences are largely eliminated.
Incident
protonTarget
A Backscattered 
/  proton
Figure 3. 5: RBS geometry
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For thick samples the RBS spectrum is made up of a number of rectangular 
signals each rectangle representing a different element, the theoretical spectrum is shown 
in figure 3.6, The height of a RBS signal is dependent on the target elements 
concentration while its channel position is dependant on the elements mass. In the 
research here thick samples are used which causes the signal from each element to extend 
back to the zero energy line. This is due to the back-scattered protons originating from 
different points in the sample and so protons are attenuated to zero energy as they pass 
thi’ough the sample matrix. The spectrum therefore has the appearance of steps though it 
should be noted that this is not the case in all RBS spectra, i.e., using ion implanted thin 
films leads to complex spectra. The step face will not be vertical due to the detector 
resolution and solid angle, this results in a slope.
CO
Channel number
Figure 3. 6: Theoretical 2 element RBS spectrum with step 
configuration.
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3.2.2. Kinematic factor.
The kinematic factor is one of the most important factors in the analysis of RBS 
spectra. The ratio of projectile energy before and after the collision with a target nuclei is 
defined as the Kinematic factor ‘üf’ and is simply expressed as:
Where: Eo
El
K  = ^
incident proton energy (figure 3.5). 
back scattered proton energy.
(3.16)
Using the conservation of energy and momentum which assumes that the collision with 
the tai'get is totally elastic then it can be shown that:
K = I + (MI / Ml) (3.17)
Where: My, M 2,
e
mass of the projectile and target, 
backscattering angle.
Figure 3.5 shows the geometry of the collision. In the experimental work carried 
out here the detector was in a fixed position and as such is therefore fixed. As the 
mass of the incident proton, ‘M f, is also known, combining equations 3.16 and 3.17 
shows that measuring the energy of the back scattered proton will result in the 
determination of the mass of the target atom. Hence ‘M2 ’ and the element name can be 
determined. The larger the mass of the target atom, the smaller the effect on the 
projectile energy. As a result of this, when a RBS spectrum is plotted the heavier 
elements appear on the higher energy end of the spectrum and lighter elements appear at 
the lower end.
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3.2.3. Cross-sections,
The differential scattering cross-section is the probability of a backscattering 
collision occumng and being detected. To determine the absolute scattering cross- 
section this is multiplied by the detector solid angle. The differential cross-section is 
given by:
— = 1 .2 9 / ^ " ^ 'dO.
N-Î-> / .4 0c o s e c  22 (3.18)
Where: Zp 
Z,
atomic number of proton, 
atomic number of target element.
The absolute cross-section is obtained by integrating over the solid angle.
For elements with a low atomic number (Z<14), resonance reactions will occur at 
certain energies. This results in the scattering cross-section being greatly increased by 
elastic scattering. As a result elastic cross sections (ECS) are used for all elements as the 
ECS are not significantly different to Rutherford cross-sections for Z>14. To determine 
the concentrations within a sample a two element model the ratio of masses element ‘A’ 
and element ‘B’, m/n, (figure 3.6) is given by [Hol97]:
m ^ H^(7b (Eq)
n H  pCT^^Eq) (3.19)
Utilising this equation, the bulk matrix of a sample can be determined with the 
assumption that the sample is entirely composed of elements determined using RBS. 
From this information the depth to which the proton beam travels within the sample can 
be calculated using stopping powers, and also the attenuation of protons and the self 
attenuation of x-rays. It is important while using the comparative method to ensure that 
the reference standard used has the same bulk matrix as the samples. This is so that 
similar proton depth, proton and x-ray attenuation exist between samples and hence a 
similar volume analysed.
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3.3. Instrumental neutron activation analysis (INAA).
3.3.1. Introduction.
Samples for INAA are in'adiated in a research reactor which provides the high 
neutron flux required for this analytical technique. The fission of produces fast 
neutrons (E>lMeV), which are then slowed down by collisions in the reactors moderator 
(epithermal neutron region) to produce thermal neutrons (E<0.4eV). When fast and 
thermal neutrons interact with target nuclei they excite the nucleus resulting in the 
production of radionuclides, some of which maybe unstable. The radionuclides will in 
turn emit protons, alpha particles, neutrons and gamma rays depending on the neutron’s 
interaction. Delayed gamma rays, which are utilised in INAA to determine elements 
which are present in a sample, are produced when a radionuclide created by radiative 
capture is unstable. In radiative capture thermal neutrons interact and excite a target 
nuclei and form a compound nucleus which after approximately 1 0 '*'^  seconds de-excites 
by emitting a prompt characteristic gamma ray. If the resulting nucleus is unstable this 
can decay further by beta emission with a characteristic delayed gamma ray. The gamma 
rays are then detected and their discrete characteristic energies used to identify their 
parent nucleus. Equations 3.20 to 3.22 show the process of radiative capture and 
production of an unstable radionuclide. The method of radiative capture production of 
delayed gamma rays was used in analysis here.
Radiative capture.
+r(prompt)  (3. 20)
V  if unstable, decays
generaUy f  (3.21)
-Q-
*\\Y + y  {delayed) (3.22)
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The neutron transmutation reaction, which utilises fast neutrons, produces a 
charged particle when the incident neutron is captured. These reactions suffer from low 
reaction cross-sections and so are of no interest in work here except as interferences 
when detecting very low level concentrations of elements through (n,y). Of note are the 
complications caused by transmutation reactions, for example, in radiative capture in Al: 
“^ Al(nth,Y)“^ Al, suffers interference from ^‘P(nf,a)"^Al. P occurs at high concentrations in 
biological materials and therefore must be accounted or irradiation must take place in a 
highly thermalised facility.
3.3.2. Spectrum analysis.
As in PIXE, a comparative method of analysis was used in INAA which removes 
uncertainties due to reaction cross sections, branching ratios, neutron flux and detector 
efficiency. The comparative method utilises a certified reference material to eliminate the 
aforementioned factors, though problems still occur with the neutron flux as this will 
vary with width and height of a sample. A flux monitor, made out of zirconium, can be 
used to measure the changing fast and thermal neutron flux [Mae70] as its isotopes have 
relatively short half lives. Though in analysis performed in this work zirconium was not 
necessary as small samples were irradiated in sequence one at a time using comparatively 
short irradiations (i.e. no variation in flux).
Growth during 
irradiation
Decay after 
irradiation
Time
Figure 3. 7: The growth and decay rates of an
irradiated sample.
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As with PIXE and RBS the number of counts in a gamma ray energy peak are a 
direct measure of the element it represents in such a way that the number of nuclei for a 
particular element is given by:
m N ^ y f (3.23)
Where: Na = no of target nuclei.
N a v  -  Avogadro’s number.
m -  mass of target nuclei.
/  = fractional isotopic abundance.
Aw = atomic weight.
The rate at which X is produced is equal to the rate of formation minus the rate at 
which it decays (figure 3.7). So for a nuclei X^^  ^ the number produced at time ‘t ’ is Na+i 
with the rate at which the nuclei aie produced given by:
= (3.24)
at
So integrating gives the number of nuclei:
(3.25)
Where: 0  = thermal neutron flux.
a  = reaction cross-section of target nucleus.
X -  decay constant of product nucleus A+l.
ti = iiTadiation time.
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The activity of at the end of irradiation is given by:
(3.26)
With the activity of X**' at the end of waiting time is given by:
A„ = A,e-^- (3. 27)
Similarly the activity at the end of the counting time is:
And the number of nuclei decayed in the counting time is:
4  = (3. 28)
(3.29)
The detector response ‘D ’ is equal to the number of discrete energy gamma rays 
detected for the decayed nuclei Na+i multiplied by the branching ratio ‘(ly)’ detector 
absolute efficiency ‘(Ey)’. Therefore substituting equation 3.26 through 3.28 into 
equation 3.29 gives the detector response:
D = y > ‘- (l (3.30)
To eliminate errors caused by uncertainties in reaction cross-section, branching 
rations, decay constants, detector efficiency and neutron flux the compaiative method of 
analysis was used. The use of a certified reference material to compare with a sample will 
cancel out the aforementioned uncertainties.
The half-life of a nuclide, as well as determining the rate of decay, also 
characterises the rate of increase in its activity during irradiation (figure 3.7). So for 
optimum results the time required for irradiation and waiting can be chosen to favour a 
nuclide of interest. Figure 3.8 shows a Bowen’s kale spectrum for a sample with an
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in-adiation time of 3 minutes favouring nuclides with half lives of similar magnitude. For 
longer iiTadiation times such as 24 hours, waiting times are also of importance as 
nuclides whose half life is of similar order of magnitude to the irradiation time will, after 
a short waiting time have a dominant peaks. Whereas increasing the waiting time further 
would result in a reduction in intensity of these peaks and so nuclides with longer half
t
lives would then dominate where before they were hidden within the background of the 
shorter half life nuclides.
Real Time: 3 mins O.CXD secs, live time; 2 mins 36.76 secs
5000
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Figure 3. 8 : Short irradiation INAA spectra. Irradiation 
time 2 min, waiting 2 min, counting, 3min.
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3.4. Positron emission tomography.
3.4.1. Introduction.
Positron Emission Tomography (PET) enables the user to obtain 3D images of 
brain function using radioactive tracers. It can be used to examine many aspects of brain 
function such as regional cerebral blood flow, regional metabolism and neurotransmitter 
turnover, all of which can change in dementia. To image the different functions of the 
brain certain radionuclides are used which have a function similar to that of the natural 
nuclides in the brain. The most common tracers are water and
fluorodeoxyglucose used in measuring cerebral blood flow and cerebral metabolic rate 
respectively. The concept of PET was first thought of in the mid 1950’s when Ter 
Pogossian suggested the idea of using positron-emitting radionuclides, despite of their 
short half-lives, as a new method for the study of regional metabolism [JNM85]. It was 
not until 15 year's later that PET started to be used as a research tool. One factor that 
makes PET an essential tool in brain imaging is the ability to measure metabolic 
processes in the body as these occur quickly enough to be traced by short-lived positron- 
emitters. Another factor is the annihilation process of the positrons, which make it 
possible to localise the position of its annihilation by coincidence detection.
The first PET scanners used single slices when performing tomographic studies 
using systems a ring of 32 Nal(Tl) detectors. The resolution of the slice had a full width 
half maximum (FWHM) of 2 cm and greater. The ‘next’ generation of PET scanners 
reduced the detector size and added additional rings to allow for simultaneous 
acquisition of multiple two-dimensional slices. The resolution of these detectors 
improved to less than 1 cm FWHM. As time has progressed, more, and smaller detectors 
using bismuth germanate (BGO), and photomultiplier tubes (PMT) have been added to 
these machines to increase their sensitivity and resolution which is typically 4-5mm 
[Tho90], Between the years 1975 to 1994 detector size has reduced from an area of 20 
cm^ of PETT III to 0.14 cm  ^of the RAT PET system [Mesb96].
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3.4,2, Positron decay and interaction.
There are two ways in which proton-rich radionuclides can decay that will 
reduce an excess of positive charge on the nucleus. These are the neutralisation of a 
positive charge with the negative charge of an electron, electron capture from an inner 
atomic orbit (equation 3.31). Or alternatively, the emission of a positron from the 
nucleus which will then combine with an electron from the suiToundings and annihilate 
(equation3.32). Electron capture (figure 3.9) is the dominant process in nuclides with 
high atomic number due to an increased amount of orbital electrons close the nucleus. 
Fortunately, most nuclides in living tissue are of low atomic number so the foremost 
process of decay for radionuclides used to mimic them is positron decay which is 
required in PET.
Electron capture 
+ + v (3.31)
Positron decay 
X->z-1l' + ;3*+v (3.32)
/
Figure 3. 9; Example of radioactive decay by positron emission
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In PET die process of positron decay is utilised witli the annihilation of positrons 
in matter (tlie annihilation medium being living tissue in case of the brain) resulting in 
the emission of two characteristic gamma-rays. Before anniliilation takes place the 
positron depending on its energy travels between 1  to 2 mm from the pomt where it was 
initially emitted losing its Idnetic energy to the smToimding matter, this is clearly a 
limiting factor in the resolution of any PET system. The position then combines with its 
anti-parlicle, the electron, to form positroniimi which tlieii quicldy decays (»1 0 0 ps). 
Wlien annihilation finally takes place both tlie position and tlie electron ar e converted to 
electromagnetic radiation in tlie form of two photons of equal energy, equivalent to the 
rest mass energy of an electron (5likeV). These are emitted at approximately 180 
degr ees away fr om each other due to tlie conservation of momentum and energy. If the 
positron were at complete rest as it anniliilates the angle would be at exactly 180 
degrees.
Photon interaction will occin with matter in a number of ways and tins in tmii 
will effect the attenuation of the photon through matter. The main processes of 
interaction are photoelectric absorption and Compton scattering, dependent on atomic 
mass niunber and mass density respectively and also the energy of the incident photon 
(figiue 3.10). For the 511 keV photons in tissue Compton scattering is die interaction 
with the liighest probability. Importantly die scattered photon will have a lower energy 
than a photon not imdergoing an interaction and can be identified as such.
p = 0.095 crn
Compton.
Pair i 
production'Photoelectric
Ln photon energy
Figure 3,10: Tlieoretical plot o f ‘log linear attenuation coefficient’ 
against ‘log photon energy’ for a tissue equivalent material.
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3.4.3. Photon detection.
The two annihilation photons are detected almost simultaneously by scintillation 
detectors on opposite sides of the object, this places the site of the annihilation on or 
about a line connecting the centres of the two detectors. Simultaneous detection 
provides a precise field of view with uniform sensitivity which occurs as the 
disintegration takes place between the two detectors. The volume between two detectors 
over which the disintegration event has occurred in called the line of response (LOR). 
The detectors have a small time window (lO'^s) added for simultaneous detection for if 
annihilation was to occur close to one detector block the opposing detector in 
coincidence requires this time for the photon to travel the extra distance [Mur98]. The 
photons themselves must in sum have travelled the full inter-detector distance in order 
that the event be recorded. If the annihilation originates outside the volume between the 
two detectors, only one of the photons can be detected, and since the detection of a 
single photon does not satisfy the coincidence condition, the event is rejected, figure 
3.11. Scattering is also an obstacle to overcome in PET analysis as this can add false 
coincidence events. For low densities such as seen in brain tissue, Compton scattering of 
photons can occur (section3.4.2). As Compton scattering reduces the energy of the 
scattered gamma ray an energy window can remove some scattered events but due to the 
poor resolution of BGO most are still detected. Both septa (shielding between detectors) 
and electronic collimation are used to eliminate scatter [Gro95].
Not detecteiAccepted
3 Rejected
Compton Scattering
Random
Figure 3.11: Possible photon interaction with detectors in coincidence.
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Detectors themselves are inorganic scintillation devices of which various 
materials are used. A photon passing through the detector undergoes Compton scattering 
and then total absorption by the photoelectric effect. During each collision energy is re­
emitted by the scintillatior material as electromagnetic radiation in the visible range. A 
light guide directs the light photons to a photo cathode within a photo multiplier tube. 
The photo cathode converts the light into an electric pulse, with the current produced 
proportional to the intensity of the emitted light and so the amount of energy transferred 
to the crystal.
Photomultiplier BGO crystal cut into an array of detectors. Photomultiplier
Figure 3. 12; Detector geometry showing photomultiplier tubes and BGO scored crystal detector.
(not to scale)
The most widely used detector material is bismuth germanate (BGO) which has 
the formula Bi4 Ge3 0 n. BGO has high density (7.31g.cm‘^ ) and so is good at stopping the 
51 IkeV photons [Cho77]. As a result BGO has a good light yield but has the drawback 
of a relatively long decay time (300ns) compared to other scintillation materials. The 
BGO block detector (figure 3.12) comprises of a crystal of BGO which is scored into a 
number of smaller detectors with averages dimensions of 4mm x 4mm x 30mm across 
most systems [Mesb96]. The dimension of a detector block clearly limits the resolution 
of the reconstructed image. The light guide is constructed out of the same BGO by 
cutting groves to different depths, this eliminates any optical coupling which would have 
occurred between detectors and light guide. The different lengths of the light guides are 
made to introduce varying light loss, which is location dependent within the BGO block.
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Events can then be uniquely identified using Anger logic [Ang59], which utilises this 
light loss.
3.4.4. Image reconstruction.
PET imaging like CT, MRI, and SPECT, relies on computerized reconstruction 
procedures to produce tomographic images. Radon [Rad 17], produced a mathematical 
model which is used widely in PET reconstructions [Dea83]. The Radon Transform 
relates a two-dimensional image space (tracer distribution) to the sinogram data 
(projections from coincidence detection). As the transform has this property, given 
projection data can be used to determine the tracer distribution.
p(/,0) = I I  f { x , y ) 5 { x s m  0  + ycos0 - l ) d x d y  (3. 33)
Where p(l ,0)  is the projection function at  distance 7 ’ angle ‘O' , f(x,y)  is the image 
function at ‘x’ and ‘y’, ‘5' is the Dirac delta function. The parameters can be seen in
figure 3.13.
Sinogram 
of a point 
source.
> S
(c)
Figure 3. 13; Image showing reconstruction of an object (a) into a sinogram (b) [Gro95]. (c) 
shows what the Sinogram of a point source would look like.
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To measure three dimensional distribution of a radionuclide contiguous circular 
arrays of detectors are used so multiple line integrals can be measured at the same time. 
Line integrals that are parallel and so have the same angle to each other across the active 
scanning volume are called parallel projections which will exist for all angles, figure 
3.13(a). These parallel projections are then sorted into an array called a sinogram which 
is a concise way of storing what would otherwise be an enormous amount of data, figure 
3.13(b) & (c). As a PET scanner can be made up of many rings a large number of 
sinograms can exist for direct and oblique planes (figure 3.14). For example the EC AT 
953B scanner consists of 16 detector rings which make it possible to measure 256 
sinograms with 16 being the perpendicular, direct planes.
I N H I l l
Direct
\  Oblique
Figure 3.14: Direct and Oblique LOR’s between coincidence 
detectors along the axial length of the scanner.
A practical solution for reconstruction uses the concept of filtered back 
projection which consists of replicating the intensity value of the profile across the image 
space [Pla98]. Each projection is convoluted with the image of a point object within the 
field of view using the convolution integral, this has the form of a point spread function 
(PSF). This leads to a modified projection integral. Using a Fourier representation of the 
convolution integral the calculations for determining tracer distribution are simplified as 
the Fourier transform of the convolution of two functions is equivalent to the product of 
the Fourier transforms of the two functions. This shows /(3c,can be made up as a sum 
of cosine and sine waves converting real space into frequency space, while the PSF is 
transformed to the ramp function. Reconstruction of the tracer function f(x,y) is
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performed by back projection of the convoluted projection integrals uniformly along a 
straight line. Both two-dimensional and three dimensional use the concept of filtered 
back projection to reconstruct images though added complications exist in 3-D due to 
oblique angles between detector pairs.
3.4.5. Random coincidence.
As the amount of data increases (detected events) the chance of random 
coincidence also increases. Suppose the number of gamma rays detected at detector ‘B’ 
and detector ‘A’ are the same and is equal to ‘C ’ during a coincidence time window ‘x \  
If the gamma rays are detected at crystal ‘A’ first then for the random events at ‘A’ is 
given by:
RA = r ( f  (3.34)
However we have to consider the chance of the gamma rays being detected by 
crystal ‘B’ first. This possibility doubles the overall number of coincidences, so the 
random coincidence ■. is:
91 = 2 rC f  (3.35)
Then true coincidence can be given by:
Rt =k C (3. 36)
Where ‘k ’ is a constant depending largely upon the object geometry but is typically a few 
percent for a single detector pair. The ratio of these detection rates is:
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Clearly this ratio is increased by decreasing the coincidence time ‘t ’ and 
increasing constant ‘k ’ (for example using shielding between rings) while it also 
decreases as ‘C' increases. So clearly the problem of random coincidences increases as 
the amount of activity increases. With scanning of the brain keeping the source activity 
low is essential to prevent unnecessary biological damage but clearly this also reduces the 
number of random coincidences. Additionally the random coincidence rate can be 
determined by adding a time delay to the coincidence window. If this time window is 
made sufficiently long enough, of the order of lO'^s, [Wil79] no true coincidences will be 
detected but the random coincidences will be the same as if collected with the correct 
time window [HofSl]. This is assuming that there has been no change in the distribution 
within the delay time. So the true coincidence can be given as:
R t =  R m - 91 (3. 38)
Where ‘Rm ’ is total number of events recorded during a measurement.
3.4.6. Attenuation.
Gamma rays can be scattered and absorbed by tissue so the depth of a source 
within matter and the matter density affects the number of photons detected. As such an 
attenuation correction has to be performed on data sets for accurate determination of 
activity and so local tracer concentration within the sample. In figure 3.15, if the number 
of gamma rays reaching the detector at ‘A’ from the source at ‘p’ in the absence of tissue 
is Wo’ then the number reaching the detector in the presence of tissue of thickness ‘z’ is:
= N ^ e  0 (3. 39)
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i
Figure 3.15: Coincidence detection of a point source at 
‘p ’ in an object of thickness ‘L’.
The number of gamma’s reaching detector ‘B’ is:
Ng =N ^ e  « (3. 40)
Then the probability of a gamma ray reaching detectors ‘A’ and ‘B’ without being 
attenuated is:
(3. 41)
(3. 42)
And remembering that the coincidence rate is the product of probabilities so the 
probability of a coincidence being detected in the presence of attenuation is:
- jXfK -juiOdC 
P = e ° .e ® = e ° (3. 43)
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Therefore attenuation is independent of the position of ‘p’ and only dependent on 
the function If attenuation is assumed to be linear throughout the whole brain
then a further approximation can be made, i.e. P  = which is dependent on the linear 
attenuation coefficient and thickness of object only. Before any analysis is performed an 
attenuation coefficient is determined by taking a transmission scan usually by an external 
®®Ge positron emitting ring source [Vol98]. This is usually performed before the tracer is 
administered to the subject.
3,4.7. Radionuclides.
The main positron emitting radionuclides used in PET are carbon-11, nitrogen- 
13, oxygen-15, and fluorine-18, with half-lives of 20.4, 9.96, 2.05, and 109.7 minutes 
respectively [Cho75]. The fact that these elements are found in almost, if not all of the 
compounds which are utilised by the human body, it makes sense that PET is an obvious 
technique to study the fate of these compounds in-vivo. Oxygen is used to measure 
oxygen utilisation and in the form of labelled water to measure blood flow. 
Fluorodeoxyglucose is labelled by fluorine-18 to measure glucose metabolism, with both 
oxygen and fluorine giving access to aspects of primary metabolic processes, the 
generation of cell energy. Carbon is used in carbon monoxide to label red blood cells for 
blood volume measurements. It can also be included in amino-acids and used to assess 
protein metabolism and used to label fats. Nitrogen in the form of NH3 can be used to 
measure perfusion in the cardiac wall. The tracers can be administered by either injection, 
inhalation or orally depending on the purpose of the examination. It is the short half-lives 
of these tracers that allow large doses to be administered to the patient with low 
radiation exposure and enable studies to be repeatedly performed.
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3.4.8. Glucose Metabolism.
There are two components involved in metabolism in the brain, these are oxygen 
and glucose. The glucose supplies electrons, reducing equivalents, which are then utilised 
by the oxygen in aerobic metabolism, this in turn maintains the correct level of adenosine 
triphosphate (ATP), biological energy. The brain, unlike other parts of the body, cannot 
substitute proteins or carbohydrates for glucose, neither can it substitute oxygen as an 
electron acceptor [Tho85]. As a consequence, any deficiency in either oxygen, glucose 
or both will cause a temporary impairment of neural activity. Any prolonged deficiency 
could result in permanent brain damage. The majority of glucose is used for maintaining 
membrane potentials and restoring ion gradients.
Glucose metabolism is measured using the tracer attached to
fluorodeoxyglucose (*®F-FDG) due to its kinetics being similar to glucose in the initial 
stages of metabolism [Rho83]. is a radioactive isotope that is produced in a cyclotron 
by proton bombardment of enriched water ( ’^ O) and has a half-life of 110 minutes. After 
injection ^^F-FDG passes through the blood brain banier where it is then phosphorylised 
intracellularly by the action of the enzyme hexokinase to form ^^FDG-6 -phosphate 
(^^FDG-6 -P). At this point ‘®FDG-6 -phosphate cannot pass through the cell membrane 
and thus enter the Kiebs cycle of normal glucose metabolism (figure 3.16). ^^F-FDG-6 - 
phosphate is therefore trapped within the cell so enabling the measurement of 
radioactivity and hence rCMRGlu.
Though the biological processes of metabolism in brain tissue are complex, 
modelling the kinematics is simplified due to the inherent limitations of PET on spatial 
and temporal resolution. The kinematics of the process are modelled using 
compartmental analysis, a way of quantifying PET information.
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3.5. PET data analysis techniques.
3.5.1. Introduction.
Pharmacokinetics describes the study of drug and metabolite levels in different 
materials within the body over a set time period, and the mathematical models developed 
to explain their effects. The models used in PET to explain the measured activity 
concentration in tissue are greatly simplified when compared to the actual processes that 
exist in the biological instance, such as metabolic processes and receptor kinetics. The 
simplifications used are valid, not only for reasons of complexity but moreover the 
consequence of the limitations in PET of temporal and spatial resolution. The method of 
pharmacokinetic compartmental modelling investigates the exchange of substances 
between certain biochemical or physiological states. It achieves this by expressing how a 
substance in one defined compartment exchanges with another compartment by using 
rate constants. Rate constants referring to the rate of change in the number of molecules 
of the examined substance in or out of a compartment. A number of ways of determining 
the regional cerebral metabolic rate of glucose have been developed which are discussed 
here along with a number of data analysis techniques which make specific assumptions 
with reference to the PET data.
3.5.2. Sokoloff two compartment model.
Energy metabolism within the brain is measured using ‘®F-FDG with calculations 
based on the two tissue compartmental model, which can be used for other PET tracers. 
As described in section 3.4.8, FDG is an analogue of glucose which when in arterial 
plasma, passes through the blood brain barrier (BBB) into brain tissue. Figure 3.16, 
shows the compartmental model of FDG and its relationship with that of glucose. The 
standard FDG model was developed by Sokoloff [Sok77] for use in autoradiographic 
studies on rats but has been shown to be successful on humans.
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Figure 3.16: Schematic of the two tissue compartment model of FDG with that of normal 
glucose. FDG-6 -P cannot proceed to the Krebs cycle and as such cannot be metabolised.
The simplified Sokoloff model removes the need for the rate constant 
shown in figure 3.16. This is assumed to be zero as the time taken for any significant de­
phosphorylation to take place fi’om FDG-6 -P to FDG is much greater than the time taken 
for the complete scanning procedure. The rate at which molecules exit or enter a 
compartment is defined as a rate constant and is expressed by:
dN
dt = - k N (3. 44)
Where ‘ Ar is the number of molecules.
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This leads to the exponential function:
N(.t) = (3. 45)
Where 'No' is the initial number of molecules in the system.
Differential equations similar to equation 3.44 can be derived for the uptake of '^F-FDG 
over time in the free tissue concentration *Cf’ and the metabolised bound concentration 
‘Cb’. Respectively these are:
d C f = k ,C .  ~  ( ^ 2  + k,)Cj.  (3. 46)
d C ,
dt = k^Cf (3. 47)
Where; Cp -  concentration of '^F-FDG in plasma.
Cf = concentration of ^^F-FDG in ‘free’ tissue compartment.
Cb = concentration of ‘®F-FDG-6 -P in ‘bound’ tissue compartment.
ki = rate constant of ^^F-FDG entering ‘free’ tissue compartment from
plasma.
k2 = rate constant of ‘^ F-FDG entering plasma from ‘free’ tissue
compartment.
kj = rate constant of ‘^ F-FDG entering ‘bound’ tissue compartment
from ‘free’ compartment.
(See figure 3.16)
To interpret these, Laplace transformations result in the concentrations of free and bound 
•^F-FDG in terms of the *^F-FDG concentrations within plasma [Lee97]:
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Cf =^1 ® c . (3. 48)
Cb -  K {kj + ^3 ) ®c. (3. 49)
The total activity within the tissue ‘Q ’, is simply;
G = Cfe + Cf (3. 50)
Which results in the following equations:
G f c + ^ 3 ) (^2 + ^ 3 )
® c . (3. 51)
G C, (3. 52)
Where the input of the system ‘Cp’ is convoluted with the convolution kernel (the 
function to the left of the convolution operator). The convolution kernel denotes the time 
response of the two compartment model.
Equation 3.51 illustrates the uptake of '^F-FDG in terms of two components. 
Within the brackets, the left hand term is the initial activity taken up by the tissue which 
win be ‘washed out’ and not be metabolised. While the right hand term denoted that of 
the metabolised ‘^ F-FDG. Equation 3.52, originally arranged by Millier [MÜ191] again 
describes the process in terms of two components but this time different. The left hand 
term being the time course of the free ^^F-FDG in tissue while the right is the time course 
of the metabolised ‘^ F-FDG-6 -P.
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Finally, to determine the regional metabolic rate of glucose it is assumed that 
after time ' T  the activity concentration in the ‘free’ '^F-FDG has reached equilibrium 
with *®F-FDG plasma concentration so that:
d C f { T )
dt =  0 (3. 53)
And so from equation 3.46 and equation 3.47:
(3. 54)
d C , { T )
dt C A T ) (3. 55)
As FDG in an analogue of glucose, the total uptake of FDG will be proportional 
to the uptake of glucose in the system. And so their total influx rate constants (the name 
given for the collective rate constants within the brackets) will also be proportional. The 
constant of proportionality is called the lumped constant ' L C  which defines the relative 
handling of glucose and ^^F-FDG within the brain such that:
L C  — ^ 2  3^
K K
(3. 56)
Where ‘ ’ are the rate constants of normal glucose.
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So writing equation 3.55 in terms of the concentration of natural glucose in plasma it 
becomes:
d C t ‘ J  k[k’.t \
dt (3. 57)
Then substituting equation 3.56 finally leads to the equation:
" K k ,  Y  c f  1rCMRGlu =
A L C
(3. 58)
From which the regional metabolic rate of glucose can be measured.
Equations 3.51 & 3.52 can be used to calculate values for ‘A:/, 'ko and 'ks' by utilising 
time activity data taken during PET scanning, which in turn can be substituted into 
equation 3.58 to determine the rCMRGlu. A more formal way of presenting this result is 
to include time activity calculations within equation 3.58 by multiplying the numerator 
and denominator by an equal amount. This results in:
rCMRGlu  = k^2
V Vp
A LC A
C .( T ) - C f
Q
(3. 59)
[Kou82]
For accurate determination of the rCMDRGlu a number of measurements have to 
be made, these include the total activity in the brain region examined at a time ' T  after 
injection of ^®F-FDG. The concentration of Glucose and '*F-FDG in plasma from 
injection to the end of the scan at time ' T .
Both the Rhodes and Patlak methods are based on the Sokoloff derivation of the 
two compartmental model for glucose and are both used in analysis here. The reasons for 
the different techniques and the different requirements for both techniques are discussed 
in terms of different requirements, such as dynamic and static scans and their 
interpretations.
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3.5.2.I. Rhodes method of analysis.
One method in which parametric images of the regional cerebral metabolic rate of 
glucose (rCMRGlu) can be formed is that of the autoradiographic Rhodes method 
[Rho83]. Though the Rhodes method is a simplification of the more complex Sokoloff 
method, the model is still based on many of the assumptions. The model again assumes 
the dephosphorylation of ^^F-FDG-6 -P back to ‘^ F-FDG is not observed and as such is 
trapped in the tissue. Luncignani [Luc93] showed that for studies taken over a period of 
less than one hour the dephosphorylation of ^®F-FDG-6 -P is not observed. But 
additionally it is assumed that for times greater than 45 minutes the tissue concentration 
is dominated solely by ‘*F-FDG-6 -P, a method originally suggested by Sokoloff [Sok77] 
but not used in the original derivation.
As accurate 'k' values are required for determination of the rCMRGlu, practical 
and technical difficulties will be imposed for each scan taken if this is to be achieved. As 
such, it was suggested that instead of rate constants being used to define the movement 
of FDG and glucose, an ‘uptake’ model should be used [Rho83]. The Rhodes method for 
working out the rate of glucose metabolism is given by:
rCMRGlu = — \  '  (3. 60)
LC f C^{t)dt
Where: C f(r) = tissue concentration of *^F-FDG & ^^F-FDG-6 -P tracer at
time T.
Cp{ t )  =  arterial plasma concentration o f ‘^ F-FDG tracer at a time ?
between 0 & T .
(0 = measured plasma concentration of stable glucose.
LC  = lumped constant (relates total uptake of FDG to total
uptake of glucose in the system).
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As previously stated, equation 3.60 assumes that the activity concentration of 
‘^ F-FDG is composed entirely of *^F-FDG-6 -P and that this is not hydrolysed back to 
^^F-FDG during the course of the study. Additionally, the plasma activity concentration i
reaches equilibrium instantaneously with the free tissue pool. Because the model also just 
examines overall uptake, there is no need for dynamic scanning which can create 
systematic eiTors during analysis. Additionally Rhodes casts doubts on the use of 'k' 
values to determine rCMRGlu when comparing two groups of subjects where one has a 
severe pathological disorder. In a severe disorder such as cerebral glioma, the blood 
brain barrier may not function resulting in the ratio of ‘Cp’ to ‘C/ being reduced. This j
would result in over approximation of the true rCMRGlu values which would only be j
offset with an increase in the rate of hydrolysis of *®F-FDG-6 -P. Even though, this only 
occurs in methods where tabulated 'k' values are used rather than derived specifically 
from the data set, as in the Patlak method. As a précis, the Rhodes method of analysis of 
PET data shows there is no need for 'k' values when examining the overall rCMRGlu.
Only if rate constants are required for infomiation for glucose transfer across the blood 
brain banier and between tissue compartments are the 'k' values required. This removesI
the need for dynamic scanning which is required in other methods such as Patlak.
3.S.2.2. Patlak method of analysis.
Compartmental models seek to determine exchange rates between different 
regions using linear differential equations. As shown in section 3.5.2, these have 
solutions involving the time response of the system which is a sum of exponential 
functions. Because of the exponential functions, calculation of the parameters, such as 
rate constants, involves non-linear fitting which can be extremely time consuming when 
working out parameters on a pixel by pixel basis. Whereas the Rhodes method of 
analysis eliminates the need for 'k' values and so the complex fitting, the Patlak method 
of analysis reduces the fitting procedure to a linear least squares fit [PatSl]. Though 
Rhodes analysis can be performed by static scanning alone, the assumptions made with 
respect to the uptake model neglects significant changes in the blood brain barrier. The
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Patlak method determines the influx rate of ^®F-FDG and so determines values for 'ki' 
and 'ko the rate constants across the blood brain barrier. The Patlak plot can be used to 
analyse tissue uptake data when the blood-plasma concentration of the test substance 
cannot be easily measured. One disadvantage of this method is if the biological state of 
the subject changes over the time interval the study was taken, this would create 
instability in the time activity curves [Bla83]. Though the technique is more commonly 
known as the Patlak plot method, in literature the name multiple time graphical analysis 
(MTGA) is also used which covers all methods of linear analysis. Again, this method like 
Rhodes has its origins in the Sokoloff two compartmental model but makes further 
assumptions. Patlak [Pat83, Pat85] assumed that j.'relatively fast exchange occurs for the 
test substance (^^F-FDG) between plasma and tissue and that the test substance can 
move freely between tissue compartments and back to the plasma. The test substance can
enter the metabolised tissue regions from blood and/or other tissue region, however after
entering the metabolised tissue region, the test substance cannot exit. Finally the test 
substance in the exchangeable region can only exchange with plasma or enter the 
irreversible region from which it can’t leave.
A simplified ‘decoupled’ compartmental model of these assumptions, with is the 
basis of Patlak analysis can be seen in figure 3.17 where the rate constants 'kT 'kT and 
‘xj’ are related to 'kP 'kT and ‘^ j’ in the previous two compartmental model (figure 
3.16) by the equations [Bio84]:
= + * , )  (3. 62)
From figure 3.16 and 3.17 we can see the relation:
C t ^ C f +  Cb — Ui + U2 (3. 64)
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Figure 3. 17: ^Decoupled’ model which is equivalent to the 
standard two tissue compartment model assumed by Sokoloff.
It is clear from figure 3.17 that ‘h/’ and *W2 * can be treated as two one 
comparment models, such as the Kety-Schmidt model of cerebral blood flow [Ket48]. 
This leads to the time dependence equations:
I I
iq =  /Cj JCpdt  -  /C2 j ii2dX (3. 65)
1I2 —  ^ 3  J *  C pdT (3. 6 6 )
When the free FDG has reached steady state equilibrium so that C/Cp becomes time 
independent, the reversible component 'uT will also reach steady state and so:
Substituting into equation 3.64 gives:
C,
(3. 67)
(3. 6 8 )
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Dividing through by 'Cp and substituting equations 3.61 to 3.63 results in:
t
\ C p d r
G  __ , ^1^3 0________  rc* r n \
This is an equation of a straight line, the Patlak plot, where the gradient and intercept are 
given respectively by:
Where 'K,n is the metabolic rate or influx rate constant described earlier, this represents 
the steady state trapping of the tracer within the tissue from which the rCMRGlu can be 
determined (equation 3.58).
As a summary, graphical analysis of ^^F-FDG brain uptake data from PET 
measurements made over a series of concurrent times, dynamic scanning, allows the 
evaluation of the individual rate constants and so the influx rate constant.
Unlike many other methods the Patlak method of analysis can be performed 
directly onto sinogram data, eliminating the need for reconstruction of the large time 
sequence data sets [Mag96]. This leads to a more rapid and straightforward analysis of 
PET data sets.
3.5.3. Statistical methods for rCMRGlu analysis.
Once PET scans have been reconstructed and interpreted in terms of the regional 
cerebral metabolic rate of glucose, various tests can be performed to distinguish one 
subject or subject group from another. These tests range from complex mapping 
routines used in statistical parametric mapping to simple t-tests perfonned between set 
regions of interest. In work presented here along with t-tests, a number of different but
D. A. Cutts 70
Investigation into Brain Function: 3. Analytical techniques:
equally valid routines have been used to determine whether any procedure is preferable 
to another when trying to categorise disease states. Three such methods described ai^ e; 
statistical parametric mapping, subprofile scalar modelling and hierarchical cluster 
analysis.
3.5.3.I. Statistical parametric mapping.
Statistical Parametric Mapping (SPM) refers, in general, to the construction and 
assessment of spatially extended statistical processed which are used to test particular* 
hypotheses about imaging data. Statistical imaging techniques are required to calculate 
whether significant differences exist between par*ametr*ic images of different 
neurological states. A standard package which is used throughout the brain imaging 
community is that of SPM developed by the Functional Imaging Labs, Wellcome 
Institute of Cognitive Studies, London, UK. Though this is a comprehensive package 
our interest lies only with procedures which produce a statistical measure of differences 
between studies and/or subjects. SPM considers the question, “are physiological 
changes due to cognitive changes in the brain characterised better in terms of 
functionally segregated areas or functionally integrated systems”. Functional localisation 
meaning function can be localised to a cortical region. Functional segregation meaning a 
segregated cortical area is specialised for a certain perceptual or motor processing task. 
SPM assumes both of these cases exist by detecting focal differences within the brain.
The SPM par ametric approach utilises univariate analysis and the General Linear* 
Model (GLM) which embodies assumptions that are required to interpret the data. The 
GLM is used to produce a statistic at every voxel (univariative statistic) from which a 
statistical or* ‘significance’ image can be produced for all regions using distribution 
approximations. The GLM equation relates what we see with what we expect to see by 
expressing the rCMRGlu images in ter*ms of a linear combination of variables [Eve91]. 
The linear* combination of variables then explain the data set and are contained within 
the design matrix of the scan(s) in question (figure 3.18).
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The distribution approximations are then used across voxels which assume that 
the data sets are from stationary homogeneous discrete Gaussian random fields i.e. Z- 
distributed. This implies that data sets are also normally distributed at each voxel and 
derived from continuous random fields. Significance in terms of p-values are then 
calculated so regions with significant differences between studies / subjects can be seen 
on a resulting brain map. A schematic of the process is shown in figure 3.18 which 
displays input and output of SPM analysis.
Statistical
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Figure 3.18: Schematic of PET data analysis performed using SPM
3.5.3.2. Subprofile scalar modelling.
After rCMRGlu results have been obtained from a scan of a patient it would be 
beneficial to characterise the brain as either ‘normal’ or of some other disease state. This 
can be difficult as most group studies consist of one scan per subject and only a handful 
of subjects per phenotype which may not display homogeneity with respect to the groups
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functional state. Many studies have tried to utilise the analysis of variance (ANOVA) 
techniques but Clai'k [Cla85] determined this to be inappropriate as the model assumes 
specific forms of regional interdependency which do not necessarily exist in the brain. 
Multivariate ANOVA also suffer from similar* problems caused by the need for 
conelation [Gbr85]. The subprofile scalling model (SSM) was developed to eliminate 
the problems associated with ANOVA techniques [Moe91].
SSM is a general form of the ANOVA two-way factor model with the primary 
goal of identifying and modelling potentially heterogeneous, multidimensional, region- 
specific variations with small numbers of subjects. Additionally, the model provides 
quantitative global and regional subject measures that may be disease related, which can 
be used to identify region-specific effects associated with the above mentioned subject 
measures. Finally, to develop a technique for calculating disease specific covariance 
patterns utilising preliminary subject measures from one or more disease and normal 
groups and independent measures of disease progression and severity. SSM is based on 
principal component analysis (PCA) where the objective is to see whether the first few 
components account for most of the variation in the original data. PCA sets out to 
describe the variation of a set of multivariate data in terms of a set of unconelated data 
variables, each of which is a particular* linear combination of the original variables. The 
new variables being described in decreasing order of importance so that the first 
principal components accounts for much of the variation of the original data. Equations 
3.72 and 3.73 show the general SSM model described by Moeller [MoeS7] which can be 
seen graphically in figure 3.19.
(rCMRGlu)ÿ = GSFy x (GMP, + SRPÿ) (3. 72)
SRPÿ = Z SSFj^ - X  GlSki + error (3.73)
Where: (rCMRGlu)ÿ = rCMRGlu for region‘r’ of subject 7 ’-
GSFj = global scaling factor.
D. A. Cutts 73
Investigation into Brain Function: 3. Analytical techniques;
GMP/
SRP„
SSFkj
GlSki
group mean profile of the GSF normalised data.
subject residual profile, portion of a subjects normalised 
profile not accounted for in by the GMP.
subject scaling factor, determines the contribution of the 
Ath independent regional covariant pattern to the metabolic 
profile of each subject.
group invariant subprofile (regional covariant pattern).
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Figure 3.19; Schematic of the subprofile scalar modelling technique.
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Figure 3.19(a) shows the SSM breakdown of rCMRGlu profiles into global 
scaling factor (GSF), group mean profile (GMP) and the subject residual profiles (SRPÿ) 
corresponding to the metabolic variation about GMP with the influence of GSF 
removed. Figure 3.19(b) displays the breakdown of the SRP; into the sum of scaled 
patterns of regional covariance. Composed of subject scaling factor (SSF) and group 
invariant subprofile (GIS). Figure 3.19(c) shows subject scaled pattern of regional 
covariance for subjects composed of subject factors (SSF,) and regional covariance 
pattern, the group invariant subprofile (GIS*). The profiles from the SSM model above 
are then used to form the residual profile of the entire data set is given by [Mol91]:
« „ = Ç (s5 F ,,-S S fi GIS,G M P
GIS, (3. 74)
These residuals are then entered into principal component analysis (PCA) in 
which conelations of variables, principal components, Eigenvector and Eigenvalues are 
determined [Eve91]. In SSM the Eigenvectors are equivalent to the SSF and the 
principal components are equal to the term in square brackets in equation 3.74 from 
which the GIS can be calculated.
The results from the PCA part of SSM analysis are interpreted graphically. 
Eigenvalues from each principal component are plotted against the principal component 
number as shown in figure 3.20. The principal component with the largest eigenvalue 
will be the component with the largest variance [ChaSO] and so its variables best 
describe the differences in cases searched for.
Once the relevant principal components have been identified plot(s) of SSF; 
(eigenvector) against subjects can be made for the required principal component. This 
will show how each subject varies from the GIS of the group (figure 3.21). Finally a plot 
of GISjt can be made (showing the pattern of regional covariation with SSF) where GIS 
is derived from the principal component scores. A plot of these scores against region of
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the brain for as given principal component number will show which regions of the brain 
separate the two phenotypes examined. Those with greatest deviation from zero being 
more predominant.
SSM scree plot
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Figure 3. 20; Example scree plot showing that principal components 1 and 2 best 
represent the data set though 3 and 4 have a definite but weak association.
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Figure 3. 21: Example of the subject scaling factor for each subject for 
the first principal component. Two groups are clearly defined.
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3.S.3.3. Hierarchical cluster analysis.
Hierarchical cluster analysis is a mathematical technique used to categorise a case 
(subject) in such a way that it is grouped in a cluster with other cases (subjects) of similar 
phenotype. If the degree of association between cases is weak then cases will exist in 
distinct but different clusters. As such each cluster will describe certain correlations that 
exist between the variables within each case and give a well-defined separation between 
states or type. The clusters are hierarchically grouped according to their similarity to 
form a dendrogram. This is performed on a step by step basis starting with cases within 
large groups with a high similarity coefficient repeating itself until subdivision into 
further cases is not possible. The hierarchical method used to subdivide cases into 
clusters in work performed here is an agglomerative technique, that is to say, grouping is 
performed by a series of successive fusions.
Before clustering can be performed on a data set a proximity matrix for aU of the 
cases has to be calculated. The proximity matrix contains dissimilarities where a small 
coefficient implies a close relationship. The method of Squared Euclidean Distance 
(SED) was utilised to determine proximities as clusters which are relatively 
homogeneous with respect to variables would be better defined. The SED is given by:
4  = Z;=i (3.75)
Where for each variable 'k' the values 'xjk and X^ik are from cases T  and ‘v’ is the 
total number of variables.
Once proximities for all variables have been calculated, they can be clustered 
using a hierarchical method. Here the method of increased sum of squares (ISS) or wards 
method was used for the same reasons given for the SED proximity model. Even though 
it should be noted that many different clustering models exist which are appropriate for 
different needs [Lee99]. The model is based on the theory that during any part of the
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analysis there is a loss in the information which arises from the grouping of cases into 
clusters. This loss of information can be measured can be measured by the total sum of 
squared deviations of every point within a cluster to the mean of the cluster itself. As 
such the ISS is given by:
t e p  J
{ i^j (3. 76)
Such that the Euclidean sum of squares *£),’ for each cluster is equal to the sum of
the squai'ed Euclidean distances between all members of the cluster ‘p’ and its mean.
Where each variable ‘.r,/ is the value in case T , is the mean cluster in ‘p ’, and 
‘v’ is the total number of variables. Therefore for all clusters the total Euclidean sum of 
squares is shown to be:
E  = 'ZpEp (3.77)
In such a way that two clusters are grouped to give with the least increase in ‘E ’ hence:
Ipuq = Epuq - Ep - Etj (3. 78)
Where Ipuq is the increase in sum of squares from the union of clusters p and q is 
minimum [Wis99].
Hierarchical Clustering was performed using the Cluster analysis package CLUSTAN 
[Wis99] and was performed on both trace element and PET results.
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4. Experimental arrangement.
4.1. Ion beam accelerator.
4.1.1. Beam line.
PIXE and RBS spectra were detected simultaneously using ion beam analysis 
equipment at the University of Surrey’s EPSRC Ion Beam Centre. A Van de Graaff 
generator was used to produce protons by using a charged inner conductor connected to 
a hollow hydrogen gas (the ion source) filled outer conducting shell. A continuously 
moving electrostatic belt on which charge is transfened makes the electrical contact 
between the inner and outer conductors. Elemental concentrations obtained here were 
determined using of a proton beam of 2MeV which led to improved detection limits for 
elements of Z = 14 to 30, the biological range [Bea94].
The Van de Graaff accelerator is connected to a beam line into which the proton 
beam is guided by the aid of a steering magnet. Figure 4.1 shows the basic arrangement 
of the beam line. After the steering magnet an automatic gate valve is positioned so that 
a constant vacuum (10*^  torr) can be maintained within the beam line [Ho 197]. A manual 
gate valve is also positioned at the target end of the beam line to maintain vacuum when 
the tai'get chamber is allowed to reach atmospheric pressure for sample changing. To 
stabilise beam energy and so stop beam oscillation, control slits are placed just after the 
automatic gate valve within the beam line. If the proton beam were to hit either of the 
slit plates it would indicate that either an increase or decrease in beam energy had 
occurred resulting from the steering magnet having either a greater or lesser effect in the 
bending of the proton beam. A feedback loop automatically conects any deviation 
which may occur.
Steering plates then align the beam is such a way that it will cleanly enter the 
target chamber, these , are adjusted by altering the voltages applied to them. Next, to 
remove the low intensity edges of the proton beam a 1mm aperture was used to select
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the more intense central portion [Ste96], An aperture of this size allows a relatively 
large area of the sample to be analysed and so eliminate problems associated with 
localised inhomogeneity. To increase the irradiated area of the sample further, scanning 
plates are added to deflect the beam in the ‘jc’ and ‘y’ directions to perform a raster scan 
leading to a 4mm^ scanning area. Finally to focus the beam onto a sample, quadrupole 
magnets consisting of four magnets of alternating poles were used. With correct 
focusing and collimation the beam halo, which is known to cause interference in the 
detection of x-rays, can be reduced [Nob75],
aeenng
magnet Controlsilts Aperture
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m « g n e ts
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Figure 4.1: Schematic of the beam line used in PIXE and RBS.
4.1.2. Target chamber.
To remove the possibility of background being produced from proton interaction 
with the target chamber itself the chamber is made from aluminium. Any low energy x- 
rays produced from the interaction of protons on aluminium can be removed using a 
mylar filter. The mylar filter also removes x-rays from all elements with Z<13 [Vis85]. 
To reduce the amount of background counts caused be secondary bremsstrahlung the 
Si(Li) detector is placed at a backward angle of 135° [JohSS], figure 4.2. The surface 
barrier detector used for RBS was placed at an angle of 165° to the incident proton 
beam though clearly for RBS it would be ideal to use an angle of 180°. An angle of
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180° would produce optimum differences in kinematic factors for elements but this 
could only be achieved using an annular detector through which the incident beam 
could pass.
Samples are affixed to a sample target plate which in turn was positioned on a 
goniometer. The goniometer allowed samples on the plate to be aligned to the path of 
the incident proton. Each plate could hold fifteen 5mm diameter samples of which two 
were certified reference materials. Attached to the target plate is a cold finger, a liquid 
nitrogen reservoir, used to keep samples cold during scanning and so prevent sample 
heating which could lead to a loss of biological materials [Kir91, Ste96]. As PIXE relies 
up accurate determination of charge deposited on a sample, each sample has to be 
charge conducting. As biological material is not naturally charge conducting a layer of 
aqueous carbon was painted along the edge of the samples, but care has to be taken not 
to introduce contamination to the sample during this procedure. Finally, to remove 
inaccurate measurements of charge caused by secondary electrons (section 3.1), a 
positive bias of 200 volts was applied to the target plate thus suppressing the electrons.
Goniometer
Si(Ii) 
detector
Incident 
proton beam
Surface barrier 
Detector Sample plate
Figure 4. 2; Beam line target chamber.
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4.1.3. Lithium drifted silicon detector.
Though Si(Li) detectors suffer from poor efficiency at energies greater than 20 
keV, compared to Ge detectors [Kno89], they are ideal for detection of x-rays with 
energies between 3 and 20 keV. For x-rays up to the energy of approximately 80 keV 
the resolution of the Si(Li) detector remains linear with respect to energy. At energies 
greater than 80 keV detectors suffer from poor resolution due to detector leakage 
current and charge collection errors within the detector itself [Kno89]. Though due to 
the energy range of x-rays emitted from biological samples this limit is of no 
consequence. The detector used had a 200nm atmospheric thin window which was 
composed of SigN^ which allows the passage of elements with Z > 5.
4.1.3.1. Detector characterisation.
Results from PIXE analysis use detector characterisation such as calibration, 
resolution and efficiency determined by Stedman [Ste96], Presented here is a summary 
of that information.
Si(Li) detectors are known to have a highly linear response over the low energy 
x-ray range. A calibration was performed using an '^^^Am alpha source which was used 
to irradiate various foils which in turn would emit characteristic x-rays of known 
energy. Calibration was performed before each ‘run’ on the accelerator, where the 
Si(Li) detector was found to have consistently high correlation (r « 1) between energy 
and pulse height. The resolution of the system and the Fano factor were calculated using 
a similar method to that of the Ge(Li) detector which is discussed in section 4.2.3. For 
the Si(Li) detector the equation relating energy resolution with photo peak energy is 
given by:
r = .^ 2.35" FEw + r" + (4. 1)
Where ‘Fe’ is the electric noise and is a constant. ‘Fx’ is the contribution to the FWHM 
from leakage current and is negligible [Hol70] for low energies. This equation is similar
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to that of tlie Ge(Li) relationship given by equation 4.5. Ge(Li) unlike Si(Li) detectors 
do not suffer the saine problems of lealcage ciuTent so T x’ is not included in equation 
4.5. Higli coiTelation (r = 0.93) was observed between resolution and energy when 
fitting tlie data to equation 4.1. The fit resulted in a Fano factor of 0.113 which is well 
within tlie range 0.084 to 0.16 stated by Knoll [Kno89] and shows the detector was 
working coiTectly.
4.2. Instrumental neutron activation analysis.
Homogenised brain tissue samples, compressed into five-millimeter diameter 
pellets were used in INA analyses. INAA was perfomied at the Imperial College 
Reactor Cenüe’s Consort II reactor, Silwood park, UK. The lOOkW swimming pool 
type reactor is moderated by liglit water. The core itself consists of 24 emiched fiiel 
rods which contain 80% tlirougli which nine ‘core’ tubes pass for long madiations. 
For short lived mediations foin pneumatic fiansfer systems exist using a thennal 
neutron flux of tlie order 1.02x10^^ n.cm'^s'\ Short Hved activation with an iiTadiation 
of 2 minutes was used in botli the cyclic activation system (CAS) and tlie in core 
irradiation system (ICIS) leading to the detection of Na, Mg, Cl, K and A1 (table 4.1).
Table 4.1; Energy, intensity and half-life of isotopes detected [Fir96].
Isoltope
'. ,4 ,...' 1 mp mr # n-n . ..m=
Energy (keV) Relative Intensity (%) Half life (min) j
"'Mg 843.76 71.8 9.458 1
1368.63 100.0 897.54
41k 1524.70 100.0 741.60 j
38ci 1642.71 39.9 37.24 1
:«A1 1778.85 100.0 2.24 ;
38cj 2167.41 42.4 37.24 ;
'^*Na 2754.03 99.9 897.54 ;
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4.2.1. Short lived irradiations.
Samples in'adiated using CAS are contained within polyethylene containers 
suitable for passing through pneumatic core tubes which are inserted within the core of 
the research reactor. CAS in an automated system whereby samples are loaded, 
irradiated, discharged and counted using computer controlled preferences leading to 
precise iiTadiation conditions. The main disadvantage with this system is the 
background originating from the iiTadiated container. This not only consists of 
iiTadiated elements within the polyethylene itself but additionally any contamination 
collected by the container from the core tube itself. Aluminium is a major contributor to 
this contamination as core tubes are formed fiom this element. To account for this 
problem a blank container is sent through the core tube under the same conditions used 
for tissue samples. Background subtraction can then be performed to remove this 
intrinsic error. Sample geometry can also cause a problem when analysing samples due 
to the size of the containers used in CAS. During the pneumatic process sample pellets 
can ‘break up’ and scatter throughout the container initiating changes in the detection 
solid angle which would make the comparative method of analysis inaccurate. Spectra 
were collected using a lithium drifted germanium detector attached to a PC Canberra 
MCA card. The time for irradiation used was 2 minutes with 3 minutes counting (real 
time). For CAS the waiting time between the end of irradiation and the start of counting 
time can be set to as low as 200ms but is usually set at I or 2 seconds.
Samples examined using ICIS were again placed in polyethylene containers but 
of similar size to the pellet so eliminating problems with sample ‘break up’. These 
sample containers were then placed within a second polyethylene container suitable for 
passage through a pneumatic in-core irradiation tube. This system has a similar 
automated input, irradiation and discharge anangement to CAS but unlike CAS samples 
sample are automatically transfened to a waiting area from which they are moved to the 
detector manually. Before counting the outer container was removed so eliminating 
contamination from the core tube itself, though background would still exist from the 
inner sample container. Again a blank sample container was irradiated to account for 
this background. ICIS spectra were collected using a lithium drifted germanium detector
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attached to a PC Ortec Maestro MCA card which also automated counting through the 
use of a carousel. The time for iiTadiation used was 2 minutes with a 2 minute waiting 
time which is required for sample transfer. Counting was perfoiTned for 3 minutes (real 
time).
4.2.2. Detector calibration.
So that full energy photopeaks found using gamma ray spectroscopy can be 
properly identified, the pulse height must be accurately calibrated in tenns of energy. 
An europium (*^^Eu) source was used to acquire a reference spectrum where peaks of 
known intensity and energy could be identified. A simple plot of channel number 
against known energy produces the calibration curve from which a linear least squares 
fit can be made to obtain the relationship between the two variables. Figure 4.3 shows 
the linear fit for the Eu source which displays an excellent correlation (r=l, p<0.001) for 
the detector used in ICIS. Calibration was performed before each group of samples were 
iiTadiated within the reactor core and for both detectors used in CAS and ICIS.
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Figure 4. 3:Energy calibration of the ICIS Ge(Li) detector.
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4.2.3. Detector resolution.
Both detector resolution and absolute efficiencies for both Ge(Li) detectors were 
determined using a ^^Eu source. The resolution is an important parameter when 
performing region of interest analysis of peak areas on gamma ray spectra. If the 
resolution of the system were to vary between measurements, results using the 
comparative method would be incorrect. Resolution is defined as the full width of the 
energy peak at half its height (FWHM) divided by the peak energy. The FWHM of an 
energy peak is characterised by; electronic noise in the detector, pre-amp and amplifier 
along with statistical fluctuations in the number of charge carrier produced in the 
detector. To determine the effect of the statistical fluctuations we consider the average 
energy ‘w’ required to produce one electron-hole pair and the total energy deposited 
within the detector is 'E \  The ratio ‘£/vv’ is then equal to the average number of charge 
carriers where Poisson statistics lead to the standard deviation of the number of 
electron-hole pairs:
CT = J —  (4.2)w
Where the Fano factor ‘F ’ is required as research has shown that observed 
fluctuations are smaller than Poisson statistics depict and so standard deviations are 
amended [Tso95]. From equation 4.2, if F - 1  then the production of electron-hole pairs 
would be controlled by Poisson statistics whereas, F = 0  would mean no statistical 
fluctuations and so no energy loss in producing charge carriers. The latter case implying 
that FWHM would be equal to 'O' if F=0. The relationship of electron-hole pair 
standard deviations to the FWHM {Td) of a Gaussian distribution is given by:
Tj =272(ln2>vo- (4.3)
Substituting equation 4.2 gives:
=2V2(ln2)F£w (4.4)
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Since the energy resolution is comprised of the FWHM (Fd) due to statistical 
effects (the detector) and the FWHM (Fe) due to electronic noise, these can be added in 
quadrature to give the total FWHM (F). Therefore the resulting equation for the FWHM 
of an energy peak can be written as:
r = - 8^ (ln 2 )F£w + r; (4.5)
Where: vv 
F.
2.97x10'^ keV at 77°K [Tso95] for Ge(Ii)
1.06 keV is constant (though unique to detector set up).
Therefore from equation 4.5 a plot of T^’ against will result in a linear' plot 
with gradient equal to the Fano factor multiplied by ‘8(ln2)w’. The Fano factor was 
calculated to be 0.163±0.021 for the detector used in ICIS (figure 4.4) and 0.145±0.018 
for CAS both of which are within acceptable limits, 0.1 to 0.2 [Kno89]. The relationship 
between FWHM squai*ed and energy shows good linear fitting for ICIS (r = 0.981) and 
CAS (r = 0.976) spectra implying a good relationship between resolution of the 
detectors and increasing energy.
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Figure 4. 4: FWHM squared against gamma ray energy to determine the 
Fano factor and goodness of fit.
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4.2.4. Detector efficiency.
The absolute efficiency of the Ge(Li) detectors was determined, as with 
resolution and calibration measurements, with a ’^ ^Eu source. The absolute efficiency is 
defined as the number of gamma-rays detected divided by the number of gamma-rays 
emitted by the source and so includes solid angle. For a coaxial Ge(Li) detector the 
relationship between the absolute efficiency of the detector with energy can be given by 
the eight parameter equation [McN73]:
(4.6)
Where e  = 
E
Cl -  C8 =
absolute efficiency 
energy of centroid 
fitting constants
This equation was fitted to ICIS data seen in figure 4.5. Over a limited energy range 
equation 4.6 can be approximated to a two parameter fit with the linear equation 
[Kno89]:
In e = Cl 4- C2 In E (4. 7)
Figure 4.6 shows the linearity of the fit using the ICIS detector with a correlation 
coefficient of r = 0.981, r = 0.979 in CAS. Both results show good detector efficiency 
variation with energy.
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Figure 4. 5: Absolute efficiency against
energy for ICIS Ge(Li) detector.
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Figure 4. 6; Linear fit of ln(absolute
efficiency) against In(energy).
D. A. Cutts 88
Investigation into Brain Function: 4. Experimental arrangement:
4.3. Sample preparation.
Trace element concentrations within a sample are highly vulnerable to 
contamination from many sources during sample preparation. One major source is that 
of environmental contamination and as such manipulation was performed within a level 
II biological cabinet. This would not only protect the sample from contamination, but 
also the possibility of contamination from the sample to the worker [HMS84]. Vinyl 
gloves were also worn for reasons of contamination. Where available, objects used in 
sample manipulation were made from polyethylene which had been shown to prevent 
leaching of elements from tools to sample [Cam77, Beh80]. To prevent cross 
contamination between samples during preparation tools were soaked in Decon 90® and 
then rinsed with double deionised distilled water before each use. Tissue samples were 
obtained from the Alzheimer Disease Brain Bank, Institute of Psychiatry, London, UK, 
where they had been stored at -70°C to preserve tissue integrity. Rapid freezing ensures 
that cell membranes are not destroyed by the formation of small ice crystals within the 
tissue this would effect trace element concentrations [Hoh96]. It is essential that 
samples be removed within 48 hours of death [Ste96] as the effect of chemical reactions 
in the brain will result in element concentration changes in samples [Iye81]. Samples 
stored with any other form of preserving technique, such as the use of formalin, were 
not used due to contamination of the preservative on the sample. Samples of 5g 
(approx.) were obtained from left and right hemispheres of the frontal, occipital, parietal 
and temporal lobes of the brain. On arrival at the university, samples were immediately 
freeze-dried until no weight loss was seen. Before any sample was homogenised the 
outer layer of brain tissue was removed to eliminate contamination from blood vessels 
or meninges. The homogenised samples were compressed into 5mm diameter pellets 
suitable for both FIXE and INA analyses. The pelletiser die having smooth faces so 
sample faces would in turn be smooth, coarse surfaces have been shown to alter x-ray 
yields [Bea94]. Once pellets have been produced they are used in methods described in 
section 4.1 (FIXE) and 4.2 (INAA).
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4.4. Positron emission tomography.
A CTI Siemens EC AT 933/04-16 scanner (Knoxville, USA) was used to collect 
PET scans. The CTI 933 scanner comprises of a series of BGO blocks each cut into an 
array of smaller crystal elements. The cuts for each of the elements are made to different 
depths to characterise the light reaching the PMT’s so precise localisation of the 
detected event using Anger logic [Ang59]. Each of the individual elements has a 15.4 
mm transaxial width, 5.6 mm axial width and a depth of 30 mm and septa of width 
2.4mm is placed between planes. The scanner contains one such ring of BGO blocks 
resulting in an axial field of view of 8 mm for each plane and 7 detector rings [Rei9I].
4.4.1. Scanner characterisation.
The resolution of any PET image depends on three important features relating to 
the scanner being used. The limiting factors are the size of individual detectors, non- 
collinearity of the annihilation photons and the positron range. Each detector within the 
scanner has the same set width and so opposing detectors will create a line of response 
of width equal to that of the detector. Any annihilation taking place between these two 
detectors will therefore be assigned a spatial location dependent on this width. Non- 
collinearity exists due to annihilation photons not travelling at exactly 180° away from 
each other. This is due to the short lived positronium not coming to a complete rest 
before annihilation and so using the conservation of energy and momentum theory, a 
small deviation will be introduced of the order 0.5°. The effect that non collinearity has 
on the detector depends on the diameter of the scanner, typically for a 1 metre diameter 
resolution will be degraded by 2 mm [Mur98]. Finally from the time at which emission 
of a positron has occurred to its annihilation it will have travelled a finite distance. 
Positrons emitted from a *^ F nucleus have energies up to a maximum of 0.63 MeV and 
so can travel between 2 and 3 mm in brain tissue before annihilation [Cho75]. Though 
this figure may appear to be large, the average range of the positron a detector pair will 
see is much smaller due to the direction of annihilation. If the positron travels towards a 
detector then no error is introduced while if it is perpendicular the error will be
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maximised. For ‘^F the average of these distances leads to the error added of 0.22 mm 
[Der79].
To determine the mean transaxial resolution of the 933 scanner a line source was 
used placed at the centre field of view for all planes. The resolution was found to be 7,9 
mm at FWHM. The axial resolution was measured using a point source where the 
resolution on axis was determined to be 11.4 mm FWHM increasing slightly towards 
the edges. The energy resolution for 511 keV was 120 keV FWHM with upper and 
lower thresholds set at 850keV and 250keV respectively. Energy resolution has shown 
good linearity with energy but clearly this is of no consequence here as we are looking 
at only one energy. The efficiency of detectors can be measured by looking at the total 
sensitivity to a calibrated line source in the entire axial field of view. For the scanner 
detecting with 2D acquisition an efficiency of 0.55% was determined [Rei91].
4.4.2. Scanning protocol.
The PET scans were all performed at the Paul Scherrer Institute Villingen, 
Switzerland. Over the period the scans were taken the protocol remained the same to 
avoid the chance of systematic errors being introduced. The scanner recorded seven 
adjoining planes of width 8mm at any one time with an axial field of view of 56 mm. 
During any one scan the field of view was not large enough for complete coverage of 
the brain. For this reason the subject was moved to a position whereby for the remaining 
section of the brain a static scan could be taken. The total number of planes recorded 
was twelve as two planes are lost due to overlapping which ensures equal planar 
spacing when combining the two scans. The total field of view for each scan was 
therefore 96 mm, not enough to cover the whole brain in an adult but enough to cover 
the main regions of interest. Each patient was fitted with a head mould made from 
polyurethane to fix the position of the patient’s head during the scanning process. All of 
the patients were imaged with their eyes and eai's un-occluded to ensure conditions were 
the same for all studies. The scanner was then aligned to the orbitomeatal line, a line 
connecting the lateral canthus of the eye with the external auditory canal, by aid of a
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laser beam. This would allow  repeated or longitudinal studies to be caiTied out with the 
head in the same position.
Before the tracer was administered a transmission scan lasting 20 minutes was 
earned out using an external *^ ®Ge ring source, with an activity of 60 MBq, to correct for 
attenuation along each line of response. The positron emitting was then prepared in 
a cyclotron using a ^^0-fÎ20 target with the reaction ^^0(p,n)'^F. The *^ F isotope can 
then be labelled to FDG [Ham86]. ^^F-FDG in a 100ml physiological saline solution 
was then intravenously administered thiough the antecubital vein (via a catheter) using 
an infusion pump over a 3 minute period with a dose varying between 100 to 300 MBq 
for individual patients. The 3 minute infusion rate is necessary to reduce error in the 
time activity course of ^^F-FDG in plasma. To measure plasma concentration of glucose 
and **F-FDG a catheter is also inserted into the radial artery from which blood is 
continuously withdrawn during the whole scanning period. Eighteen arterial blood 
samples were taken from each subject at the times 0.3, 0.6, 1, 1,3, 1.6, 2, 2.5, 3, 4, 5, 7, 
10, 15, 20, 25, 30, 41 and 48 minutes after injection of the tracer. After being 
centrifuged the samples were used to determine plasma radioactivity, glucose and FDG 
concentration. For the first 48 minutes after injection of ^^F-FDG and with the patient in 
the first position, dynamic scanning was carried out. A time sequence of sixteen PET 
acquisitions were recorded in the order of three 1 minute, ten 3 minute and three 5 
minute scans. After this time the patient was then repositioned and a static study lasting 
5 minutes was taken covering the second half of the brain.
4.4.3. Parametric reconstruction.
Parametric images of the rCMRGlu were obtained using the autoradiographic 
Rhodes method and Patlak method of analysis. Each technique was performed on a 
pixel by pixel basis of individual planes for each subject scan. This resulted in a 
reconstructed image defined in terms of rCMRGlu rather than radionuclide activity 
within the brain. Equations 3.60 and 3.58 were used to determine rCMRGlu for the 
Rhodes and Patlak methods respectively using MATLAB based routines. Figure 4.10 
shows a typical reconstructed brain image in terms of rCMRGlu. The image planes
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produced with the Rhodes method of analysis are static i.e. one set of images planes per 
scan. While the Patlak method of analysis comprises of dynamic planes, i.e. a set of 
image planes for different tracer uptake times. For Patlak analysis to be performed 
accurately attention needs to be drawn towards the uptake of ‘®F-FDG within brain 
tissue. The rate of uptake of *^F-FDG into tissue must be constant due to assumptions 
made in the Sokoloff model [Sok77] concerning rate constants. From figure 4.7 it can 
be seen that uptake is only linear after approximately nine minutes after the injection of 
‘^F-FDG and as such for the Patlak method of analysis only scans performed after this 
time can be used. Times before this will give varying rate constants.
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Figure 4. 7; Time activity curves for ^^F-FDG concentration in plasma 
‘0’ and ^^F-FDG concentration within tissue ‘x ’ [Lee97].
Before any analysis on the rCMRGlu images can be performed all image sets 
from a subject have to be linearly normalised to a standard template. This is so inter­
subject comparisons can be made as image planes from each subject will have the same 
spatial co-ordinates [Fox95]. Normalisation was initially performed on the Alzheimer 
subject images using the MATLAB based application SPM ‘classic’ but later using 
SPM96 (Functional Imaging Lab., Welcome Institute, London, UK). The major
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difference between the two as far as work here is concerned, being the template used to 
normalise the image data. SPM classic used a 26 plane template based on the Talairach 
[Tal88] system while SPM 96 used the MNI (Montreal Neurological Institute) 68 plane 
normalisation template [Eva92]. The model is built upon a 305 mean subject image data 
base [Eva93] although in SPM the 152 image subjects was used to conform with the 
International Consortium for Brain Mapping (ICBM). Unfortunately differences have 
been reported between the two mapping routines with the MNI model resulting in a 
larger brain template leading to the need to coiTect stereotaxic results.
The normalisation of images from different subjects begins with an affine 
transform which is then followed by a set of linear transformations. Linear transforms 
were chosen as non-linear ‘stretching’ of a voxel will decrease the activity per unit 
volume and would lead to the possibility of false significances when comparing 
subjects. Additionally to linear transforms, zooms and shears are used to register brains 
of different shapes and sizes to the template. In SPM the method of normalisation that 
incorporates these techniques is the nine parameter rigid body (affine) transform. These 
parameters are, three translations, three rotations and three scaling where all scaling was 
linear. Once the original image has had transform parameters determined for 
normalisation, each voxel in the transformed image requires the corresponding intensity 
to be determined from the original image. To perform this task sine interpolation was 
used. The sine function preserving the resolution of the original image.
At this juncture subject scans are in the format required for SPM Gaussian field 
theory analysis which can be performed to determine significances (Z scores) between 
subject or states. For analysis involving hierarchical clustering, subprofile scaling and 
simple t-tests, regions of the brain have to be selected which are of functional interest. 
Eighteen regions of interest (ROI) were determined using the Talairach co-ordinate 
system for each hemisphere of the brain, these are listed in Table 4. 2 and shown 
pictorially in figure 4.9. ROI’s varied in size from 5 to 11 mm in width and length. A 
template normalised to the same specifications of the subject data was prepared over 
which the pre-selected regions of interest were superimposed. Scans which were 
normalised using SPM classic required a template composed of 26 planes, while SPM
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96 normalised scans required 68. Figure 4.10 shows rCMRGLu images with ROI 
overlaid.
Though 36 main regions of each brain were selected the total number of ROFs 
chosen was far greater due to the selected regions of the brain being measured on 
contiguous planes. For example the ff onto lateral ROI normalised with SPM classic 
consists of twelve smaller regions from twelve contiguous planes (Table 4. 2). To avoid 
confusion when discussing these regions, the 36 main functional regions of the brain 
will be referred to as ‘ROT, while the smaller regions associated with each plane will be 
termed ‘PROF.
The template prepared for SPM classic contains 160 PROI from which 36 ROI 
are formed, whereas the SPM 96 template has considerably more with 398 PROI for the 
same 36 regions per subject scan. In reality the total number of PROI will be less than 
398 due to limitations caused by the dimensions of the scanner. Not all of the brain will 
be covered by the axial field of view which results in PROI at the top and bottom of the 
brain not being measured. The cerebellum and temporal pole at the base of the brain and 
the motor cortex and somatosensory cortex at the top are prime examples of this. Scans 
reconstructed in terms of rCMRGlu using the Patlak method suffer this loss to a greater 
degree than Rhodes. Patlak relies on dynamic data for reconstruction of rCMRGlu 
images and as only half of the brain can be imaged this way, due to the limited axial 
length of the scanner (section 4.4.2), an average of 30% of PROI are lost. ROFs for 
both Rhodes and Patlak techniques are expressed in terms of rCMRGlu with the units 
‘jLimol/lOOg/minute’ (p,mol of glucose per lOOg of tissue per minute).
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Table 4.2; The eighteen major regions of Üie brain selected for analysis witli tlie 
number of minor regions wliich constitute them for SPM ‘classic’ / 96.
Region of Brain Abbreviation
Number of regions of interest 
per brain region
SPM ‘classic’ | SPM 96
1 Caudate nucleus CAU 5 12 ;
! Cerebellum CER 2 5 g
1 Cingulate anterior CGA 4 14
1 Cingulate posterior CGP 4 14 Î
1 Frontolateral cortex FRL 12 28 i
I Frontomedial cortex FRM 12 28
I Insula INS 1 6 i
1 Motor cortex MOT 4 8 :
1 Occipitolateral cortex OCL 4 6 !
1 Occipitomedial cortex COM 4 6
1 Parietal cortex PAR 3 10 i
Putamen PUT 5 12 i
Somatosensory cortex SMS 4 8
1 Temporolateral 
I cortex TEL 4 7 i
1 Temporomedial 
; cortex TEM 3 9
1 Temporal pole TEP 3 10
i Thalamus THA 5 12
1 White matter WHM 1 4
1 Number of ROFs 18 80 199
I Total number of 
1 ROI’s for both 
I hemispheres
36 160 398
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VA
Figure 4. 8: Normalised rCMRGlu PET scans of a subject suffering from Alzheimer’s
disease.
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Figure 4. 9: Co-ordinates determined using Talairach co-ordinate 
system which is superimposed over normalised PET scans.
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Figure 4.10: Normalised rCMRGlu images with regions of interest overlaid for a
control subject.
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5. Elemental concentrations in the ‘normal’ and 
Alzheimer’s brain.
5.1. Trace elements in the ‘normal’ brain.
A review of literature on the elemental composition of the human brain shows 
that while levels of minor elements are all in fairly good agreement with each other 
between publications, trace element concentrations have quite large variations. 
Additionally there is a lack of consistency in the way different studies present their data, 
some presenting dry weights while others wet which cannot be directly compared. 
Concentrations can be complicated further due to the amount of grey and white matter 
contained in a sample. Duflou [Duf89] and later Van Lierde [Van97] found that grey 
and white matter could be clearly separated in terms of trace element concentrations 
which they both attributed to an increase in neuron density. The increase in neuron 
density generally resulting in higher concentrations in grey matter although phosphorus 
had a higher concentration in white matter for the latter study. Stedman [Ste96] also 
found there to be higher Zn and Cl concentrations in grey matter. Cl being three times 
higher in the occipital lobe. Three other variables not generally examined in elemental 
analysis of brain tissue are those of the separation of hemispheres, sex and age. 
Particular trace element concentrations have been found to vary between left and right 
regions and sex [Ste95] while increasing age has been found to either increase or 
decrease many elemental concentrations [Heb99]. Researches have also used different 
analytical techniques to determine trace element concentrations which begs the 
question, can concentrations derived from different techniques be directly compared? 
Work previously performed at the University of Surrey shows lai'ge differences in 
concentration for an element when one technique is compared with another for the same 
subject group. For example, potassium was found to have a ‘normal’ brain fresh 
concentration of 2490 p,g/g using FIXE analysis while using long iiTadiation INA 
analysis 3000 pg/g was obtained [Ste96]. Van Lierde found concentration variability in
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elemental concentrations using macro and micro PIXE analysis, a further complication 
to work. Iyengar [Iye78] and more recently Stedman [Ste96] have assembled a 
comprehensive review of literature into elemental concentrations. Since this time a 
number of papers have been published on elemental concentrations though researchers 
do not generally separate the cortical regions which are of interest here. The reseaiches 
Marco [Mar99], Van Lierde [Van97], Makjanic [Mak99], Hebbrecht [Heb99] and Raj an 
[Raj97] all performed wide-ranging analysis on regions within the midbrain but all 
grouped the cerebral cortex regions together. This being said, the concentrations found 
were not significantly different between publications or with the standard compilation 
put together by Iyengar.
5.1.1. Sample details.
The ‘normal’ tissue samples were obtained from the Alzheimer Disease Brain 
Bank, Institute of Psychiatry, London, UK, where they had been stored at -70°C to 
preserve tissue integrity. A complete histopathological examination was performed to 
confiim that no evidence of Alzheimer’s disease or any other form of dementia existed. 
The mental state of the patient before death was also checked for any neurological signs 
of dementia. Additionally to their histology, the subject’s family profiles were examined 
for any history of dementia. Table 5. 1 lists sample details with respect to age, sex and 
sample location. The samples were prepared for either PIXE or INA analyses using the 
techniques described in section 4.3. Before any analysis could be performed on tissue 
samples they had to be freeze dried so that after elemental analysis the dry to fresh 
weight ratio could be used to determine the correct fresh weight concentration. The dry 
to fresh conversion ratios between the two hemispheres exhibited no significant 
differences for each lobe, but differences were noticed between lobes. The highest ratio 
was in the parietal lobe (0.208+0.026) while the lowest ratios were in the occipital 
(0.199±0.020) and frontal (0.199+0.019) lobes. The dry to fresh weight ratio has been 
found to vary with age, decreasing with increasing age, the change attributed more to 
males than females. It was also discovered that the ratio increases to a maximum at the 
age of 58 and then decreases thereafter. {
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Table 5.1: Sample details for ‘normal’ brain tissue from tlie fr ontal, occipital and
parietal lobes.
Subject
Reference Age Sex Hem Fro' Occ' Par’
N89.099F90 90 LR /
yy yy  ;
1 N89.098M8S 85 LR // yy yy
j N89.072M73 73 LR
// yy
y  ? 
y  i
N89.096F68 68 LR
/
N89.097F83 83 V LR
1 N89.074F85 85 LR
y
y
1 N89.090M62 62 LR
yy y
! N89.075M48 48 § LR
y
y
yy
; N89.053M79 79 0 RL
y
y
; N89.082F64 64 Ü LR
y
y
y
y
■ N89.057M60 60 0 LR yy
N89.060M51 51 0 LR
yy yy y
1 N89.081F89 89 0 LR y
N89.089M72 72 0 LR y
; N89.059F75 75 Û LR y
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5.1.2. Elemental composition of the ‘normal’ frontal lobe.
PIXE analysis was used to determine concentrations of elements within the 
frontal lobe. The eight elements detected with this arrangement were P, S, Cl, K, Ca, Fe, 
Zn and Cd. The two hemispheres of the brain perform different functions. The right 
hemisphere being primarily concerned with non-verbal skills, left field of view and the 
left side of the body. The left hemisphere controls verbal skills, right field of view and 
the right side of the body. As the two hemispheres caiTyout different functions requiring 
specific enzymes and neurotransmitters it is expected that the elemental concentration in 
each hemisphere would be different. To examine this twenty six ‘normal’ brain tissue 
samples, mean age 71.1 ± 13.2, were taken from both hemispheres of the frontal lobe. 
Fifteen samples were taken from males of mean age 65.9 ± 12.6, while eleven were 
from female cadavers, mean age 78.3 ± 10.1.
To determine which significance test would be suitable to use when comparing 
two sample groups the distribution of trace and minor element concentrations across all 
samples was examined. A normal distribution from Gaussian field theory would show 
that a students t-test would be suitable for significance testing while a non-normal 
distribution would lead to the use of the non-parametric Wilcoxon test. A normal 
distribution can also be used to determine whether or not an element is essential to brain 
function, that is to say, is the element under homeostatic control. An element 
maintained under homeostatic control would result in a ‘normal’ distribution while a 
non-essential element (enviionmental contaminant), would have a log normal 
distribution [Lie6 8 ], To examine the distribution the method of probits was used 
[Kir8 8 ]. A Probit plot essentially compares known frequency distributions with a set of 
pro bit points which represent a normal distribution. The resulting probit plot will be 
linear if the data is normally distributed or curved if it is not. The elements P, S, Cl, K, 
Ca, Fe and Zn gave a normal distribution and so implies they are essential for life. 
These are also known to have essential roles in the functioning of the brain therefore 
these results were expected. Cadmium displayed a non-normal distribution associated 
with an environmental contaminant. Cd has been found to increase steadily in the body 
during life, independent of the amount of cadmium already absorbed [Und77]. Figure
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5.1 shows the histogram and cumulative frequency plot of Cd, figure 5.2 presents the 
associated probit plot.
V T  1 0 0 %
- 75%
- 50%
- 25%
0 %
C o n c e n t r a t i o n  ^ g / g C o n c in lr i llo n  ^g/g
Figure 5. 1: Histogram and cumulative Figure 5. 2: Probit plot of Cd fresh weight 
frequency of Cd fresh weight concentrations. concentrations.
To examine elemental concentrations between brain hemispheres it was decided 
to use tissue samples from subjects where left and right samples were available. This 
would allow a matched pair significance test to be used and so give a better indication 
of left/right differences. Eleven subjects fitted this criteria (mean age 69.5±13.4) with 
the concentration of elements determined in brain tabulated in Table 5. 2. The 
significant differences (p-values) between left and right hemispheres are also shown. 
When grouping both sexes together trace element concentrations showed significant 
differences between left and right hemispheres for P (p<0.1) and Fe (p<0.01) with 
concentrations being higher in the right hemisphere. For the remaining elements S, Cl, 
K, Ca, Zn, and Cd there were no significant differences between hemispheres. Even 
though S, Cl, K, Ca, Zn, and Cd did not show any significant difference in the ‘normal’ 
brain a general trend of higher concentrations in the right hemisphere compared to the 
left was seen, mirroring that of P and Fe, figure5.3.
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Table 5.2: Fresh weiglit concentrations in tlie frontal lobe for left / right matched
‘nonnal’ subjects.
’ Element 7 Concentra Right hemisphere
lion (pg/g)/ ,
Left hemisphere p -  value
i  P 32471453 28161535 <0.09
S 1035 ± 126 9441192 0.27
i  Cl 18681242 18501534 0.97 ;
; K 25581 522 22461637 0 . 2 1  1
! Ca 51116 53119 0.89
Fe 69110 56110 <0.009
Zn 10.312.9 12.013.7 0.25
Cd 0.10010.034 0.08910.030 0.52 1
Where not quoted all en ors are standard deviations.
Wlien examining the sexes independently, matched samples for females 
followed tlie left/right trend seen on the grouped data set. Significantly higher 
concenti'ations of P (p<0.08) and Fe (p<0.06) were seen in tlie right hemisphere. The 
male matched data set again exhibited higlier concentrations in the right but only in Fe 
(p<0.07). Phosphorous is well laiown to be involved in biological energy witliin the 
brain in the form of adenosine triphosphate (ATP). ATP can only be produced by 
neiu'ons from tlie metabolism of glucose which is phosphoiylised mtmcellulai'ly. Iron is 
loiown to be involved in neurotransmitter synthesis and metabolism in tlie brain so the 
concentration following tlie same fiend as phosphorous might have been expected. 
Examining differences between female and males using umnatched testing resulted in 
no significant differences being observed for eitlier hemisphere.
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Fronta l  lobe concen t ra t ions
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Figure 5. 3: Elemental concentration between left and right hemispheres in the frontal
lobe for ‘normal’ brain tissue.
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5.1.3. Elemental composition of the ^normaP occipital lobe.
INA analysis was used to determine concentrations of elements within the 
occipital lobe. The five elements detected witli short lived activation (2 minute 
irradiation) were Na, Mg, Cl, K and Al. Brain tissue samples were again talcen fi-om 
botli hemispheres. Ten tissue samples were talcen fi-om tlie occipital lobe witli 6  male, 4 
female ‘nonnal’ subjects, mean age 72.6 ±14.1.
The distribution of trace and minor element concentiations across samples was 
examined resulting in the elements Na, Mg, Cl and K displaying noiinal distributions 
and so implying that they are essential for brain fimction. These are laiown to have 
essential roles in the fimctioning of the brain tlierefore these results were expected. The 
concentration of elements determined in tlie brain can be seen in Table 5. 3 with tlie 
significant differences between left and right hemispheres also shown. Matched paired 
tests were used to determine significances on sample groups as both left and right 
hemisphere samples were available. Wlien grouping botli sexes together trace element 
concentrations showed no significant differences between left and riglit hemispheres for 
any element. Tlie data set was too small to perform significance testing on individual 
sexes wliich may also be tlie reason for tlie lack of significance between hemispheres.
Table 5.3; Fresh weiglit concentr ations in the occipital lobe for left / right matched
‘normal’ subjects.
I Element Concentrât 
Left hemisphere
ion (pg/g)
Right hemisphere p “  value
I  Mg 473 ±20 464 ± 23 0.28 ;
Na 1575 ±94 1560 ±112 0.90
1 K 2335 ±94 2318 ±150 0 . 8 8
Cl 1743 ± 136 1753 ± 55 0.93
' Al 6 . 8  ± 0 . 8 6.7 ±0.4 0.94
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5.1.4. Elemental composition of the ^normaF parietal lobe.
As in tlie instance of tlie occipital lobe, INA analysis was again used to 
detennine concentrations of elements witliin tlie paiietal lobe. As before tlie five 
elements detected witli shoit lived activation were Na, Mg, Cl, K and Al. Ten tissue 
samples were talcen fi om botli hemispheres of the parietal lobe witli 8  male, 2  female 
‘normals’ subjects, mean age 69.4 ± 17.2.
The elements Na, Mg, Cl and K agam displayed nonnal distributions and so 
infers tliat tliey aie essential for life. The concentration of elements detennined in the 
brain can be seen in Table 5. 4 with the significant differences (p-values) between left 
and right hemispheres determined using matched paired tests. When gioupmg both 
sexes together trace element concentrations showed ho significant differences between 
left and right hemispheres for any element. As with tlie occipital lobe the data set was 
too small to perfonn significance testing on individual sexes which could account for 
tlie lack of significance seen between hemispheres. Though differences had not been 
seen here, it should be noted that in previous work perfoimed at tlie University of 
Surrey^ differences between hemispheres for die parietal lobe were foimd [Ste96]. 
Tliis previous work involved a lai ger sample selection and a different analysis teclinique 
and so a gi eater number of elemental concentiations detected.
Table 5. 4: Fresh weight concentrations m the parietal lobe for left / right matched
‘nonnal’ subjects.
Element Concentra 
Left hemisphere
tion (pg/g)
Right hemisphere p “  value
Mg 488 ±14 444 ±65 0.28
Na 1773 ± 225 1632 ±265 0 . 2 2
K 2973 ±492 3009 ± 60 0.89 1
1 Cl 1897 ±275 1746 ±305 0.57 Î
AluLs:^ 3Hsmee-! 7.5 ±1.8 6.7 ±1.4 0.54 1
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5.2. Comparison between ‘normal’ brain and Alzheimer diseased brain 
concentrations.
Many elements have been implicated in the onset of AD such as mercury 
[Hoc98], lead [YunOO] and aluminium [Rob98]. The latter element has achieved 
notoriety in connection with the onset of AD even though no evidence has as yet been 
found to substantiate this prominence. For example one group of researches has shown 
that aluminium accumulates within the nuclei of brain cells [Yum96] while a more 
recent report discovered no aluminium deposits around neurons [Mak99], An 
examination of literature on the elemental composition of the AD brain compared to the 
‘normal’ human brain shows varied results between publications. One author describing 
how an element such as iron increases between ‘normal’ and AD states [And95] while 
another will find evidence of a decrease [War87] while to contradict both of these no 
change may be seen [Pla87]. As with elemental concentrations in the ‘normal’ brain a 
review of literature and analysis into trace element concentration within the AD brain 
prior to 1997 has been summarised by Stedman [Ste96].
5.2.1. Sample details.
Alzheimer tissue samples were obtained from the Alzheimer Disease Brain 
Bank, Institute of Psychiatry, London, UK, where they had been stored at -70°C to 
preserve tissue integrity. A complete histopathological examination was performed to 
confirm that each subject displayed the hallmarks of AD. The mental state of the patient 
before death was also used to verify a subject as having AD. Family history was also 
examined for any occurrence of AD, the search was made to eliminate genetic variants 
of AD which exist (chapter 2). Most research is performed on familial AD (FAD) as 
defective genes can easily be linked to protein imbalances within the brain. Here, only 
sporadic AD (SAD) subjects were examined where as yet no Icnown mechanism for 
onset of AD has been determined. Table 5. 5 lists sample details with respect to age, sex 
and sample location.
D. A. Cutts 108
Investigation into Brain Fmiction: 5. Elemental concentrations in ‘normal’ & AD brain:
Table 5.5; Subject details for Alzlieimer brain tissue samples tissue from the frontal,
occipital and parietal lobes.
Subject 
j Reference Age Sex Hem Fro’ Occ* Par’
. A90.003F87 87 0 LR
/
/
yy ■ yy j
; A89.061F84 84 Ü LR //
A89.162M80 80 0 LR
/
/
yy
! A89.121F91 91 0 LR
/
/
yy yy
! A90.014F79 79 LR
/
/ y
A90.074M68 68 0 LR
/y
; A88.197F81 81 0 LR
y
1 A88.198M81 81 LR
yy
i A88.199M90 90 Î RL y
: A88.173F76 76 Ü LR y
: A88.176F88 88 Ù LR
y
A89.012F87 87 \} LR
y y
A89.131F78 78 0 LR yy
: A89.107F78 78 0 LR y
i A89.262F84 84 0 LR y yy yy
A89.0S6M73 73 0 LR y
I A90.017F64 64 Ü LR y yy yy
A90.052F78 78 Ü LR y
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The samples were prepared for either PIXE or IN A analysis using the techniques 
described in section 4.3. The samples were then studied for their elemental composition 
using PIXE for the frontal lobe and IN A analysis for the occipital and parietal regions. 
As well as their elemental composition, the water content of the samples was examined 
along with their frequency distribution.
The dry to fresh weight ratio of AD brains tissue samples shows significant 
differences than those of ‘normal’ tissue. A significant decrease was seen in dry to fresh 
ratio in the frontal (ratio 0.185+0.027, p<0.05) and parietal (ratio 0.185±0.020, p<0.01) 
lobes but no significant difference in the occipital (ratio 0.19610.019), This shows 
strong correlation with the areas most affected by plaques and tangles where the parietal 
lode contains plaques and tangles and the frontal lobe, just plaques, while the occipital 
remains relatively undamaged [Gia95].
Disease duration also had an effect with respect to water content within the 
brain. With increased disease duration the dry to fresh ratio in regions of the brain 
examined decreased, that is, the subjects brain tissue accumulates more water with 
disease progression. This was seen only after a 6  year disease duration had been 
reached.
5.2.2. Elemental changes in the AD frontal lobe.
With the onset of AD the frontal lobe is one of the most severely affected 
regions of the brain and it is assumed that the pathology in this area maybe associated 
with impaired cognition and changes in personality [Bar99]. Twenty six Alzheimer 
brain tissue samples with mean age 80.6 ± 6.9, 8  male (77.6 ± 7.0), 18 female (81.9 ± 
6.4), were taken from both hemispheres of the frontal lobe. As with analysis in the 
‘normal’ brain, the frequency distributions of the trace and minor elemental 
concentrations was examined. This was to determine if the elements were essential or 
non-essential to brain function.
Generally the distribution of elements in AD deviated from the Gaussian fit with 
K and Ca being particularly affected. This shows that the homeostatic control of these 
elements, deemed to be important in ‘normal’ brains, was destroyed by the onslaught of
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AD. It has been suggested that these changes could be due to alterations in membrane 
transport systems or the blood brain barrier [Ehm8 6 ]. One exception from the change 
from normality was that of Cd which in ‘normals’ was shown to have a non-normal 
distribution associated with environmental contaminants (figure 5.1, 5.2). However in 
AD it now showed a normal distribution thus showing some form of homeostasis. Cd in 
known to be involved in the protein metallothionein which prevents the formation of 
free radicals [Apo99]. (Figure 5.4, 5.5).
T  100%
- 75%
-  50%
-  25%
m
M o r e 0.05 0.1 0.15 •
C o n c e n tra t io n  ^ g /g
0.2 0.25
C o n c e n t r a t i o n  ^ ig/g
Figure 5. 4: Histogram and Cumulative 
frequency of Cd fresh weight concentrations.
Figure 5. 5: Probit plot of Cd fresh 
weight concentrations.
To examine elemental concentrations between brain hemispheres subjects where 
left and right samples were available were used. This would allow the use of a matched 
paired significance test. Eight subjects fitted this criteria (mean age 81.0±6.4) with the 
concentration of elements determined in brain tabulated in Table 5. 6 . In the frontal lobe 
of AD subjects the elemental concentrations again differed for P (p<0.05) and Fe 
(p<0 .0 1 ) between left and right hemispheres as they had in the ‘normal’ subject group 
but additionally variation was seen for S (p<0.05) and Cl (p=0.11). However, unlike the 
‘normal’ subject case where the right hemisphere concentrations were found to be 
higher than the in left in AD the converse was true, figure 5.6. The remaining trace 
elements K, Ca, Zn, and Cd were not significantly different though concentrations in
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AD brain tissue again had generally higher concentrations in die left hemisphere 
compared to that of the right mirroring Cl, P, S and Fe.
Cr is a ion whose movement across membranes causes action potentials for the 
transport of neiuotransmitters. Sulphin is foimd in glutathione peroxidase which an 
antioxidant that coimteracts tlie effect of free radicals which ai e loiown to cause damage 
witliin tlie brain, section 2.4.7. The roles that P and Fe play in brain fruiction were 
mentioned briefly in section 5.1.3.
Table 5 . 6 : Fresh weiglit concentiations in the fr ontal lobe for left and right matched
Alzheimer samples.
I Element Concentr 
Left hemisphere
ation (pg/g)
Right hemisphere p -  value
P 3637 ± 970 2727 ±440 <0.03
S 1177 ±361 935 ± 191 <0.06
Cl 3024 ± 678 2597 ± 740 0 . 1 1
K 2582 ± 969 2188 ±365 0.19
i Ca 62 + 2 0 59 ±11 0.62
Fe 73 ±17 55 ±12 <0 . 0 1
Zn 10.7 ±3.1 1 0 . 8  ± 2 . 2 0.98
i Cd 0.088 ±0.034 0.087 ± 0.045 0.948
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Figure 5. 6 : Elemental concentration between left and right 
hemispheres in the frontal lobe for Alzheimer brain tissue.
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When examining the sexes independently, matched samples for females 
followed the left/right trend seen on the grouped data set with the exception of Cl. 
Significantly higher concentrations of P (p<0.02), S (p<0.02) and Fe (p<0.08) were seen 
in the left hemisphere. The male matched data set only presented a significantly higher 
concentration of Cl (p<0.06) in the left hemisphere, though generally higher 
concentrations were seen in the left. When examining differences between female and 
males, the left hemisphere concentrations were generally lower in females though the 
lowest observed significance was only seen in Fe (p~0.1). The right hemisphere 
displayed a more drastic variance with P (p<0.05), S (p<0.08) and Fe (p=0.1) all 
significantly lower in the female study. In the normal subject group no variation in 
elemental concentration between male and female subjects was seen. This may suggest 
females suffer a greater loss of elements vital to brain function during AD.
The hemispherical differences between elemental concentrations in the matched 
‘normal’ and AD subjects though not always significant, followed a general trend. S, Cl, 
K, Ca, Zn, and Cd did not show any significant differences in the ‘normal’ brain but 
there was a general trend of higher concentrations in the right hemisphere compared to 
the left. These mirrored the significant differences of P and Fe. On the other hand, 
concentrations in AD brain tissue had generally higher concentrations in the left 
hemisphere compared to that of the right with elements Cl, K, Ca, Zn, and Cd miiToring 
P, S and Fe. To further examine this trend each elemental concentration was normalised 
over all subjects and then a significance test performed by grouping the normalised 
elemental concentrations together for each hemisphere. The change in normalised 
concentration can be seen in figure 5.7 as a percentage. A positive percentage denotes a 
greater concentration in the right hemisphere compared to that of the left. A negative 
value shows higher concentrations in the left hemisphere of the brain.
For all subjects the normalised elemental concentrations were significantly 
higher in the right hemisphere of ‘normal’ subjects (p<0.04) while in AD the left was 
greater than the right (p<0.005). Wlien separating the sexes, the concentrations in the 
male brains followed the same trend in AD but showed no significance (p<0.17) in the
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‘normal’ brain whereas the female values showed significant differences in both cases. 
The none significant change in the ‘normal’ males may be due to the significantly lower 
age of the male sample selection. Previous work has shown that trace elements vary 
with age [Heb99].
T r e n d  in e l e m e n t  c o n c e n t r a t i o n s
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Figure 5. 7: Difference in the concentration of elements between right and left 
hemisphere normalised concentrations across all brains and all elements.
5.2.2.I. Concentrations between AD and normal' groups.
Though we have talked about elemental concentrations, such as Fe and P, being 
higher in the right hemisphere of the ‘normal’ subjects but higher in the left in AD for 
the frontal lobe, it does not necessarily follow that the elemental concentrations of these 
two elements increase in the left and decrease in the right with the onset of AD. It is 
more likely that with the beginning of AD the concentrations of Fe and P in the left 
hemisphere decrease at a slower rate than that of the right hemisphere. Figure 5.8 shows 
the change in the normalised concentrations for all elements over all subjects between 
‘normal’ and AD subjects. It should be noted that all fifty two available samples were
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used in tlie study of elemental concentrations between disease states, as such mean 
values vary slightly to those in tables 5.2 and 5.6. Cleaiiy from figure 5.8, the right 
hemisphere has a greater rate of decrease in concentration of elements examined at 
26%, while tlie rate at which the left hemisphere decreases is much slower at 6 %. 
Though it should be made cleai’ tliat this result does not mean tliat all elemental 
concentiations in tlie AD subject gioup were lower, tliis is just tlie general trend of tlie 
elements detected using PDŒ analysis.
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c  0.65
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0.5
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Figure 5. 8 ; Change in noimahsed concentration of all elements over 
all subjects between ‘iioiinar and AD subjects.
To examine elemental concentrations between disease states tlie original twenty 
six ‘nonnal’ and twenty six AD brain tissue samples were used as matched paired 
statistics camiot be used between groups containing different subjects. Wlien examining 
elemental concentiations sepaiately the only significant change seen in tlie left 
hemisphere was for Cl. The concentiation of Cl from ‘noiiiial’ to AD brain tissue 
changed wiüi a significant increase in AD (p<0.002). The right hemisphere however, 
showed significant differences in P, S, Cl, K, Ca and Fe between ‘nonnaP and AD. In 
iioimal ageing K had been reported to decrease witli increased age whereas Fe is seen to
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increase [Heb99]. Cl again showed a significant increase in concentration with the onset 
of AD (p<0.01) as did Ca (p<0.1). Calcium has also been observed to increase in 
concentration in normal ageing [Heb99] P, S, K and Fe all displayed a significant 
decrease (p<0.01, p<0.07, p<0.03, p<0.03, respectively) in concentration in the AD 
group. These latter results confirm what was seen in figure 5.8. The majority of 
elements with the right hemisphere have a significantly lower concentration in AD 
which results in the high rate of decrease in normalised concentrations. Whereas no 
significantly lower concentrations were seen in the left hemisphere only an increase in 
Cl. But generally over all elements examined, there was a small decrease leading to the 
lower rate of decrease.
A reason for the changes seen in concentration was suggested by Ehmann 
[Ehm8 6 ]. He argued that an element such as phosphorus which has a small ionic radius 
whereas other elements like potassium larger ionic radius. So if phosphorus is increased 
and potassium is decreased in AD then a possible reason for the change could be due to 
alterations in the membrane transport systems or the blood brain barrier. Though it has 
to be said here that both elements decreased. Ehmann also stated that the increase in 
sodium and chlorine concentrations may be as a result of the increase in water content 
of the Alzheimer brain. An increase in sodium and chlorine would be required to 
achieve the right osmotic balance, an increase in chlorine was detected.
One suggestion for the change in calcium concentration is that ^-amyloid which 
is present in senile plaques in AD (section 2.4.2.1) forms small channels in nerve cell 
membranes, these channels then allow excess calcium to enter the nerve cell which then 
kill the cell. Other recent studies indicate that |3-amyloid disrupts potassium channels 
which also could affect calcium levels.
c r ,  IC, Ca^ '*’, are ions, which by their movement across membranes cause action 
potentials for the transport of neurotransmitters. As a result, any change in 
concentration will have an adverse affect on brain function. Fe is used in energy 
metabolism and in neurotransmitter homeostasis, it has particular associations with 
enzyme systems, all of which may alter as a result of varying concentration.
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5.2.3. Elemental changes in the AD occipital lobe.
Hist( opathologically die occipital lobe suffers the least damage of the thi ee lobes 
examined. Ten AD brain tissue samples, 4 male, 6  female, mean age 76.8 ± 7.7, were 
removed from both hemispheres of the occipital lobe. Short-lived INA analysis was 
used to determine the concentiations of five elements, Na, Mg, Cl, K and Al. The 
distribution of trace and minor element concentrations across samples was examined to 
detennine wliich significance test would be used.
The elemental concentiations witii significances between left and right 
hemispheres of AD brain tissue can be seen in Table 5.7. Matched paiied tests were 
used to deteimine significances as samples frmn both hemispheres of a subject were 
obtained. Wlien grouping both sexes togetiier trace element concenfiations showed no 
significant differences between left and right hemispheres for any element similar to 
results seen in die ‘nonnal’ brain subjects. The data set was too small to examine 
whether any significances existed between genders.
Table 5.7: Fresh weight concentrations in die occipital lobe for left / right matched
Alzlieimer subjects.
1 Element Concentra 
Left hemisphere
tion (pg/g)
Right hemisphere p -  value
Mg 427 ±11 437 ±15 0.32
Na 1762 ± 6 6 1822 ±150 0.36
K 2186 ±187 2215 ±89 0.78
Cl 1795 ±80 1889 ±158 0.26
: Al 6 . 1  ± 0 . 2 5.0 ±0.6 0 . 1 2
As no significance was observed between brain hemispheres in bodi ‘nonnal’ 
and AD samples, differences in concentiation between ‘normal’ and AD subjects were 
deteimined by giouping the two hemispherical data sets togedier. Bodi Na and Cl had
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significantly lower concentrations in AD (p<0.001, p<0.003 respectively), wliile K was 
significantly higher (p<0.07). Mg was also higher but of low significance.
Zn generally serves the purpose of a catalyst. Lindu [Lin91] shows it to be 
associated witli over 200 en2 yines. One iinpoitant enzyme to note of wliich Zn is a 
constituent part is CuZn-superoxide dimutase (CuZn-SOD). This is thought to be 
important in AD as CuZn-SOD catalyses the reaction which converts tlie harmful 
superoxide free radical to hydrogen peroxide and water.
5.2.4. Elemental changes in the AD parietal lobe.
For the examination of the AD affected par ietal lobe ten, 2 male, 8 female, brain 
tissue samples with mean age 81.2 ± 9.3, were talcen fiorn both hemispheres. Short lived 
INA analysis was again used. The concentration of elements determined in tlie brain can 
be seen in Table 5. 8 where no distinction has been made between sex. No significant 
differences were between left and right hemispheres for any element and tlie data set 
was again too small to peiTorm significance testing on individual sexes.
Table 5. 8: Fresh weiglit concentr ations in tlie parietal lobe for left / right matched
Alzheimer subjects.
! Element Concentn 
Left hemisphere
ition (pg/g)
Right hemisphere p -  value
! Mg 362 + 32 422 ± 78 0.19 ;
Na 1912 ±262 2286 ± 358 0.24 :
K 2833 ± 190 2572 ±331 0.30 1
Cl 2095 ±261 2520 ± 456 0.25
i Al 6.5 ±1.1 5.9 ±1.0 0.42 •
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As no significant differences were observed between brain hemispheres, the 
variation in concentration between ‘normal’ and AD subjects was determined by 
grouping the two data sets together. The elements detected followed the same trends as 
seen in the occipital lobe with both Na and Cl again having significantly lower 
concentrations in AD (p<0.03, p<0.04 respectively), while K was significantly higher 
(p<0.08). Mg was again higher but of lower significance.
5.2.5. Correlations between trace elements.
In Alzheimer’s and ‘normals’ a number of elements were found to be 
significantly correlated, these were: P-S, P-Cl, P-K, P-Fe, S-K, S-Fe, Cl-Ca, Cl-Fe, K- 
Fe, K-Cd, Na-Cl and Mg-K. Generally the elements Na, K, Cl, P, S and Ca were found 
to be well correlated in both ‘normal’ and AD with the exception of K-Cl and K-Na 
which were not correlated in AD. These relationships would be expected as all of the 
elements are present in intracellular and extracellular fluid and their role in cell 
exchange mechanisms. A list of significant correlations for both AD and ‘normal’ 
subjects is tabulated in Table 5. 9.
Interestingly, for all ‘normal’ subjects none of the elements detected had 
correlations with Zn but in AD five pairs were significantly conelated, namely P-Zn, S- 
Zn, Cl-Zn, Ca-Zn, Fe-Zn. Corollary to this three of the elements, P, S and Fe had 
significant correlation coefficients with Cd in the ‘normal’ brain but not in AD, an 
interesting result as cadmium and zinc have known antagonism towards each other. 
Moreover Zn and Cd displayed no coiTelation in the ‘normal’ subjects but did so in AD 
so perhaps implying a substitutive effect.
Zinc is known to protect against cadmium toxicity [Und77] so some form of 
correlation would be expected. The significantly positive correlation seen between 
cadmium and zinc in AD may be expected as they are both bound to the free radical 
absorber protein metallothionein (MT). Sulphur is also found in MT [Mar95] and 
sulphur was found to be highly correlated with cadmium in normals but only weakly in 
AD suggesting a reduction of MT in AD. The binding of cadmium in the place of zinc 
is believed to act to detoxify the effects of cadmium [Und77], so a reduction in MT
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would expose the brain to more toxic cadmium without the level needing to increase. 
Phosphorus is one of the most important elements in the biological system providing 
energy in biological processes. Phosphates provide energy by their role in adenosine 
triphosphates (ATP), Na and K form complexes with ATP [Lin99], this suggests the 
reason for the correlation seen. Other correlations expected were sodium and potassium, 
their ions are known to work together to make the sodium pump which controls the flow 
of fluids across cell membranes. The correlation between iron and sulphur can be 
explained by electron transport systems in which both iion-sulphur proteins have 
functions.
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Table 5.9: Conelations for elemental concentrations in tlie ‘normal’ and Alzheimer
brain for PIXE and INAA,
Element
‘NormaP ( 
Coefficient ‘r*
Correlations
p-value
Alzheimer ( 
Coefficient ‘r ’
Correlations
p-value
P-S 0.902 <0.001 0.958 <0.001
P-CL 0.703 <0.005 0.651 <0.01 !
P-K 0.776 <0.001 0.842 <0.001
P-FE 0.653 <0.01 0.824 <0.001
1 P-ZN 0.229 NS 0.687 <0.005
P C D 0.796 <0.001 0.382 NS
S-CL 0.576 <0.01 0.728 <0.005
S-K 0.870 <0.001 0.916 <0.001 '
S-FE 0.701 <0.005 0.843 <0.001
S-ZN 0.292 NS 0.715 <0.005
S-CD 0.807 <0.001 0.440 <0.1 ;
CL-K 0.465 <0.1 0.577 <0.1
CL-CA 0.600 <0.01 0.627 <0.01
CL-FE 0.688 <0.005 0.641 <0.01
CL-ZN 0.287 NS 0.738 <0.005
K-CA 0.398 NS 0.596 <0.01
K-FE 0.617 <0.01 0.741 <0.005 ;
K-CD 0.964 <0.001 0.685 <0.01
CA FE 0.M6 <0.1 0.558 <0.01
CA-ZN 0.057 NS 0.523 <0.1
FE-ZN 0.262 NS 0.573 <0.01
FE-CD 0.599 <0.01 0.339 NS
ZN-CD 0.121 NS 0.601 <0.01
MG-NA 0.386 NS 0.653 <0.01
MG-K 0.820 <0.001 0.64 <0.05
1 MG-CL 0.314 NS 0.722 <0.005
1 NA-K 0.746 <0.005 0.121 NS
NA-CL 0.757 <0.005 0.978 <0.001
1 K-CL 0.549 <0.01 0.213 NS
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5.2.6. Hierarchical cluster analysis.
Though correlations between trace elements can be a good way of identifying 
AD and ‘normal’ groups, how the elements cluster with relation to each other is also 
means of classification. Figure 5.9 shows how, even when correlations are the same, the 
clustering of the groups can be distinct. The method used to identify these cluster 
groups is that of hierarchical cluster analysis. This had the advantage of been able to 
examine all elements simultaneously in terms of their dissimilarity coefficients between 
concentrations. Alzheimer’s and ‘normals’ subject groups were compared for the 
frontal, occipital and parietal lobes.
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Figure 5. 9; Clustering of element concentrations for AD and 
‘normal’ samples for P and S.
5.2.6.1. Frontal lobe.
Hierarchical clustering was performed on the 26 AD and 26 ‘normal’ frontal 
lobe subject samples using all elemental concentrations available (P, S, Cl, K, Ca, Fe, 
Zn and Cd). This led to a cluster dendrogram which displayed no distinct separation 
between the AD and ‘normal’ subjects. Therefore, to improve clustering different 
combinations of elements were examined. The elements leading to the best clustering
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was the combination of S, Cl and Ca, this resulted in significant clustering (p<0.001) 
with 23 ‘normal’ and 11 AD in one cluster, with 15 AD and 3 ‘normal’ in the other, 
figure 5.10. Additionally, adding the elements Fe, Zn and Cd to the clustering group did 
not improve or worsen the result. Similar grouping was seen when separating data into 
sexes with a significant separation (p<0.001) between an all male ‘normal’ group (11 
‘normal’) and a predominantly male AD group (8 AD, 4 ‘normal’). Female studies 
resulted in a predominantly ‘normal’ group (11 ‘normal, 5 AD) and a predominantly 
AD group (10 AD, 1 ‘normal’).
Further investigation of whether the left or right hemisphere would increase 
separation led to the left hemisphere showing improved clustering while the right 
hemisphere displayed less distinctive clusters. In the left hemisphere a significant 
separation (p<0.001) between a predominantly ‘normal’ group (10 ‘normal, 4 AD) and 
a predominantly AD group (9 AD, 2 ‘normal’), figure 5.11. The right hemisphere was 
split into 3 significant groups (p<0.001), the first consisting of 3 AD subjects, the 
second group containing 4 AD and 1 ‘normal’ and the final cluster 13 ‘normal’ and 6 
AD, figure 5.12.
An explanation as to why S, Cl and Ca grouped well while K and P did not may 
be the way in which the elemental concentrations correlate with each other. If elements 
correlate well together the proximities between them will be similai* for all subjects 
which in turn will lead to good clustering. If proximities between elements vary, 
possibly due to a lack of correlation then these elements would lead to poor clustering. 
Therefore if correlations between concentrations of elements in AD subjects were 
similar to correlations in ‘normal’ subjects then clustering would not easily separate the 
two states, whereas if correlations were strong in one state and poor in the other, distinct 
clustering would be seen. Consequently the way in which S, Cl and Ca act together is of 
interest. C f and Ca^  ^ ions move across cell membranes creating action potentials which 
lead to the release of neuro-transmitters, so any changes to the concentrations or 
correlations may be detrimental to ‘normal’ functioning of the brain. Sulphur is found in 
the protein metallothionein which is able to prevent the formation of free radicals 
[Eba95] which are harmful to brain function.
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•  = Alzheimer subject
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Figure 5.10: Frontal lobe clustering of elemental concentrations S, CL, Ca for AD and 
‘normal’ subjects using both hemispheres.
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Figure 5.11: Left frontal lobe clustering for AD and ‘normal’ 
subjects using elements S, Cl and Ca
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Figure 5.12: Right frontal lobe clustering for AD and ‘normal’ 
subjects using elements S, Cl and Ca.
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5.2.6 2. Occipital lobe.
The elemental concentrations of Mg, Cl and K determined by INAA were used 
to examine hierarchical clustering for 10 AD and 10 ‘normal’ subject samples. The use 
of the elements Na and Al led to poor separation of clusters. Distinct clustering into AD 
and ‘normal’ states was found with high significance between cluster groups (p<0.001) 
shown in figure 5.13. The first cluster consisted entirely of AD subjects while the 
second contained all 10 ‘normal’ plus 2 of the AD subjects. Further investigation into 
left and right hemispheres similarly showed distinct groupings between the two states. 
The left hemisphere with 4 AD in one cluster and 5 ‘normal’ and 1 AD in the other 
while the right hemisphere had 4AD and 1 ‘normal’ in the first cluster and 4 ‘normal’, 
and 1 AD in the second cluster. Hierarchical Clustering additionally showed that the 
removal of K did not significantly change the results of the clustering model. This 
implies the relationship in which K acts with respect to other elements is similar in both 
AD and ‘normal’ subjects for this region of the brain.
▲ = ‘Normal' subject 
#  = Alzheimer subject
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Figure 5.13: Occipital lobe clustering for AD and 
‘normal’ subjects using elements Mg, Cl and K.
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5.2 6.3. Parietal lobe.
Using Na, Mg, Cl and K to cluster the 10 AD and 10 ‘normal’ subject samples 
resulted in no significant separation between mental states. As with the fi'ontal lobe, to 
improve clustering the best combination of trace elements was determined. Removing K 
resulted in an improved separation of AD and ‘normal’ again with significance of 
p<0.001. The predominantly AD cluster consisted of 8 AD and 3 ‘normal subjects while 
the other contained the remaining 7 ‘normal’ plus 2 of the AD subjects, figure 5.14. 
Examining the left and right hemispheres further resulted in similar separation seen in 
the left/right grouped data. One cluster in the left hemisphere had 3 ‘normal’ and lAD 
while the second had 4 ‘normal’, 2 AD. The right hemisphere again separated well into 
two clusters, one cluster with 4 AD and 1 ‘normal’, the other with 4 ‘normal’ and 1 AD.
▲ = ‘Normal’ subject 
#  = Alzheimer subject
S 5 § S 5
Figure 5.14: Parietal lobe clustering for AD and ‘normal’ 
subjects using elements Na, Mg, Cl.
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5.3. Conclusions.
Ideally, it would have been desirable to obtain elemental concentrations for all 
three regions of the brain for all patients using the same techniques. This may have 
resulted in an improved distinction between the ‘normal’ and AD subjects in terms of 
significances between brain hemispheres, disease state, grouping into cluster and 
conelations.
When examining significant differences in the ‘normal’ brain elemental 
concentration between left and right hemispheres both phosphorus and iron had higher 
concentrations in the right hemisphere. And though the remaining elements did not 
show any significant difference a general trend of higher concentrations in the right 
hemisphere was seen. In AD higher concentrations of phosphorus, iron, sulphur and 
chlorine were discovered in the left hemisphere. And again, though the remaining trace 
elements did not show any significant difference in concentration, they generally had 
higher concentrations in the left hemisphere compared to that of the right.
Though a switch from right side dominance to left was seen between ‘normal’ 
and AD disease states the concentrations did not necessarily increase in the left 
hemisphere or decrease in the right with the onset of AD. This was observed in the right 
hemisphere which showed significant increases in chlorine and calcium and decreases 
in phosphorus, sulphur, potassium and iron. This showed that the majority of elements 
in the right hemisphere had significantly lower concentrations in AD which resulted in a 
high rate of decrease in normalised concentrations. In the left hemisphere the only 
elemental concentration to significantly change was that of chlorine which increased. 
No significantly lower concentrations were observed in the left hemisphere although 
when normalised values for all elements was examined a small decrease was seen 
leading to a low overall rate of decrease. This suggests AD affects the right hemisphere 
of the brain more so than the left. The right hemispheres of the brain being primarily 
associated with non-verbal skills, such as spatial awareness.
Both iron and phosphorus are involved in metabolism within the brain therefore 
the changes seen in these elements may have implications on the metabolic rates within 
the brain. Phosphorous in the form of adenosine triphosphate is involved in the brains 
biological energy and can only be produced by neurons from the metabolism of glucose
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by phosphorylisation. The effect of the metabolic rate of glucose within the brain 
determined using positron emission tomography and their probable links with trace 
elements will be discussed within the remaining chapters.
Finally hierarchical clustering of certain elements for a particular brain region 
led to distinct grouping between AD and ‘normal’ brain states. To improve the 
clustering it would be advantageous to have brain tissue samples from all regions of the 
brain for all subjects with the same analysis techniques performed on them. The results 
suggest that this would improve cluster separation and help determine influential 
elemental changes between ‘normal’ and AD subjects, thus leading to better 
understanding of the disease.
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6. Cerebral metabolic rate in AD and disease duration.
6.1. Introduction.
The majority of reseai'ch into the regional cerebral metabolic rate of glucose 
(rCMRGlu) in AD has focused on familial Alzheimer’s disease (FAD). Subjects who 
match this criteria can be followed from a pre-AD age to, and past, the time which they 
may develop AD. People who have both parents develop AD have a 54% chance of 
developing the disease by the age of 80, while 34% chance exists for those with one 
parent affected [Sma95]. A study by Kennedy [Ken96] followed such cases on which 
phenotypes of the disease showed distinct rCMRGlu changes. Research here is centered 
on Sporadic Alzheimer’s disease (SAD) where no family history of AD exists and as 
such no clear evidence for its onset. In such cases there is an 11% probability of 
developing AD.
In chapter 5 elemental concentrations which are essential for the correct 
functioning of the human brain were seen to change between ‘normal’ and AD subjects. 
The precise reason for the changes is not known but it had been suggested that the 
mechanism in which an element enters the brain may have changed. For a trace element 
to enter the brain a biological transport mechanism is required, the main mechanism 
being the blood brain barrier (BBB). Under normal functioning the BBB (section 2.2) 
stops harmful trace elements passing into the brain but it is believed in AD the barrier is 
somehow weakened and so allows many harmful elements through. One reason for the 
changes in elemental concentrations was suggested by Ehmann [Ehm86] who put the 
change down to alterations in the membrane transport systems of the blood brain barrier, 
this would in turn affect metabolic rates. A review of Positron Emission Tomography 
(PET) studies shows hypometabolism in Alzheimer subjects generally in the parietal, 
temporal and frontal lobes of the cortex with the cerebellum, motor cortex and basal 
ganglia relatively unchanged. The observed change in metabolism could, as suggested 
Ehmann, be due to elemental changes.
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The brain is one of the most metabolicaily active organs in the body though it 
only constitutes approximately 2% of the body’s total weight (for healthy humans) so 
any change in metabolism due to the BBB could be detrimental. The two important 
components of blood involved in brain metabolism are oxygen and glucose. The glucose 
supplies electrons which are consumed by the oxygen in aerobic metabolism to maintain 
the correct level of biological energy, adenosine triphosphate (ATP). Unlike other parts 
of the body the brain cannot substitute other metabolic substances such as proteins and 
cai'bohydrates, for glucose, or other electron acceptors for oxygen. So consequently, any 
deficiency in either or both oxygen and glucose will cause impairment of neural activity 
with prolonged deficiency resulting in permanent brain damage. The effects of any 
damage that results from a change in the blood brain barrier can be investigated using 
PET with the tracer ^^F-Fluorodeoxyglucose (^^F-FDG).
A literature review shows many papers discussing the different phenotypes of 
FAD, but with very few researches examining SAD cases. For those who do, they rarely 
examine the age and sex dependence of rCMRGlu or even the subjects disease duration. 
Again as seen in trace element work, the left and right hemispheres of the brain are 
rarely examined separately. Only one publication covering all of these aspects was 
discovered but the study contained just ‘normal’ subjects [Mur96]. Much research into 
metabolic rates within the brain concentrate upon cognitive function and changes 
between ‘normal’ and AD subjects such as ‘naming’ impairments [Wat99] and vision 
disturbances [FujOO]. As a result many papers do not quote resting state metabolic rates 
for subject groups. Others just report differences between disease states where 
significant differences were obtained between brain regions using packages such as 
SPM [Ima97]. Confusion also stems from the variations in techniques used to obtain 
quantitative rCMRGlu results. Some papers relying on models based on the 
compaitmental model rate constants ki to ki while others ki to ks (section 3.5.2), at the 
same time as resear chers also used general uptake models such as the Rhodes method. 
Each of these models will result in either higher or lower rCMRGlu values even if the 
same data set is used [Rho83] due to constraints applied to each model. The only way of
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directly comparing data from these different models is the use of metabolic gradients (or 
ratios). Here the ratio of rCMRGlu between two regions of interest is used to define 
concentrations in those areas.
As a precursor to complete analysis of the rCMRGlu in ‘normal’ and AD brains, 
an initial study was performed on AD data using the Rhodes method [Rho83] of 
analysis (section 3.5.2.1). This would reveal which regions of the brain should be 
examined in more detail or even dismissed in AD, along with gender and hemispherical 
variations. The study used subject data from the PSI, Villigen, Switzerland which had 
been normalised to the standai'd Talairach template using SPM ‘classic’ as in the 
method discussed in section 3.5.3.1. The implications of using SPM ‘classic’ with 
reference to SPM 96 will be discussed later in chapter 7.
From this point on, to keep notation consistent with other PET publications, 
subjects with no neurological disorders will be termed controls rather than ‘normal’ as 
denoted in the trace element studies.
6.2. Subject selection.
Eighteen Alzheimer diseased subjects, average age 66.5 ±8 .1  where nine were 
female with an average age 69.8 ± 6.2 and nine males aged 63.2 ± 8.5, were examined 
for changes in rCMRGlu. One female in the study had 3 PET scans taken over a two- 
year period giving an insight into the longitudinal effect of AD. Ten of the subjects were 
clinically diagnosed with AD using the. National Institute of Neurological and 
Communicative Disorders and Stroke and the Alzheimer’s Disease and Related 
Disorders Association (NINCDS-ADRDA) criteria [Mck84]. The remaining eight 
subjects were diagnosed by qualified hospital and PSI (Paul Scherrer Institute Villigen 
Switzerland) MD’s.
The ten subjects meeting the NINCDS-ADRDA criteria were assessed using the 
Evaluation Rapide des Fonctions Cognitives (ERFC) scale [Gil86], The ERFC values
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available ranged from 32 to 48 with a mean value of 39 ± 5. The ERFC scale is ranged 
from 0 to 50 with a score lower than 46 deemed to show the subject having decreased 
cognitive function. Additionally Mini Mental State (MMS) scores [Fol75] were also 
taken with available values ranging from 17 to 26 with mean 22 ± 3 for the Wettstein 
test and a range from 14 to 24 with mean 19 ± 4 for the Folstein test. Magnetic 
Resonance Imaging (MRI) or computer tomography (CT) results for the ten subjects 
showed mild diffuse cortical atrophy in subjects and no evidence of vascular lesions 
which may have resulted in mental states similar to those of AD [Cur99]. Finally a 
number of laboratory tests with complimenting medical and neurological examinations 
were performed to eliminate the probability of the dementia being anything other than 
AD. Meticulous attention was paid to eliminate any factors which could ‘contaminate’ 
the data set such as nutritional peculiarities as in diabetes [Aue98], drug abuse [OmOO, 
Les99], alcoholism [Nei98, Kri97], head injury that resulted in loss of consciousness 
[Rei99]. Depression along with other psychiatric illness were also eliminated along with 
general mental retardation. Follow up studies were performed 1 to 2 years after the first 
test for confirmation that each subject did indeed have AD. The disease duration for the 
patients was between 1 to 4 years, though is was impossible to ascertain the individual 
subjects disease duration due to difficulties in defining the begining of AD. Each 
subjects details can be seen in Table 6. 1.
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Table 6.1: Alzheimer subject details.
Subject
Scan
Ref.
Sex Age
Diagn
B)
Hospital
osis
PSI
ITT-llt
Severity
Suggested 
by MD
Mei
EFRC
max=50
dtal state t
MMS (W) 
max=30
ests
MMS (F) j 
max-30 j
311 (1) 69 y Beginning - - ;
! 362 (2) 0 78 y - 33 - 1
i 803 (3) Ü 68 / y Beginning - - ;
: 873 (4) È 54 / y Moderate - -
: 1484(5) 0 62 y Mod/Sev - - -
; 1539(6) # 65 / y - - “ !
Ï 1624 (7) 64 y Mod/Sev - - '
1674 (8) 5 56 / y Beginning 48 - !
1859 (9) \}/-V... . 71 / y Mod/Sev 41.5 22.5 24 ;
1958(10) 79 / y - 44 - !
80 / y - 42 - ?
81 / y Mod/Sev 38 - -
2112(11) 65 / y Mod/Sev 35 19.5 16
; 2196(12) # 66 / y - - - :
; 2210(13) 65 y Beginning - - -
I 2369(14) ÿ 72 y Beginning - - -
: 2438(15) 0 60 / y Mod/Sev 32.5 21 14
1 2500(16) 5 52 / y Beginning 39 26 23 i
I 2597(1?) S 82 y y Beginning 32.5 17.5 19.5
; 2684(18) V 67 y y - - - -
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6.3. rCMRGlu between hemispheres.
As different hemispheres in the brain perform different tasks metabolic rates in 
these regions may also be expected to differ. To examine this a comparison of rCMRGlu 
between each hemisphere of a ROI was performed. Before any statistical testing could 
be carried out, the subject data had to be examined to determine whether the parametric 
t-test or non-parametric Wilcoxon test would produce valid results. The rCMRGlu for 
each of the 160 planar regions of interest (PROI) was calculated using the Rhodes 
method of analysis. Gaussian frequency distributions were then examined for each of the 
PROI using the 18 AD subjects. Furthermore PROI from the same main regions of the 
brain were grouped into 36 major brain regions as described in section 4.4.3 and the 
frequency examined again. Plotting the histograms in this way would make it easy to 
detect and eliminate rCMRGlu values which were clearly not correct. These values were 
unusually low and were caused by the PROI being misaligned during normalisation into 
Talairach space, i.e. if areas outside the brain were covered this would result in 
inaccurate and low readings. Also during the scanning reconstruction process not all 
planes were completely processed due to artefacts within the data, this also leads to 
erroneous readings. Figure 6.1 shows a typical histogram with PROI covering areas 
which are either misaligned or where measurements of rCMRGlu are not available, 
figure 6.2.
14 10 0 %
7 5 %
5 0 %
- 2 5 %
0%
54
rCMRGlu
Figure 6.1 : Frequency distribution for the caudate 
region of tire brain showing bad data points.
Figure 6. 2: Misaligned ROI for the 
CAU.
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Histograms of rCMRGlu were also expected to be slightly left skewed as PROI 
which incoiporate a small amount of background within its area would produce readings 
slightly lower than actual values, figure 6.1 exhibits this trend. As the t-distribution is a 
broadened normal distribution it is able to absorb this small deviations during statistical 
analysis. To determine whether the rCMRGlu had a normal distribution across brain 
regions the method of probits [Kir88] was applied to the frequency distribution. A 
Probit plot compares known frequency distributions with a set of probit points which 
represent a normal distribution. The resulting probit plot will be linear if the data is 
normally distributed or curved if it is not. This method was applied to the rCMRGlu 
data for the 160 PROI and 36 main ROI minor brain regions. Determination of how far 
the probit plot differs from linearity was performed on a statistical/visual basis.
Examination of the 36 left and right hemisphere ROI for all subjects led to CAU, 
INS, OCL, OCM, PAR, PUT, THA, and WHM (Table 4.2 explains the abbreviations) 
exhibiting non-normal distributions in both hemispheres of the brain. The right 
hemisphere additionally showing the CGP affected in the same way. Though the INS 
and WHM demonstrate a non-noimal distribution their data sets are small and so will 
affect their histograms. As sex has been shown to effect trace element distributions 
[Ste96] and rCMRGlu [Mur96], the separate hemispheres of males and females were 
explored. For the female left hemisphere the CAU, CGA, CGP, INS, OCL, OCM, PAR, 
PUT, SMS, THA, WHM showed a non-normal distribution. The right hemisphere 
showed even more drastic results with all ROI apart from the CER, MOT, and TEP 
producing a non-normal distribution. For the male left hemisphere the CAU, CGP, INS, 
PAR, PUT, TEP and THA had non-normal distributions while the right hemisphere did 
not show the extreme change that was observed in the females. Again CAU, CGP, INS, 
PAR, PUT, TEP and THA displayed non-normal distributions with the added region of 
WHM. Figures 6.3 and 6.4 show the histogram, cumulative frequency and probit plots 
for the female frontolateral region of the brain.
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Figure 6. 3; Distribution of rCMRGlu in the 
female left frontolateral region with the 
associated probit plot.
Female Right Frontal lateral cortex
rx/
y
50%
16 18 20 22 24 26 28 30 32 34 36 38 40 42 More
rCMRGlu
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Figure 6. 4: Distribution of rCMRGlu in the 
female right frontolateral region with the 
associated probit plot
In both female and male cases the thalamus, insula, caudate nucleus and 
putamen appear to be most affected regions in terms of distribution. Figure 4.9 shows 
these regions are centrally located within the brain. The normalisation of brain images 
predominantly uses the outer surface of the brain to resize the images. As such it may be 
expected that outer ROI are well placed resulting in good frequency distributions, while 
the location of the inner ROI may differ slightly from the actual position of the region 
specified.
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There aie clearly similarities for frequency distributions between left and right 
hemisphere for some ROI while differences exist for others, the later case been more 
noticeable in the female subjects. Whether these results show a loss of homeostatic 
control of glucose metabolism in AD, which can be attributed to a non-normal 
frequency distribution is hard to say as ideally a data set larger than eighteen subjects 
would be preferable. For some ROI the non-normal distribution may be due to small 
data sets such as in the CER, WHM and INS, this would lead to error within the 
statistical process. Even though, the lack of normal distributions in certain ROIs does 
bring into doubt the use of packages such as SPM 96 which inherently rely on Gaussian 
field theory to calculate significances between group studies. Clearly not all regions of 
the AD brain obey these laws.
Significance testing between hemispheres was performed using the relevant 
parametric or non-parametric test as determined by the probit analysis. Differences in 
rCMRGlu were examined between the eighteen left and eighteen right hemisphere ROI. 
The thirty-six ROI from the different hemispheres were also examined on an individual 
subject basis to determine whether any significant differences observed in the group 
analysis occurred for one particular person. Tables 6.2 a, b and c show the significant 
differences found between the hemispheres in all, female and finally male AD brains 
respectively.
Significant differences between rCMRGlu were found in fifteen of the eighteen 
regions examined when sexes were grouped. The three regions with no significant 
difference were the INS, WHM and TEM. A reason for there being no significant 
difference for the left and right insula and white matter may be statistical as only one 
ROI was taken for each patient for these regions. Female left and right rCMRGlu 
followed the same trends in significance and difference as seen in the grouped sex data. 
Again the male left and right differences followed the same trends with one notable 
exception, that of the temporal pole. The females having a significance value of p<0.1 
while for the males p=0.26, cleaiiy not significant. As significant differences were found 
between hemispheres in the majority of ROI, subsequent analysis separates all equal 
regions of the two hemispheres.
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Table 6 .2a: rCMRGlu between hemispheres of AD subjects.
; Region 
of 
Brain
rCMRGlu ii 
Left
I all subjects 
Right
Variation betwc
Difference
L-R
en hemispheres |
sig’ ; 
p-value
CAU 23.34+7.32 18.46+8.37 4.88+2.90 <0.001 i
CER 32.68+6.94 31.64+6.57 1.03+0.15 <0.002 ;
1 FRL 29.10+6.47 30.86+7.73 -1.76+1.57 <0.001
1 FRM 28.92+6.13 30.45+7.24 -1.53+0.70 <0.001
ICGA 29.12+6.78 32.27+7.20 -3.14+0.58 <0.001I CGP 30.13+7.10 32.49+7.86 -2.36+0.27 <0.001
flNS 31.68+6.02 32.60+7.62 -0.92+3.68 NS
I m o t 28.90+7.33 32.20+9.12 -3.30+1.89 <0.001
lOCL 24.94+6.81 29.70+8.09 -4.77+0.64 <0.001I  OCM 32.48+8.04 34.76+9.59 -2.28+0.66 <0.001
jPAR 22.02+6.65 27.35+8.67 -5.33+0.70 <0.001
PUT 28.48+7.64 25.61+7.12 2.87+1.90 <0.001
SMS 28.14+8.01 31.39+9.33 -3.25+1.34 0.001
fXEL 27.04+5.24 29.81+6.00 -2.77+0.38 <0.001
i TEM 22.22+4.11 22.73+5.25 -0.51+0.20 NS
I TEP 24.60+3.67 23.58+4.46 1.03+0.37 <0.08
1 THA 24.09+7.72 23.18+9.86 0.91+0.57 <0.004
I  WHM 15.15+3.29 14.93+3.88 0.21+1.43 NS
Table 6. 2b: rCMRGlu between hemispheres of female AD subjects.
[ Region 
of 
Brain
rCMRGlu in f
Left
emale subjects 
Right
Variation betwc
Difference
L-R
;en hemispheres |
Sig’ i 
p-value
i CAU 21.13+9.72 16.93+8.45 4.20+2.83 <0.001
1  CER 31.73+4.10 30.59+4.12 1.14+0.35 <0.003 1
FRL 28.03+6.20 29.33+6.50 -1.30+1.86 <0.001 :
FRM 27.39+5.77 28.75+6.43 -1.36+0.65 <0.001
i  CGA 27.86+7.29 30.36+7.02 -2.50+0.92 <0.002 i
i  CGP 29.14+7.18 31.55+7.90 -2.42+0.52 <0.001 i
! INS 30.90+5.16 30.68+4.94 0.22+1.95 NS ,
i MOT 26.82+6.85 29.79+7.17 -2.97+2.09 <0.001
I OCL 25.32+6.81 29.56+7.36 -4.23+0.90 <0.001 i
OCM 31.92+7.51 34.27+8.04 -2.35+0.79 <0.001 ■
PAR 22.89+8.22 26.91+8.77 -4.03+1.00 <0.002
i PUT 27.21+8.13 23.99+7.50 3.22+1.51 <0.001
SMS 26.78+6.99 30.05+8.06 -3.27+1.83 <0.03 I
1 TEL 27.25+4.26 29.48+5.13 -2.23+0.34 <0.001
1 TEM 22.16+3.20 22.26+3.91 -0.10+0.43 NS I
TEP 23.71+2.81 22.96+3.47 0.75+0.13 <0.1
THA 23.03+10.20 22.14+10.46 0.90+0.64 <0.01
WHM 15.11+3.91 14.57+4.36 0.55^+1.41 NS
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Table 6. 2c; rCMRGlu between hemispheres of male AD subjects.
1 Region 
of 
i Brain
rCMRGlu in 
Left
male subjects 
Right
Variation betwc
Difference
L-R
;en hemispheres
Sig’ ! 
p-value
i CAU 25.55+10.79 19.98+7.99 5.57+2.98 <0.001
CER 33.62+8.81 32.70+8.19 0.92+0.04 <0.02 •
FRL 30.17+6.57 32.40+8.53 -2.23+1.39 <0.07
! f r m 30.45+6.09 32.15+7.61 -1.69+0.87 <0.02
1 CGA 30.35+6.01 34.12+6.88 -3.76+0.40 <0.001
1  CGP 31.01+6.91 33.32+7.73 -2.31+0.39 <0.001 I
i INS 32.46+6.68 34.52+9.18 -2.06+4.55 NS ;
1 MOT 30.78+7.22 34.38+10.10 -3.60+1.73 <0.001
OCL 24.55+6.78 29.85+8.76 -5.30+0.47 <0.001 !
I  OCM 33.03+8.49 35.25+10.90 -2.22+0.55 <0.004 1
! PAR 21.26+4.73 27.73+8.57 -6.47+0.91 <0.001 i
PUT 29.75+6.87 27.23+6.32 2.52+2.30 <0.001 !
i  SMS 29.19+8.56 32.44+10.09 -3.25+1.39 <0.01
1 TEL 26.82+6.05 30.13+6.75 -3.32+0.44 <0.001 !
1 TEM 22.29+4.84 23.20+6.28 -0,91+0.23 NS
1  TEP 25.57+4.20 24.28+5.27 1.30+0.72 NS
1 THA 25.14+9.68 24.22+9.10 0.92+0.67 <0.01
1 WHM 15.18+2.51 15.30+3.29 -0.12+1.37 NS 1
Table 6. 3: Individual subject left/right differences.
Female left and right Male left and r ight 1Region of 
Brain Significantin Range of p-value
Difference. 
Trend as in 
grouped.
Significant
in
Range of 
p-value
Difference, j 
Trend as in | 
grouped, j
i CAU 7/9 0.1-0.002 8/9 8/9 0.1-0.001 ALL 1
CER 6/9 0.1-0.005 7/9 0/9 NS 7/9 1
FRL 6/9 0.1-<0.001 7/9 5/9 0.1-<0.001 6/9 ii FRM 6/9 0.1-<0.001 7/9 7/9 0.01-<0.001 7/9 :
1 CGA 6/9 0.1-0.002 8/9 7/9 0.1-0,001 ALL :
CGP 5/8 0.1-0.01 ALL 7/9 0.1-0.005 8/9 ;
INS - - 4/9 - 6/9 :
MOT 5/7 0.1-0.008 5/7 3/8 0.1-0.002 7/8 1
OCL 7/9 0.1-0.001 8/9 9/9 0.1-0.001 8/9 '
1 OCM 7/9 0.1-0.001 ALL 5/9 0.1-0.002 6/9 :
1 PAR 5/7 0.1-0.005 5/7 7/8 0.1-0.007 7/8 i
1 PUT 7/9 0.1-0.005 ALL 5/9 0.1-<0.001 8/9 1
1 SMS 2/7 0.1-0.05 5/7 1/8 0.1-0.008 ALL i
TEL ALL 0.1-<0.001 7/9 9/9 0.1-0.001 7/9
TEM 4/9 0.1-0.006 4/9 1/9 0.1-0.04 4/9 1
TEP 5/9 0.1-0.02 6/9 5/8 0.1-0.4 6/8 S
THA 4/9 0.1-0.04 7/9 2/9 0.1-0.03 8/9 i
WHM - 6/9 - - 5/9
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Exainkdng differences on an individual subject basis showed an evident 
heterogeneity to tlie disease. Table 6. 3 shows tlie number of individual subjects who 
had ROI witli significant differences in rCMRGlu between hemispheres. Also shown are 
number of subjects whose left and riglit hemispherical differences followed the same 
trend as observed in the sex grouped data. The subjects who did not show the same 
trend as the grouped data did so with no statistical significance. This as before, could be 
due to tlie disease duration of tlie patient, witli rCMRGlu in lobes of opposite 
hemispheres changing at a different rates. This is examined ftutlier in the longitudinal 
study in section 6.5. Finally rCMRGlu for both left and right regions of tlie brain were 
analysed witli respect to differences between the male and female subjects. Cleaily 
subject gioups could only be compai’ed using an impaired student t-test (or impaired 
Wilcoxon ranic test) due to the obvious nature of the data. As may be expected fi'om the 
results discovered when examining the fiequency distribution of rCMRGlu in tlie brain, 
significant differences were foimd between the sexes shown in Table 6.4.
Table 6,4: rCMRGlu differences between AD male and female subjects.
Region
of
Brain
Left femal
Difference 
M-F SD
e and male
Significance
p-value
Right femi
Difference 
M-F SD
lie and male
Significance
p-value
■ CAU 4.43 0.77 <0.05 3.05 0.71 <0.09
1 CER 1.89 0.39 NS 2.11 0.78 NS s
I f r l 2.14 1.28 <0.02 3.07 0.92 <0.003
IFRM 3.06 0.95 <0.002 3.40 0.90 <0.001
ICGA 2.49 1.05 <0.13 3.75 0.61 <0.03
! CGP 1.88 0.54 NS 1.76 1.03 NS
INS 1.56 0.78 NS 3.84 1.92 NS
MOT 3.96 1.00 <0.04 4.60 1.89 <0.05
OCL -0.77 0.60 NS 0.30 1.14 NS
1 OCM 1.11 0.91 NS 0.98 0.67 NS
I p a r -1.62 0.82 NS 0.82 0.97 NS
I p u t 2.54 0.83 <0.12 3.25 1.57 <0.03
I sm s 2.41 2.05 NS 2.39 0.69 NS
1 TEL -0.44 0.24 NS 0.65 0.17 NS
TEM 0.13 0.10 NS 0.94 0.66 NS
TEP 1.87 0.52 <0.07 1.32 0.72 NS
THA 2.11 1.02 NS 2.08 1.35 NS
WHM 0.06 0.03 NS 0.74 0.37 NS
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Generally rCMRGlu in both hemispheres was greater in males than female 
subjects with significant differences between the left female and male hemispheres 
detected in the CAU, FRL, FRM, CGA, MOT, PUT and TEP regions of the brain. In the 
right hemisphere female and male metabolic rates produced similar results but with the 
exception of the TEP region which was not significantly different, though the same 
trend was followed. The frontal region of the brain is in charge of awareness, 
intelligence, and storing memories along with some emotional function [CaiGO]. The 
frontal lobe is also responsible for administering all motor activity and contains parts of 
the heteromodal and supramodal association cortexes [BanOO]. The association cortex 
collates information from other parts of the brain and interprets them, the heteromodal 
and supramodal are just two ‘levels’ of the association cortices.
These results demonstrate that future analysis to be performed on AD data and 
controls must clearly separate information from PET into different sex and hemispheres. 
Furthermore, data has to be examined to discover whether the ROI exhibit a normal or 
non-normal distribution otherwise significance testing could be senseless. Additionally 
the age of a subject is a factor which has to be examined further, as research has shown 
differences in rCMRGlu with age [Mur96, Ble97]. The effect age has on rCMRGlu in 
the control brain is discussed in the forthcoming chapter.
6.3.1. Correlation between hemispheres.
With the noimal functioning of the brain it may be assumed that glucose uptake 
and metabolism in the left hemisphere of a particular lobe may not be the same but 
would be coiTelated to the metabolic uptake in the right hemisphere. The left and right 
regions of a hemisphere generally being used in similar tasks though one side is related 
to spatially executed tasks while the other is for non-spatial ones. Plotting rCMRGlu for 
left and right regions of a paiticular lobe resulted in sixteen of the eighteen regions 
having significant correlations all with correlation coefficients r>0.85 all with 
significance p<0.001. The two regions which did not show any significant correlation 
were the temporolateral region (r=0.50, p<0.001) and the temporal pole (r=0.48.
D. A. Cutts 143
Investigation into Brain Function: 6. rCMRGlu in AD and disease duration:
p<0.003). The lack of correlation was also observed in both male and female groups 
separately. The correlation for the frontomedial, temporal pole and temorolateral/medial 
regions are shown in Figure 6.5. Why the hemispheres of the TEL and TEP do not 
correlate is not known. Moreover why TEM correlates well while its other two 
associated regions do not is more puzzling. The temporal pole is known to be related to 
object recognition and memory [Nak96] along with general speech and auditory control, 
functions connected to the TEM and TEL regions [Stai98]. Correlations between lobes 
aie presented in chapter 7 with reference to the control subject group.
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Figure 6. 5; CoiTelation of rCMRGlu between hemispheres for the FRM, TEM, TEL and TEP.
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6.4. rCMRGlu between brain regions.
Whilst investigating the elemental concentrations in the AD brain only three 
lobes, the frontal, occipital and parietal were examined due to sample limitations. 
Furthermore, as different analysis techniques were used to detemiine elemental 
concentrations for the several lobes, different selections of elements were determined 
for each lobe. This meant that elemental concentrations between lobes could not be 
examined. Even though, a previous study of a selection of ‘normal’ brain tissue samples 
[Ste96] showed significant differences existed between lobes. For example P, S, K and 
Fe were significantly higher in the occipital compared to the frontal lobe with similar 
results found for the parietal lobe. These differences in elemental concentration may 
suggest a rCMRGlu that varies between lobes, as such an examination of rCMRGlu 
between lobes in the same hemisphere was undertaken. The differences between lobe 
metabolic rates are presented as metabolic ratios (MR), sometimes termed metabolic 
gradients. This is simply the ratio of one region’s rCMRGlu with reference to another 
with a ratio greater than 1 demonstrating that the region used as the numerator has a 
higher rCMRGlu and vice versa. MR between all regions of the brain studied by PET 
ROI analysis were calculated leading to a total of 306 pairs/ratios. Presented here are 
135 MR with relation to hyper or hypofrontal, occipital, parietal and cerebellum 
metabolism. The metabolic ratios for the separate male and female groups were also 
examined in addition to the grouped gender data.
The MR values can be seen in Table 6. 5 where significances from unity are 
quoted and significances between left and right MR. The change from unity for any ratio 
informs us of any differences in rCMRGlu between the two lobes examined. The 
metabolic ratios for the FRM lobe were significantly higher in the right hemisphere 
compared to left for the ratios with CAU, CER, PUT, THA and TEP, while the TEL, 
OCL and PAR were significantly lower. Although if the ratio was greater than unity in 
one hemisphere then this was also the case in the other. Interestingly the MR of the 
temporomedial region of the brain showed no change between hemispheres when 
significant differences were seen in the temporolateral region. The same can be said 
about the occipitolateral region which, when compared to the occipitomedial did display
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a significance between hemispheres. These groups were not differentiated between in 
the previous trace element work possibly inferring the need to separate these regions in 
future work. The frontolateral region displayed the same characteristics as the 
frontomedial, this was expected due to their metabolic ratio being equal to one.
For the occipitomedial lobe, significant valuations were seen between 
hemispheres for ratios with the CAU, CER, PUT, THA and TEP with higher MR in the 
right while the OCL and PAR had significantly lower ratios. The higher ratios denote 
that metabolic rates are higher in the OCM relative to the other regions in the right 
hemisphere than those of the left, vice versa for lower ratios. As differences were 
observed between OCL and OCM for the frontal lobe ratios, it was expected that ratios 
connected with the OCL would be different to those observed for the OCM region. All 
of the MR studied for the OCL, apart from the parietal, had a significantly higher 
metabolic ratio in the right hemisphere. Table 6. 5.
The parietal lobe again demonstrated significantly higher ratios in the right 
hemisphere for all regions except the OCL where as previously discussed no difference 
was observed. Finally the cerebellum revealed a decrease of ratio in the right 
hemisphere for the TEL, OCL, OCM, FRL and FRM, while the PUT and CAU showed 
a significant increase.
Further to examining whether the MR varied significantly between left and right 
hemispheres, a study was made to identify which ratios significantly varied from unity 
within each hemisphere. This will inform as to which regions have higher or lower 
rCMRGlu when compared to the other shown in Table 6. 5. Differences were noted in 
the FRM/TEL ratio where only the left hemisphere showed a significant difference from 
unity. The MR with OCL and CER followed the same trend while the PUT displayed a 
difference from unity in the right but not in the left. The remaining regions showing 
similar significances in either hemisphere. The FRL as expected followed the same 
vaiiation seen in the FRM. The metabolic ratios for the OCM only showed no 
significance from unity in the left cerebellum while the right differed in all regions. 
Eight out of the eleven pairs of ratio studied for the OCL differed. Again, five left and 
right parietal metabolic ratios showed significance in one hemisphere only, as did five in 
the cerebellum. Table 6.5 displays all relevant information.
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Though the results found here in AD subjects have not been compaied with, 
control subjects, the paper by Vollenweider [Vol97] provides information of control 
subject data for frontolateral and medial regions. Vollenweider used the same scanner 
and normalisation technique used in the studies here. A data set of controls is compared 
in the next chapter but these cannot be compaied directly here as different normalisation 
packages were used leading to the possibility of different results, this is discussed in 
chapter 8. The data set from Vollenweider’s work came from a group of 8 males and 7 
females roughly matching the set examined hero but the mean age was 33.3 ± 4.8. This 
clearly does not match the data here which has a mean age of 66.5 ± 8.1. As subjects 
should be age matched any compaiison made between the two studies only implies that 
there may be differences. The control study by Vollenweider was performed at the PSI 
under the same protocol as the AD scans used in the data analysis here, the same ROI’s 
were also used. And more importantly the same normalisation package SPM classic was 
also used. As significance testing could not be performed on the two data sets, as full 
sample details were not available for the Vollenweider study, a simple examination of 
the standard deviations was used. The MR examined by Vollenweider were with respect 
to the FRM and FRL and the regions TEM, TEL, OCM, OCL,PAR, CAU, PUT and 
THA.
The metabolic ratios for the left and right hemispheres between the AD work performed 
here and the VoUenweider work is presented in Table 6.6.  Metabolic ratios can be seen 
in certain lobes between AD and control subjects with some showing a greater change in 
the right hemisphere regions than in the left. Interestingly the MR between FRM/TEM 
in left and right hemispheres remains roughly the same in the young control study and 
the AD study. This may imply that these two regions are related functionally in some 
way and so the rCMRGlu decreases at the same rate. Kopelman [Kop89] found weak 
correlations between frontal lobe dysfunction and the temporal lobe in Alzheimer 
patients while a similar relationship between the lobes when one region suffered 
diencephalic lesions [Sta98].
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Distinguishing between genders for the MR of AD subjects led to just two 
differences in MR between left and right hemispheres for males. The metabolic ratio of 
FRM/TEL and FRL/TEL showed no significant difference between hemispherical 
regions unlike the grouped case (marked with a *  in Table 6. 7). The number of ratios 
in the separate hemispheres whose metabolic ratio significantly changed from the 
collective data set was five. These are marked on tables with a **’ in Table 6. 7 shows 
MR values for AD subjects only in the regions which varied significantly from the 
grouped data though ratios if greater than one in the grouped data were still greater than 
one in the male group, and vice versa. The reason for the changes seen may simply be 
due to the temporolateral region of the brain in AD may be affected to a greater degree 
in the female subjects. The AD female group displayed a far greater deviation in MR 
between hemispheres with six significant changes from the grouped data compared to 
just two in the males (marked with a *  in Table 6.8). These were seen for the ratios 
FRM/TEL, FRL/TEL, as observed in the males but additionally with FRM/TEM and 
FRL/TEM. The remaining two being the OCM/TEM and CER/TEM MR, again both 
involving the temporomedial region of the brain. Fourteen pairs had their metabolic 
ratio significance changed from the collective data to either significant or non­
significant, these are also marked with a in Table 6.8.
These results clearly show the need to distinguish between the rCMRGlu of 
female and male subjects and to separate the hemisphere. Researches who present MR 
data or even absolute rCMRGlu measurements without separating sex and hemispheres 
of the brain may be introducing false significances into their data. The relevance of the 
AD data analysed here will be examined in terms of a control data set in the next 
chapter though it can be seen that the preliminary comparison with Vollenweider’s 
controls shows interesting results.
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Table 6. 5: Metabolic ratios for all AD subjects.
/ Region of 
Brain
Aill
Metabolic
gradients.
SD
eft.
Sig’ from 
one. 
p-value
All ri
Metabolic
gradients.
SD
gilt
Sig’ fiom 
one. 
p-value
Significance j
between L & R ' 
ratios. ;
p-value
FRM/FRL 1.00 0.06 NS 0.99 0.05 NS NS 1
FRM/TEM 1.31 0.19 <0.001 1.35 0.20 <0.001 NS ;
FRM/TEL 1.08 0.16 <0.02 1.02 0.14 NS <0.13
FRM/OCM 0.90 0.10 <0.001 0.89 0.10 <0.001 NS
FRM/OCL 1.18 0.17 <0.001 1.04 0.13 NS <0.002 ;
FRM/PAR 1.34 0.23 <0.001 1.13 0.19 <0.03 <0.001 j
FRM/CAU 1.29 0.25 <0.001 1.80 0.58 <0.001 <0.001 !
FRM/CER 0.89 0.10 <0.001 0.96 0.12 NS <0.001 !
FRM/PUT 1.02 0.09 NS 1.20 0.15 <0.001 <0.001
FRM/THA 1.24 0.25 <0.001 1.37 0.34 <0.001 <0.001
FRM/TEF 1.16 0.12 <0.001 1.27 0.16 <0.001 <0.004 :
FRL/FRM 1.00 0.06 NS 1.01 0.05 NS NS
FRL/TEM 1.32 0.20 <0.001 1.37 0.20 <0.001 NS 1
FRL/TEL 1.08 0.13 <0.01 1.04 0.14 NS <0.09 I
FRL/OCM 0.91 0.11 <0.003 0.90 0.08 <0.001 NS g
FRL/OCL 1.19 0.15 <0.001 1.05 0.12 NS <0.001 :
1 FRL/PAR 1.35 0.24 <0.001 1.14 0.18 <0.02 <0.001 I
FRL/CAU 1.31 0.29 <0.001 1.84 0.61 <0.001 <0.001 f
FRL/CER 0.89 0.09 <0.003 0.97 0.11 NS <0.001 '
FRL/PUT 1.03 0.11 NS 1.22 0.15 <0.001 <0.001
FRL/THA 1.25 0.27 <0.001 1.40 0.36 <0.001 <0.001 1
FRL/TEP 1.17 0.13 <0.001 1.29 0.18 <0.001 <0.001
OCM/TEM 1.48 0.32 <0.001 1.54 0.26 <0.0001 NS
OCM/TEL 1.22 0.27 <0.001 1.17 0.20 <0.001 NS
OCM/OCL 1.32 0.22 <0.001 1.17 0.11 <0.001 <0.007 *
OCM/FRL 1.12 0.14 <0.004 1.13 0.09 <0.001 NS
OCM/FRM 1.12 0.12 <0.001 1.14 0.12 <0.001 NS r
OCM/PAR 1.51 0.29 <0.001 1.28 0.21 <0.001 <0.001
OCM/CAU 1.45 0.33 <0.001 2.07 0.70 <0.001 <0.001
1 OCM/CER 0.99 0.10 NS 1.09 0.13 <0.08 <0.001 ;
i OCM/PUT 1.14 0.15 <0.002 1.37 0.20 <0.001 <0.001 Î
j OCM/THA 1.39 0.30 <0.001 1.57 0.42 <0.001 <0.001
1 OCM/TEP 1.31 0.25 <0.001 1.45 0.23 <0.001 <0.001
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Table 6. 5: Metabolic ratios for all AD subjects (Continued).
! Region of 
Brain
A lll
Metabolic
gradients.
SD
eft.
Sig’ from 
one. 
p-value
Allr
Metabolic
gradients.
SD
ight
Sig’ from 
one. 
p-value
Significance
between L & R ! 
ratios. ■
n-value i
OCL/TEM 1.13 0.23 <0.02 1.32 0.24 <0.001 <0.001 s
OCL/TEL 0.92 0.14 <0.04 0.99 0.13 NS <0.006 i
OCL/OCM 0.77 0.11 <0.001 0.86 0.08 <0.001 <0.001
OCL/FRL 0.85 0.10 <0.001 0.96 0.11 NS <0.001 ;
1 OCL/FRM 0.86 0.12 <0.001 0.98 0.12 NS <0.001 J
OCL/PAR 1.15 0.19 0.05 1.09 0.13 NS NS ;
OCL/CAU 1.11 0.23 NS 1.77 0.61 <0.001 <0.001 ;
OCL/CER 0.77 0.12 <0.001 0.94 0.13 NS <0.001
OCL/PÜT 0.88 0.15 <0.003 1.17 0.20 <0.001 <0.001 1
j OCL/THA 1.06 0.24 NS 1.35 0.37 <0.001 <0.001 ;
1 OCL/TEP 1.00 0.16 NS 1.24 0.19 <0.001 <0.001 j
!1 PAR/TEM 1.03 0.25 NS 1.26 0.29 <0.001 <0.001
1 PAR/TEL 0.83 0.15 <0.001 0.94 0.13 NS <0.006 1
PAR/OCL 0.89 0.13 <0.05 0.93 0.10 NS NS ;
PAR/OCM 0.69 0.13 <0.001 0.80 0.12 <0.001 <0.001 !
PAR/FRL 0.76 0.13 <0.001 0.90 0.12 <0.02 <0.001 1
1 PAR/FRM 0.77 0.14 <0.001 0.91 0.15 <0.03 <0.001 :
j PAR/PUT 0.78 0.15 <0.001 1.07 0.18 <0.1 <0.001 1
I PAR/CAU 0.98 0.23 NS 1.62 0.53 <0.001 <0.001
I PAR/CER 0.68 0.14 <0.001 0.87 0.15 <0.03 <0.001 [
1 PAR/THA 0.94 0.28 NS 1.21 0.33 <0.007 <0.001
PAR/TEP 0.90 0.18 <0.04 1.17 0.24 <0.002 <0.001 1
1 CER/TEM 1.49 0.26 <0.001 1.42 0.20 <0.001 NS ;
CER/TEL 1.23 0.23 <0.001 1.08 0.17 NS <0.004
i CER/OCL 1.34 0.24 <0.001 1.09 0.16 NS <0.001
CER/OCM 1.02 0.11 NS 0.93 0.11 <0.09 <0.001
1 CER/FRL 1.13 0.11 <0.002 1.04 0.12 NS <0.002
1 CER/FRM 1.14 0.12 <0.001 1.06 0.13 NS <0.001
CER/PUT 1.15 0.15 <0.005 1.27 0.20 <0.001 <0.003
I CER/CAU 1.48 0.38 <0.001 1.92 0.67 <0.001 <0.001 1
CER/PAR 1.52 0.30 <0.001 1.18 0.22 <0.03 <0.001 !
1 CER/THA 1.41 0.34 <0.001 1.45 0.39 <0.001 NS J
CER/TEP 1.32 0.20 <0.001 1.34 0.16 <0.001 NS
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Table 6.6: Metabolic ratio for Vollenweider [Vol97] controls with oni AD.
Region of 
Brain
I
A
jeft boti
Metabolic
D
SD
I gender
gradients
Nor
S
mal
SD
A
Light botl
Metabolic
D
SD
1  gender
gradients.
Nor
S
mal
SD 1
FRM/TEM 1.31 0.19 1.32 0.13 1.35 0.20 1.39 0.18 I
FRM/TEL 1.08 0.16 1.08 0.07 1.02 0.14 1.10 0.08 !
FRM/OCM 0.90 0.10 1.03 0.09 0.89 0.10 1.06 0.13 :
FRM/OCL 1.18 0.17 1.22 0.11 1.04 0.13 1.26 0.08 :
FRM/PAR 1.34 0.23 1.06 0.06 1.13 0.19 1.10 0.07 i
FRM/CAU 1.29 0.25 1.04 0.08 1.80 0.58 1.06 0.06 1
FRM/PUT 1.02 0.09 1.03 0.10 1.20 0.15 1.02 0.07 !
FRM/THA 1.24 0.25 1.16 0.15 1.37 0.34 1.21 0.10 ;1
FRL/TEM 1.32 0.20 1.31 0.14 1.37 0.20 1.33 0.16 !
FRL/TEL 1.08 0.13 1.07 0.06 1.04 0.14 1.05 0.05 i
FRL/OCM 0.91 0.11 1.03 0.09 0.90 0.08 1.01 0.12 i
FRL/OCL 1.19 0.15 1.22 0.10 1.05 0.12 1.20 0.06 :
FRL/PAR 1.35 0.24 1.05 0.04 1.14 0.18 1.04 0.04 1
FRL/CAU 1.31 0.29 1.04 0.07 1.84 0.61 1.01 0.06 ;
FRL/PUT 1.03 0.11 1.03 0.09 1.22 0.15 0.97 0.05 !
1 FRL/THA 1.25 0.27 1.15 0.15 1.40 0.36 1.16 0.08 1
Table 6.7: Metabolic ratios for male AD brain, different to the grouped gender data.
; Region of 
Brain
Male
Metabolic
gradients.
SD
left,
Sig’ from 
one. 
p-value
Male
Metabolic
gradients.
SD
right
Sig’ from 
one. 
p-value
Significance
between L & R \ 
ratios. )
p-value !
1 FRM/TEL 1.15 0.15 <0.003 1.08 0.15 NS *NS 1
! FRL/TEL 1.14 0.14 <0.008 1.08 0.16 NS *^ NS '
! OCL/TEL 0.92 0.11 »NS 0.99 0.12 NS <0.05
1 PAR/PUT 0.71 0.08 <0.0001 1.01 0.16 *NS <0.002 !
PAR/CAU 0.85 0.16 * <0.07 1.49 0.55 <0.001 <0.003
PAR/THA 0.85 0.10 * <0.07 1.17 0.31 <0.12 <0.006
CER/OCM 1.02 0.06 NS 0.94 0.11 *NS <0.04 '
Î
* = Metabolic ratios different to tliose in tlie grouped gender study.
* = Significance between hemispheres different to grouped gender study.
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Table 6.8: Metabolic ratio for female AD brain, different to tire grouped gender data.
, —  111
i  Region of 
! Brain
 ^1 T r f f i * ' i n f i i  fciMii i if i
Femal
Metabolic
gradients.
SD
e left.
Sig’ from 
one. 
p-value
Female
Metabolic
gradients.
SD
right
Sig’ fi om 
one. 
p-value
Significance \ 
between L & R \ 
ratios. Î
p-value :
FRM/TEM 1.24 0.16 <0.001 1.30 0.18 <0.001 * <0.02 !
FRM/TEL 1.01 0.13 *NS 0.97 0.11 NS *NS !
FRM/PAR 1.20 0.23 <0.05 1.06 0.16 *NS <0.12
FRL/TEM 1.27 0.17 <0.001 1.33 0.21 <0.001 * <0.04 I
FRL/TEL 1.03 0.09 *NS I.OO 0.10 NS .^NS i
FRL/PAR 1.25 0.25 <0.007 1.08 0.14 *NS <0.04 i
OCM/TEM 1.44 0.28 <0.001 1.55 0.28 <0.002 * <0.004 1
OCL/TEM 1.15 0.26 *NS 1.34 0.27 <0.001 <0.001 i
OCL/TEL 0.93 0.16 *NS 1.00 0.13 NS <0.08 i
OCL/PAR 1.13 0.24 *NS 1.08 0.11 NS NS
1 OCL/CAU 1.23 0.17 * <0.03 1.94 0.60 <0.001 <0.002 I
1 OCL/PUT 0.93 0.13 *NS 1.25 0.20 <0.001 <0.001 '
1 PAR/OCL 0.92 0.15 *NS 0.93 0.09 NS NS ;
I PAR/FRL 0.83 0.15 <0.007 0.94 0.12 ’^ NS <0.02 1
1 PAR/FRM 0.86 0.16 <0.002 0.97 0.15 *NS <0.11 !
PAR/CER 0.74 0.17 <0.001 0.91 0.17 ’^ 'NS <0.007 !
PAR/TEP 1.00 0.21 *NS 1.23 0.25 <0.004 <0.02 ;
CER/TEM 1.44 0.14 <0.001 1.39 0.15 <0.001 * <0.07 !
* = Metabolic ratios different to tliose in the grouped gender study.
* = Significance between hemispheres different to grouped gender study.
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6.5, rCMRGlu with disease duration.
It is hard to determine the exact starting point of any form of dementia as the 
initial signs are often subtle. Even with the best cognitive tests used to determine brain 
function there will always an element of doubt in the result concerning the subjects 
natural mental ability. As such the AD subjects used in research here were diagnosed as 
having had dementia for between 1 to 4 years, the time taken to make certain that 
subjects indeed had AD. Even though, subjects may have had AD for a longer time 
period due to problems in determining the disease start date. Fortunately it was possible 
to obtain three PET images from one subject who had been suffering the effects of AD 
over a two year period. These images give an insight into the longitudinal effect of AD 
causes on the brain. Because the time period over which the scans were performed is 
known, accurate, relative disease duration is known. This information is usually hard to 
gather for reasons of ethics whereby there is no medical reason to expose the patient to 
unnecessary procedures which will not benefit but only be detrimental. As a result a 
literature search on AD duration with PET for individual subjects resulted in one hit 
[Sie95] for the period of 1990 to 2000 though much work has been performed on biopsy 
samples in terms of histopathological hallmark density [Bob97, 98] and psychological 
testing with disease duration [Sev93]. The subjects in the research by Siegel [Sie95] 
were also only scanned twice over a short six month period. Clearly for general, 
impression of how the brain is affected by disease duration more than one patient has to 
be examined. Moreover information from previous results have shown there is a 
difference in metabolic rates between males and females so a male study would also be 
required. This study seeks to establish whether such future research would be valid. 
Significance tests (paired t-testsAVilcoxon rank paired) were performed to determine 
rCMRGlu variation between hemisphere with disease duration and for the same lobes in 
one hemisphere with successive years. As results in the grouped data analysis lead to 
hemispherical differences, analysis here was performed on the two hemispheres 
separately.
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6.5.1, rCMRGlu between hemispheres.
An examination into the hemispherical differences in rCMRGlu between major 
regions of the brain was performed to see whether variations occurred with disease 
duration, these are seen in Table 6. 9. Ten regions, CAU, CER, FRL, FRM, OCL, OCM, 
PAR, PUT, SMS, TEL and TEM all mirrored the changes and significance seen in the 
female grouped data (Table 6. 2b) across all three scans while differences were noticed 
between hemispheres for the CGA, CGP, MOT, TEP and THA. There were insufficient 
data points to perform a statistical analysis on the INS and WHM but the absolute 
rCMRGlu values are shown. The difference between left and right hemisphere CGA 
regions exhibited no change for the first two scans but showed a lower left rCMRGlu 
for the final scan (p<0.01) where disease duration was greatest and so cognitively at its 
most severe. The CGP again exhibited no significant difference during the first scan but 
did in the next two in the left hemisphere, as seen in the CGA, having lower rCMRGlu. 
(p<0.1 at 67 yeai's, p<0.01 at 67.8 years). The rCMRGlu in the TEP was significantly 
higher in the left hemisphere for the first scan (p<0.1) but no significance was seen over 
the next two scans. Finally for the THA a significance of p<0.05 was obtained with the 
left hemisphere having the lower rCMRGlu contrary to the grouped data which showed 
a significant (p<0.01) higher rCMRGlu in the left hemisphere. No difference was 
observed over the next two scans. The results presented here indicate that disease 
duration should be considered when examining rCMRGlu in AD patients as differences 
in hemispherical metabolism are seen to change with the duration of AD. The fact that 
disease duration does appear to have an effect on rCMRGlu between hemisphere could 
explain the differences observed in the female and male groups. If ^  mean disease 
durations were significantly different between subject groups then hemispherical 
differences would be expected.
To investigate whether the rate of change of rCMRGlu varied during disease 
duration varied between hemispheres, rCMRGlu values for left hemisphere brain region 
were plotted against their associate right for all regions. A linear graph of gradient equal 
to one would then represent an equal rate of change in rCMRGlu for either hemisphere.
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It should be made clear that this does not mean that the rate of change within each 
hemisphere was also linear, this will be examined in the next section. All of the major 
regions were found to coixelate with their hemispherical twin with correlation 
coefficients of r>0.94 (p<0.001 for all), apart from the temporal pole r=0.7, p<0.01 and 
white matter r=0.88, p=0.1. Figures 6.6 and 6.7 show the correlations between 
hemispheres for the frontal lobe and temporal pole. With this method it was possible to 
remove any data points which cleaiiy did not fit the general trend. These regions were 
checked against ROI image maps for each scan in question and where ROI were 
observed to be misaligned, resulting in erroneous values of rCMRGlu, the ROI regions 
were removed.
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Figure 6. 6: Correlation of rCMRGlu between 
FRM left and right with disease duration for the 
female subject.
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Figure 6. 7: Correlation of rCMRGlu between 
TEP left and right with disease duration for the 
female subject.
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Table 6. 9: Differences in rCMRGlu of one female AD subject between hemispheres
with disease dur ation.
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6.5.2. Effect of disease duration on brain regions.
Although metabolic rates are not generally studied with respect to the disease 
duration of individual subjects, rather different subjects with different but possibly 
inaccurate disease duration determinations, brain function and metabolism are known to 
decline with increasing time [Her99]. What is not known is whether the decrease is a 
gradual decline during the disease time span or a sudden decrease which levels off. With 
the aid of the three scans here the progression rate of the disease was researched. The 
rate at which the rCMRGlu changes over the 2 year period in all 160 PROI along with 
the main 32 ROI was examined. As only three measurements were taken for each PROI 
the data would therefore not be expected to result in any significant differences. 
Preliminary analysis of the PROI showed each of these region associated with a 
particular main ROI changed at a ‘significantly’ equal rate and so indicating that 
grouping of PROI into ROI was acceptable. All major regions decreased in metabolic 
rate with increased disease duration apart from both the left and right cerebellum, left 
and right temporomedial regions and the right temporal pole. These showed an increase 
between the first two scans (one year period) followed by a decrease thereafter. Table 6. 
10 and 6.11 show the differences in rCMRGlu between contiguous scans and from first 
to last scans for the left and right hemispheres. As discussed in section 6.5.1 the rate of 
change of rCMRGlu over the two years the female subject suffered from AD were, in 
general, seen to decrease with similar rates for each hemisphere of a lobe/brain region. 
The correlations did not show what trend the rates followed so plots were made to 
determine whether the rate of change over the two year period was linear or non-linear. 
Linear least squares fitting was used to determine whether a linear or non-linear trend 
would best suit a particular ROI. To ascertain as to which relationship prevailed a 
coiTelation coefficient of r>0.95 was chosen as a threshold for each fitting technique. 
For the left hemisphere the MOT (p=0.19), OCL (p=0.21) and WHM (p=0.15) all had 
conelation coefficients of >0.95 but of very low significance and so a linear relation 
cannot be assumed. PAR (p<0.04), THA (p<0.06) did exhibit highly significant linear 
fits. The linear trends seen in the right regions were, CAU (p=0.14) and SMS (p=0.16) 
again both with low linear significances while the PAR (p<0.1) and THA (p<0.02) were 
seen to be significantly linear again, as observed in the left hemisphere. The majority of
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the remaining regions of the brain, including the regions of low linear significance 
visually had an ‘increasing rate of decrease’ in rCMRGlu between contiguous scans.
That is to say, in general a curve with increasing negative gradient was seen between 
scanning measurements. As already described there were five regions which were 
exceptions to the two generally decreasing trends described, these were the CER and 
TEM in both left and right regions while the TEP displayed a difference in only the right 
hemisphere. The metabolic rates increase in these regions over the first year and 
decreased thereafter although it cannot be said that the cerebellum rose significantly as 
the data set for this region did not contain enough PROI for significance testing. Even 
though if a simple comparison of the error on the rCMRGlu values were used the 
change seen was distinct. Figure 6.8 shows the parietal, frontal, occipital and temporal 
lobe along with the cerebellum and temporal pole, each showing the different trends 
observed. The temporomedial region increased with low significance with p=0.12 for 
the left, p<0.08 for the right hemisphere in the period between the two scans as did the 
temporal pole with high significance, p<0.02, in the right hemisphere. Over the next 
year the metabolic rate was seen to decrease significantly in all five regions which had I
initially shown an increase, these can be seen in figure 6.8 which show the trends seen |
in rCMRGlu over the period the three scans were performed. Interestingly the right 
temporal pole displayed the same change of rate as the right temporomedial region 
which may have suggest an error in placing the PROI on the left temporal pole region.
With re-examination of the PROI this was determined not to be the case. The different 
rates of change seen in the left and right hemispheres for the temporal pole also 
confiiTUS the lack of correlation observed between hemispheres in the previous section.
These results are again a clear indication for the need to separate left and right regions of 
the brain in future analysis along with the need for the length of disease duration to be 
known as accurately as possible. Attention must also be brought to the differences seen 
between the temporolateral and temporomedial regions. Here both regions exhibited 
different rates of change with disease duration this has implications in trace element 
studies where biopsies are only defined as being talcen from the temporal lobe. Clearly 
there is a need to separate such data in the future.
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Table 6.10: Difference in rCMRGlu of a region between increasing disease 
duration. Female subjects left hemisphere.
Î Region of 
! Brain.: LEFT
65.6 to 67.8
Difference
SD
years I
Sig’ 
p-value 1
65.6 to 67.0
Difference
SD
years
Sig’
p-value
67.0 to 67.8
Difference
SD
years 
Sig' 1jp-value :
I CAU -15.07 3.79 <0.001 1  -3.15 2.46 <0.06 -11.92 4.57 <0.006 ;
; CER -9.67 0.23 <0.02 B 2.97 1.56 NS -12.64 1.33 <0.07 Î
FRL -15.47 4.49 <0.001 1 -4.75 4.27 <0.004 -10.72 1.59 <0.001 !
FRM -13.48 3.29 <0.001 -3.34 3.83 <0.02 -10.14 1.86 <0.001 1
ICGA -17.40 1.52 <0.001 -4.59 2.06 <0.03 -12.81 1.66 <0.001 !
CGP -16.31 0.80 <0.001 -1.90 0.85 <0.03 -14.42 0.30 <0.001 i
IlNS -17.31 - - -5.28 - - -12.03 - i
MOT -19.25 3.62 <0.02 -6.99 3.65 <0.12 -12.25 1.31 <0.001 1
OCL -18.29 0.60 <0.001 -6.21 3.35 <0.05 -12.08 3.24 <0.008 !
OCM -18.83 1.21 <0.001 -4.41 2.60 <0.06 -14.43 1.48 <0.001 1
|P A R -19.86 1.99 <0.005 -11.43 1.63 <0.01 -8.43 0.96 <0.006 ;
PUT -18.38 3.67 <0.001 -6.04 1.63 <0.002 -12.34 2.68 <0.001 i
SMS -15.70 2.11 <0.08 -3.27 2.40 NS -12.43 1.82 <0.001 !
ÏTEL -11.56 1.68 <0.001 -1.17 0.99 <0.13 -10.40 0.93 <0.003 Î1 TEM -4.35 1.53 <0.06 3.12 1.81 <0.13 -7.47 0.27 <0.001 i
TEP -8.17 2.12 <0.03 -1.88 1.36 NS -6.29 1.50 <0.03 !I tha" -15.72 3.13 <0.001 -8.61 2.18 <0.001 -7.12 3.55 <0.02 !
! WHM -7.87 - -3.47-T--- - - -4.41 - _ -
Table 6.11: Difference in rCMRGlu of a region between increasing disease duration.
Female subject right hemisphere.
Region of 
Brain. 
RIGHT
65.6 to 67.8
Difference
SD
years
Sig’
p-value
r  65.6 to 67.0
Difference
SD
years
Sig’
p-value
67.0 to 67.8
Difference
SD
years ;
Sig’ i
p-value j
i CAU -13.35 4.11 <0.003 -5.79 1.43 <0.001 -7.56 2.75 <0.005 1
1 CER -9.76 0.41 <0.03 2.40 1.56 NS -12.16 1.15 <0.06 ;
| f r l -16.03 5.42 <0.001 -5.79 3.77 <0.001 -10.24 2.52 <0.001
IFRM -13.68 4.30 <0.001 -3.64 3.80 <0.009 -10.03 1.92 <0.001 j
CGA -16.60 1.42 <0.001 -3.14 1.33 <0.03 -13.46 1.17 <0.001 1
! CGP -16.99 2.52 <0.001 -2.91 1.42 <0.04 -14.08 1.50 <0.001 1
INS -13.44 - - -4.65 - - -8.79 - i
MOT -14.84 1.47 <0.003 -3.07 3.21 <0.06 -11.77 1.80 <0.001 I
OCL -16.48 1.21 <0.001 -3.75 2.32 <0.07 -12.74 1.19 <0.001 !
OCM -20.01 0.63 <0.001 -4.83 2.55 <0.05 -15.18 2.36 <0.002 1
PAR -19.75 0.58 <0.001 -8.81 1.71 <0.02 -10.95 2.24 <0.02 1
PUT -16.87 3.00 <0.001 -5.84 2.56 <0.01 -11.02 0.55 <0.001 1
SMS -20.81 1.98 <0.005 -8.60 0.83 <0.004 -12.21 1.78 <0.001 ,
TEL -11.02 2.63 <0.005 -1.82 2.06 NS -9.20 0.70 <0.001
TEM -3.55 0.20 <0.002 3.41 1.49 <0.08 -6.96 1.45 <0.02
1 TEP -5.50 1.11 <0.02 2.63 0.48 <0.02 -8.13 1.13 <0.01
I THA -17.42 3.27 <0.001 -10.46 1.32 <0.001 -6.95 3.32 <0.01 !
I WHM -6.78 - - 1 -0.63 0.00 - -6.14 -
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Figure 6. 8: rCMRGlu with disease duration in selected lobes of a female AD subject.
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6.5.3. Metabolic ratios with disease duration.
Metabolic ratios (MR) are a common way of presenting rCMRGlu data as 
absolute measurements can be of different magnitudes due to the different techniques 
used to inteipret PET information. As absolute rCMRGlu measurements were seen to 
vary with disease duration it may imply that MR do the same. If the ratio between two 
regions remains the same throughout the duration of AD this would imply the 
correlation of rCMRGlu between the two regions also remains the same. As with the 
AD subject grouped data 135 metabolic ratios were again examined but this time for 
changes over the two-yeai' scanning period.
6.5.3.1. Ratios of the frontomedial/lateral regions (FRM/L).
No significant changes were observed in metabolic ratios for the left hemisphere 
with FRM for the FRL, OCM and TEL regions. Throughout the two year period both 
FRL and TEL did not vary from unity showing equal metabolic rates between these 
regions with disease duration, Table 6. 12. These MR matched data determined for the 
earlier female group AD study. Correlations between the function of the frontal lobe and 
the temporal lobe in Alzheimer and control subjects were found to exist in research by 
Kopelman [Kop89] which may explain the FRM/TEL pattern, though it should be noted 
that this was not observed for the TEM region. The remaining ratios were all observed 
to change with disease duration with the TEM, TEP and CER region all decreasing, 
though the latter region only noticeably decreased after the second scan. A decreasing 
ratio signifying that the rCMRGlu in the FRM region is decreasing at a faster rate than 
that of its associated region. The remaining ratios with the regions OCL, PAR, PUT, 
THA and CAU all increased with disease duration with the CAU ratio not changing for 
the first two scans but then increasing between the second and final scans. Here an 
increasing ratio indicates rCMRGlu for the FRM now decreases at a slower rate than 
regions OCL, PAR, PUT and CAU.
For the right hemisphere MR were similar to those seen in the left. Ratios with 
FRL, TEL and OCM were again constant throughout the scanning period but also with 
the addition of OCL which, though increased slightly did not significantly do so in
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contrast to the left hemisphere where it did. The ratios containing the regions TEM, 
TER and CER all decreased as was seen in tlie left hemisphere with CER again only 
seen to decrease after the second scan. Similarly increases were seen for Üie regions 
CAU, THA, PUT and PAR again with die same ttends as the left hemisphere. Figure 6.9 
shows MR witii disease duration for the selected FRM ratios, the mean values for the 
female group data are also shown. Due to die shnilaiity between the FRM and FRL witii 
the metabolic ratio between both being approxhnately equal to one in all dnee scans, 
MR results for the FRL regions were expected to and did follow the same trends as die 
FRM. The average ratios for the all AD subjects are hsted in Table 6.5.
Table 6.12: Metabohc ratios with disease duration for a female AD subject for the
FRM left and riglit regions.
< Region of 
Brain 
Left
65.6 ]
Metabolic
gradients.
fears
SD
67.0 >
Metabolic
gradients.
ears
SD
67.8 J
Metabolic
giadients.
ears
SD
FRM/FRL 0.95 0.17 0.99 0.11 1.01 0.14 i
FRM/TEM 1.60 0.16 1.24 0.11 1.18 0.12 ;
FRM/TEL 1.08 0.12 1.01 0.07 1.03 0.07
FRM/OCM 0.79 0.08 0.80 0.08 0.86 0.08
FRM/OCL 0.92 0.10 1.00 0.19 1.12 0.15 1
FRM/PAR 0.90 0.12 1.18 0.13 1.17 0.13 ‘
FRM/CAU 1.12 0.28 1.13 0.36 1.37 0.40
FRM/CER 0.95 0.09 0.78 0.06 0.77 0.06 I
FRM/PUT 0.87 0.16 0.93 0.16 1.01 0.14 i
FRM/THA 0.97 0.25 1.18 0.40 1.08 0.32 ^
FRM/TEP 1.25 0.15 1.20 0.09 1.06 0.08 ■
Right
FRM/FRL 0.91 0.17 0.96 0.11 0.96 0.10 i
FRM/TEM 1.69 0.21 1.29 0.13 1.22 0.09
FRM/TEL 1.02 0.15 0.96 0.09 0.91 0.06
FRM/OCM 0.78 0.10 0.79 0.10 0.87 0.08 >
FRM/OCL 0.89 0.11 0.88 0.09 0.93 0.08 !
FRM/PAR 0.81 0.10 0.92 0.10 0.93 0.07 ;
1 FRM/CAU 1.39 0.33 1.62 0.36 1.83 0.22
! FRM/CER 1.02 0.12 0.85 0.07 0.86 0.06 Ï
FRM/PUT 0.99 0.17 1.06 0.11 1.16 0.13 ^
1 FRM/THA 0.97 0.25 1.25 0.41 1.17 0.33 i
1 FRM/TEP i  1.47 0.19 1.18 0.10 1.15 0.09 g
: _ _ _ _ _ _ _ _ _  1  _
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6.S.3.2. Ratios of the occipitomedial/lateral regions (OCM/L).
The ratio OCM/PUT was tlie only MR not to vary over tlie scanning period in 
tlie left hemisphere. However in the right hemisphere ratios witli PUT, PAR and OCL 
remahied constant. The OCM/OCL MR presents tlie most intriguing result with the left 
hemisphere displaying an increase in rCMRGlu over tlie tliree studies wliile no change 
was observed in tlie riglit. Reasons for this are not Icnown but the fimction of tlie two 
medial and lateral regions witliin a hemisphere may be different. This adds to evidence 
for the need to separate medial and lateral regions of brain tissue samples. The ratios 
involving TEM, TEL, CER and TEP were all obseiwed to decrease at various rates 
during scaiming wliile tlie CAU ratio in tlie left hemisphere was the only one seen to 
increase. Fmally tlie THA had a unique trend with an mcrease in ratio over the fist year* 
but decreasing in the second. With the exception of the THA generally across regions, 
rCMRGlu is decreasing at a faster rate in die OCM than other region examined.
Table 6,13: Metabolic ratios witii disease dmation for a female AD subject for the
OCM left and right.
Region of 
Brain 
Left
65.6
Metabolic
giadients.
pears
SD
67,0:
Metabolic
gradients.
pears
SD
67.8:
Metabolic
gradients.
pears
SD 1
OCM/TEM 2.02 0.06 1.55 0.15 1.38 0.12
OCM/TEL 1.37 0.08 1.27 0.10 1.20 0.07
OCM/OCL 1.16 0.06 1.26 0.24 1.31 0.17 !
OCM/PAR 1.13 0.11 1.48 0.17 1.36 0.15 I
OCM/CAU 1.42 0.33 1.42 0.45 1.60 0.46 :
OCM/CER 1.20 0.03 0.98 0.08 0.90 0.05 f
OCM/PUT 1.10 0.17 1.17 0.20 1.18 0.15 1
OCM/THA 1.23 0.29 1.49 0.51 1.26 0.37 >
OCM/TEP 1.57 0.11 1.51 0.13 1.23 0.08
1 Right
OCM/TEM 2.16 0.10 1.63 0.20 1.40 0.10 ;
OCM/TEL 1.30 0.13 1.22 0.13 1.04 0.08 !
i OCM/OCL 1.13 0.04 1.11 0.14 1.06 0.10
OCM/PAR 1.04 0.04 1.17 0.15 1.06 0.08 !
! OCM/CAU 1.77 0.37 2.06 0.47 2.10 0.25
OCM/CER 1.30 0.06 1.08 0.11 0.99 0.07 '
OCM/PUT 1.26 0.16 1.35 0.16 1.33 0.15 1
OCM/THA 1.24 0.28 1.58 0.53 1.33 0.38
OCM/TEP 1.88 0.11 1.49 0.16 1.31 0.11 1
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As may be expected by the variation in OCM/OCL ratio in the left hemisphere 
the OCL ratios are not the same as OCM ratios. These ratios can be seen in Table 6. 13. 
The CER, TEL, TEM and TEP followed the same decreasing trend as the OCM though 
the ratio was lower in the OCL. THA decreased as previously seen but the CAU and 
PAR region displayed different trends to those of the OCM, both ratios not changing 
with time. In the right hemisphere the ratios decrease or increase with trends seen for the 
OCM right, this was expected as the ratio OCM/OCL was constant in this hemisphere.
6.S.3.3. Ratios of the parietal lobe (PAR).
Generally ratios decreased between first and final scans implying a greater rate 
of decrease for rCMRGlu in the parietal region compared to other regions examined. 
The MR with TEM, TEL, CER and TEP decreased in both hemispheres while PUT only 
did so in the left. The ratios are presented in Table 6. 14.
6,5.3.4. Ratios of the cerebellum (CER).
In general MR increased in the cerebellum for both hemispheres. Table 6. 14. 
This signifies that the rCMRGlu for the CER decreases at a slower rate than the regions 
it is compared with. This result is in keeping with research that has shown that the CER 
in relatively preserved with the onset of AD although recently research has brought this 
assumption into question with numbers of senile neuritic plaques being detected 
[Lar97]. The only ratio not seen to increase with disease duration is that of the 
temporomedial which decreases. This region has also been shown to preserve some 
integrity with the onset of AD.
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Table 6.14: Metabolic ratios with disease duration for a female AD subject for 
tlie PAR & CER left and riglit.
1  Region of 65.6 67.0 67.8
Brain
Left Metabolicgradients. SD Metabolicgradients. SD Metabolicgradients. SD
PAR/TEM 1.78 0.18 1.05 0.11 1.01 0.12 i
1 PAR/TEL 1.21 0.13 0.85 0.08 0.88 0.08 !
I  PAR/PUT 0.97 0.19 0.79 0.15 0.86 0.13 i
1 PAR/CAU 1.25 0.31 0.96 0.31 1.17 0.34 1
1 PAR/CER 1.06 0.10 0.66 0.06 0.66 0.06 1
1 PAR/THA 1.09 0.28 1.00 0.35 0.93 0.28 !
1 PAR/TEP 1.39 0.16 1.02 0.10 0.90 0.09 1
' CER/TEM 1.68 0.05 1.58 0.10 1.53 0.11 !
1 CER/TEL 1.14 0.07 1.29 0.05 1.33 0.03 !
i  CER/PUT 0.92 0.14 1.19 0.19 1.31 0.15 !
1  CER/CAU 1.18 0.27 1.44 0.45 1.78 0.50 !
1  CER/THA 1.03 0.24 1.51 0.51 1.40 0.41 i
i  CER/TEP 1.31 0.09 1.54 0.07 1.37 0.05 j
Right
1 PAR/TEM 2.08 0.07 1.39 0.14 1.32 0.06
1 PAR/TEL 1.25 0.12 1.04 0.09 0.98 0.04 i
1 PAR/PUT 1.21 0.15 1.15 0.12 1.26 0.12 !
1 PAR/CAU 1.70 0.36 1.76 0.38 1.98 0.21 Î
I  PAR/CER 1.26 0.04 0.92 0.07 0.93 0.04
i  PAR/THA 1.20 0.27 1.35 0.44 1.26 0.35 Î
! PAR/TEP 1.81 0.10 1.27 0.11 1.24 0.07 :
! CER/TEM 1.66 0.06 1.52 0.10 1.42 0.04 !
; CER/TEL 1.00 0.10 1.13 0.05 1.05 0.03 i
1 CER/PUT 0.97 0.12 1.25 0.09 1.35 0.12 g
! CER/CAU 1.35 0.29 1.91 0.39 2.13 0.21 S
CER/THA 0.95 0.22 1.47 0.47 1.35 0.37 i
1  CER/TEP 1.44 0.08 1.39 0.05 1.33 0.06 i
In relation to tlie MR detennined for all female subjects, the ratios for all regions 
determined ftom tlie longitudinal study tend to approach these mean values, then siupass 
them. Tliis was tlie case for both hemispheres of the brahi. This result may be expected 
as tlie grouped data will contain subjects in a variety of different stages of dementia 
therefore tlie mean rCMRGlu values obtained will represent the mean disease duration 
of the group. Results here have shown tliat infoimation on tlie effect AD has on 
rCMRGlu witliin tlie brain will be lost if AD subjects are grouped together. Some
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research has shown that, at the beginning of FAD and SAD, the temporomedial region is 
noticeably affected [MizOO, ConvOO], Results here on SAD subjects tend to point to the 
same conclusion with rCMRGlu in the temporomedial being significantly lower than the 
lateral region in AD early stages, shown in figure 6.9. Clearly fi"om this figure if 
comparisons are made between temporomedial and lateral regions at the early and later 
stages of AD they will give different results. Corollary to this, determining the MR fi'om 
a patient could be used to determine the disease duration if a definite pattern in MR can 
be found with time. In future research care has to be taken in terms of disease duration 
of a subject.
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Figure 6. 9: Variation in metabolic ratio with disease duration for a female AD subject. FRM 
ratios with the regions OCM, OCL, TEM and TEL.
The Boxes denote the average MR for the female group study.
6.6. Psychological testing.
It is essential to test the mental state of subjects in order to determine whether 
their dementia has been correctly identified. Simple correlations were performed to 
discover whether the psychological tests given to the subjects showed any general trend 
with glucose utilisation in a particular region. Both ERFC and MMS tests used to
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categorise subjects concentrate on cognitive tasks and not experiences of the subject so 
the variables may be expected to correlate with quantitative cognitive decline measured 
with PET. Previous research by Mouton determined a high degree of correlation 
between MMS score and atrophy in the brain [Mou98]. A copy of a typical MMS test is 
given in Appendix A with the advice that anyone with a score lower than 28/30 is 
considered demented. Regional rCMRGlu and total CMRGlu for the whole brain was 
plotted against ERFC and MMS score. For all the ROI and the whole brain no 
significant correlations were observed with no correlation coefficient greater than r = 0.4 
for both EFRC and MMS. In fact the Folstein MMS test appeared to show an overall 
increase in CMRGlu with decreasing MMS score contrary to logic, though the 
correlation coefficients all had no overall significance. One subject (1958) had their 
EFRC scores measured over a period of 2 years though unfortunately only one PET 
study was carried out at the end of the this period. Interestingly when the scores are 
plotted against time a curve is produced which follows the same trend as the majority of 
the ROI in the AD female longitudinal study, figure 6.10.
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Figure 6.10: Plot showing how the trend in the standardised 
mental score of subject 1958 compares with the standardised 
metabolic rate of the FRM in the female AD subject.
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Though there appears to be correlation between EFRC and rCMRGlu, this 
cannot be confirmed as data are from different subjects. Even though it is clear from 
these results that for accurate information for the diagnosis and progression of dementia, 
a number of mental tests should be taken over a period of time as a low score may 
simply show a lack of mental ability rather than brain deterioration. This is shown in the 
lack of coiTelation observed in the grouped mental state data. As the MMS and EFRC 
data showed no coixelation with rCMRGlu, it was decided not to carry out a severity 
matched study as clearly this would not result in any practical or useful conclusions.
6.7. Conclusions.
The PET investigation into AD subjects has shown that there is a need to study 
both sex and hemispheres of the brain separately. AD subjects were seen to have 
significantly different rCMRGlu in the left and right regions of the frontal, occipital and 
parietal lobes. This is also important as the trace element work showed differences in 
the concentrations of certain elements between hemispheres, other research has also 
proved this [Ste95]. As differences were observed in rCMRGlu between the sexes it 
cannot be assumed that both male and female subjects follow the same trends in terms 
of disease duration. For example, the frontal lobe displayed significant differences 
between male and female subjects with females having a rCMRGlu significantly lower 
to males with the onset of AD. Generally, there is little information on how metabolic 
rates differ between hemispheres of the same lobe. These provisional results illustrate 
that differences do exist between hemispheres in AD subjects. Vollenweider [Vol97] 
and Muiphy [Mur96] have shown differences between left and right hemispheres in 
control subjects which show different results to the AD study which were obtained here. 
A control group is studied in the next chapter.
Investigating links between rCMRGlu data and the elemental work led to a 
number of possible connections. A significant decrease in the dry to fresh weight ratio 
of brain tissue was observed with increased disease duration in AD so informing us of a 
progressively increasing amount of fluid in the AD brain. Values for the rCMRGlu were 
also found to decrease in these lobes with disease duration but whether these two
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parameters are correlated cannot be remai'ked upon here. A general decline in rCMRGlu 
was observed in the majority of brain regions during AD duration with an increasing 
rate of decline in later years. However the temporomedial rCMRGlu was seen to be 
significantly lower than its temporolateral associate at the time of the first scan then 
rising until eventually decreasing, figure 6.8. The temporomedial region has been shown 
to be affected eaiiy by many reseai'ches [MizOO, ConvOO] and these results confirm this 
finding. As a result problems will occur when comparing elemental data with metabolic 
rates as the temporal lobe was examined as a whole so no distinction was made between 
medial and lateral regions. The concentration of zinc has been found to increase in AD 
subjects in the temporal lobe [Ste96] and it has been suggested that this was due to the 
increase of CuZn-SOD as a protective mechanism against free radical production 
[Smi95]. The temporomedial region showed an increase in iCMRGlu over the first year 
of the longitudinal study, this maybe due to the increase in the production of CuZn-SOD 
or its protective effect. One important finding from Kennedy [Ken94] was the 
hypometabolism in the left temporal lobe seen at a relatively short disease duration time. 
Results here appear to corroborate with this finding as metabolic rates in the TEM for 
the longitudinal study were initially significantly lower than the TEL.
The elemental composition of the parietal lobe only differed in the chlorine 
concentrations which were lower than in the frontal lobe. During the duration of the 
disease the metabolic ratios between FRM/PAR and FRL/PAR were initially less than 
one and rising above one at the time of the final scan. This shows a change from 
hypermetabolism to hypometabolism from the parietal lobe compared to the frontal 
regions. In work by Kennedy [Ken94] atrophy was also seen in the parietal lobe to a 
greater significance than other lobes this may suggest that atrophy and metabolism are 
linked, a result which is documented [Yam97, Sla95] although not all researches agree 
with this finding [Iba98]. Frackowiak discovered frontal hypometabolism in the severely 
affected patients when compared to controls [FraSl], this is associated with poorer 
attention skills and verbal fluency [Hax88]. Frontal reductions of blood flow have been 
shown to be associated with depression [Dol92].
The in vitro study of trace elements between left and right hemispheres 
differences in concentrations for P and Fe in the frontal lobe were detected where in
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‘normal’ subjects the concentrations were significantly higher in the right hemisphere 
than in the left. Murphy [Mur96] and Vollenweider [Vol97] showed the left hemisphere 
to have a higher rCMRGlu in the frontal lobe in control subjects compared to the right. 
Contrary to this, the AD brain tissue showed P and Fe and additionally S to have 
significantly higher concentrations in the left hemisphere than in the right. While our 
work on rCMRGlu in AD shows the right hemisphere to have a higher rCMRGlu for the 
frontal lobe compared to the left.
Phosphorous is well known to be involved in biological energy within the brain 
in the form of adenosine triphosphate which can only be produced by neurons from the 
metabolism of glucose. As a result, the higher concentration of P in the right hemisphere 
of the normal brain may explain the lower rCMRGlu in the same hemisphere. The lower 
rate of rCMRGlu, which requires less P would therefore result in a higher concentration 
of the element in this particular hemisphere. The converse can be said about the left 
hemisphere in the ‘normal’ brain, with a lower concentration of P and higher rCMRGlu. 
Again this same hypothesis can be applied to the AD subjects but why there should be 
an inversion in the concentration of P and Fe and the rCMRGlu between left and right 
hemispheres cannot at present be explained. Iron followed the same trend as 
phosphorous and is known to be involved in neurotransmitter synthesis and metabolism 
[Tho88] so the concentration following the same trend as phosphorous might have been 
expected. To determine whether the suggested relationship between P, Fe and rCMRGlu 
exist it would clearly be desirable to perform correlations between these variables. 
Unfortunately this is impossible to achieve as PET studies of patients who have donated 
brain tissue samples would have to be performed before the patient died to be able to 
perform correlation analysis.
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7. Age variation of rCMRGlu in control subjects.
7.1. Introduction.
It has been reported by many researches that the metabolic rate of glucose within 
the brain decreases in many regions with the onset of many neurological disorders such 
as AD [Sie95], Parkinson’s [Ots96] and Huntington’s disease [Ant96]. Analysis usually 
consists of a set of control subjects which is then compared to a set containing one 
particular kind of neurological disorder. Rarely are groups matched for age or sex and 
even those which have, do not further distinguish between hemispheres of the brain. 
This is a variable that appears to be of some importance with reference to chapter 6 and 
the rCMRGlu in the AD brain.
In chapter 6 regional cerebral metabolic rates of glucose (rCMRGlu) were seen 
to vary between sex and hemispheres of the brain with the added variable of disease 
duration. The precise reason for the changes is not known but changes in the blood 
brain barrier have been suggested [Ehm86]. This would result in vital trace elements not 
entering the brain which in turn would decrease the function of the part of the brain 
which requires this element. As a consequence the region would then not require as 
much ATP and hence lead to a lower metabolic rate. A review of PET studies into the 
ageing brain has shown small but general hypometabolism across most brain regions 
[Mur96, Ble97]. As with studies on AD subjects a review of literature resulted in large 
variations in the way quantitative rCMRGlu results for control subjects were obtained. 
Again some researchers using models based on rate constants ki to k4 while others kj to 
ks (section 3.5.2), while others used general uptake models such as the Rhodes method. 
Many researchers completely neglect to publish the method used to reconstruct 
metabolic images and as such comparisons between publications or published data 
cannot be directly made. It has been shown that absolute rCMRGlu values can vary 
greatly depending on the pharmacokinetic model even if the same data set is used due to
constraints applied to each model [Rho83]. A brief review of calculated metabolic ratios
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can be seen in Table 7. 1 which shows the variation in ratios between papers witli 
respect to different age ranges. Clearly tlie table shows the disparity in the vaiiables 
examined with medial and lateral regions sometimes grouped along witli gender and 
hemispheres. The majority of control studies are conducted along side tliose of 
nemological disorders such as depression [ConOO], schizophrenia [Mal98] or even the 
physical effects of anorexia nervosa [Del95, 97]. As a result, rai ely are all regions of die 
brain examined as many are not relevant to the disorder.
Table 7.1: Literatiu e review of rCMRGlu metabolic ratios widi age in control subjects.
; Region of 
Brain Vol9733y
Left I Right
DeI97
26y
Both
Me
Del9S
24y
Both
tabolic ratios
Mui’96
53y 
Left Right
KatOO
63y
Both
Haz9S
20y
Both
Haz98
SOy
Both 1
; FRM/TEM 1.32 1.39 1.19 1.18i FRM/TEL 1.08 1.10 1.13m 1.13m 1.01 1.05 0.97i FRL/TEM 1.31 1.33 1.20 1.20 l.llf l.llfi FRL/TEL 1.07 1.05
; FRM/OCM 1.03 1.06
1 FRM/OCL 1.22 1.26 1.09m 1.07m 1.01 1.11 0.97
; FRL/OCM 1.03 1.01 1.09f 1.08f
1 FRL/OCL 1.22 1.20
FRM/PAR 1.06 1.10 0.86 0.87 1.02m 1.00m 1.14 1.07FRL/PAR 1.05 1.04 0.87 0.89 0.98f 0.98f
FRM/CAU 1.04 1.06 0.92 0.92 0.94m 0.95m
FRL/CAU 1.04 1.01 0.93 0.93 0.90f 0.92f
1 FRM/PUT 1.03 1.02 0.84 0.84
; FRL/PUT 1.03 0.97 0.85 0.85
FRM/THA 1.16 1.21 0.94 0.93 0.99m 0.98m
; FRL/THA 1.15 1.16 0.95 0.95 0.97f 0.97f
(m = male, f  = female)
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Complete analysis of the effect age and sex has on rCMRGlu in controls was 
performed using the Rhodes method [Rho83] of analysis (section 3.5.2,1). This would 
reveal which regions of the brain should be examined in more detail or even neglected 
and whether the control subjects should be aged matched with the AD subjects. The 
control subjects were again examined at the PSI, Villigen, Switzerland so ensuring the 
same protocols were used as with the AD subjects.
7,2. Subject selection.
All studies examining the effect of neurological disorders on regional metabolic 
rates require a standard control subject data set to compare against^ these are termed 
controls. All control subjects were screened by psychiatric interview to exclude those 
with personal or family histories of any psychiatric disorder such as depression or 
mental retardation. Screening was also performed to eliminate those who had 
experienced dmg [OmOO] and/or solvent [Ras93] abuse and head injury [Rei99] all 
which have been shown to affect the mental status of a subject along with nutritional 
abnormalities such as diabetes [Aue98] and alcoholism [Kri97]. Subjects were defined 
as healthy by the use of physical examination, blood and urine tests, MRI scans and 
electrocardiogram measurements. In total seventy two control subjects, average age 
38.7 ± 15.4, where 32 were female with an average age 40.1 ± 16.5 and 40 males aged 
37.5 ± 14.3, were examined for changes in rCMRGlu. Table 7. 2 lists sample details 
with respect to age, and sex with the final three columns relating to the three distinct age 
groups used in significance testing, the older group was selected to age match with the 
AD subject group. Data for this study was obtained and normalised at the PET Centre, 
Academic Hospital Groningen, Netherlands (formerly at the Paul Scherrer Intitute, 
Switzerland). The AD subjects used in this study were the same eighteen used in 
chapter six (Table 6.1) but analysis here relied on SPM 96 for normalisation which was 
found to affect absolute values of rCMRGlu. The distinction between the routines is 
discussed further within this section.
D. A. Cutts 173
Investigation into Brain Function: 7. Age variation of rCMRGlu in control subjects:
Table 7.2: Control subject details.
1 Subject 
Scan 
Ref.
Sex Age
Ai
22-30
le Groi
31-42
Ip
43-82
1 397 (25) 9 30 /
i 439 (27) 9 30 /
; 509 (33) 9 30 y
! 520 (34) 9 27 y
1 588 (41) 9 23 y
I 589 (42) 9 29 y
i 613 (43) 9 26 y
1 629 (44) 9 30 y
1 687 (46) 9 26 y
i  831 (47) 9 28 y
851 (48) 9 26 y
852 (49) 9 29 y
860 (50) 9 25 y
1 894 (52) 9 22 y
I  908 (53) 9 29 y
1 1233 (62) 9 24 y
1 1260 (63) 9 25 y
i 1283 (65) 9 30 y
I 1311 (67) 9 28 y
1316 (68) 9 24 y
Subject
Scan
Réf.
Sex Age
Ai
22-30
;e Groi
31-42
ip
43-82 ;
: 1319 (69) 9 26 y
: 1326 (70) 9 24 y
: 1336 (71) 9 25 y
i 1362 (72) 9 22 y
i 1364 (73) 9 24 y
: 1384 (74) 9 28 y
1410 (76) 9 22 y
i 1458 (78) 9 26 y
' 220 (20) 9 36 y
: 232 (21) 9 37 y
: 395 (24) 9 40 y
i 430 (26) 9 36 y
i 440 (28) 9 32 y
; 457 (29) 9 41 y
; 458 (30) 9 38 y
: 474 (31) 9 31 y
! 477 (32) 9 37 y
; 525 (35) 9 34 y
542 (37) 9 32 y
: 555 (38) 9 36 y
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Table 7.2: Control subject details. (Continued).
Subject
Scan
Ref.
Sex Age
A|.
22-30
;e Groi
31-42
up
43-82
; 582 (40) 9 38 y
i 672 (45) 9 32 y
i 874 (51) 9 36 y
! 1111 (54) 9 35 y
i 1112 (55) 9 42 y
i 1119 (56) 9 32 y
* 1124 (57) 9 39 y
! 1134 (58) 9 34 y
! 1140 (59) 9 40 y
j 1141 (60) 
! 1165 (61) 
I 1282 (64)
9 36 y
9 33 y
9 34 y
1 1294 (66) 9 34 y
1 1419 (77) 9 34 y
I 219 (19) 9 82 y
1 255 (22) 9 65 y
Subject
Scan
Réf.
Sex Age
Al
22-30
;e Groi
31-42
ip
43-82
: 266 (23) 9 55 y
; 535 (36) 9 43 y
: 560 (39) 9 53 y ;
; 1385 (75) 9 42 y
1 1538 (79) 9 64 y
1561 (80) 9 44 y
1 1565 (81) 9 61 y
: 1566 (82) 9 64 y
1 1882 (83) 9 52 y
- 2222 (84) 9 72 y
; 2343 (85) 9 71 y
! 2344 (86) 9 67 y
i 2527 (87) 9 71 y
: 2611 (88) 9 62 y
2762 (89) 9 76 y
2923 (90) 9 73 y
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7.3. Differences between SPM ‘classic’ and SPM 96 normalisation.
During the period of research the method in which subject scans were 
normalised was changed. Primarily the change was introduced due to the use of an 
updated version of the SPM normalisation routine, updated from SPM ‘classic’ to SPM 
96. This was expected not to affect results as methods of normalisation such as sine 
interpolation remained the same. However, the noiTnalisation template to which all 
scans are fitted was changed. Initially in SPM ‘classic’ a 26 plane system based on the 
Talairach idealised brain was used while in SPM 96 the template used was that of the 
MNI 68 plane. This would result in an increased amount of ROI per subject scan as 
discussed in section 4.4.3. Hence this would in turn lead to the possibility of more errors 
being introduced in placing the ROI template over the desired regions as each of the 
original 26 ROI templates was used for approximately three planes on the new plane 
system. This increases the probability of covering regions outside the desired region of 
interest. As the actual scanning routine only measured 12 planes, I would suggest that 
the 26 plane normalisation is more valid than the 68 plane scenario. Interpolating 12 
planes into 26 perceptibly will introduce far fewer errors than 68.
A provisional test between AD data normalised with SPM ‘classic’ and that 
normalised with SPM 96 showed definite changes in absolute values. Absolute values 
of rCMRGlu were higher for all ROI determined using SPM 96, in fact 35% of all ROI 
had 10% higher rCMRGlu values or greater. More problems were created by 
significance testing between hemispheres with far fewer distinctions between left and 
right regions being observed. Four regions in the AD subjects now displayed no 
significance whereas in SPM ‘classic’ they had. More importantly of the remaining 
regions, eleven were still significant, but if the left hemisphere of a lobe was higher 
using SPM ‘classic’, the opposite was found to be true in the SPM 96 instance. A 
simple explanation for this latter change would be confusion between the radiological 
and neurological conventions whereby left and right hemispheres were switched. To 
confiim that no errors had been introduced into analysis by using wrong conventions all 
subjects were re-analysed with SPM ‘classic’ and SPM 96 only to find the same 
outcome.
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One possible source of error as already mentioned is that of regions of interest 
being misaligned with the increase in the number of planes to 68, more inaccuracies are 
introduced due to interpolation between planes. To counter this a routine was written 
which would examine the intensity of rCMRGlu of a ROI relative to the PROI which 
constitute it. The PROI which make up the main ROI would be expected to have a low 
intensity on the outer edges of the ROI and high intensity in the centre as shown in 
figure 7.1. If the activity occurred at a single point this curve would be expected to have 
a 1/rMistribution. The peak of the curve would then be equal to the maximum rCMRGlu 
within the ROI examined.
rCMRGlu
?
Figure 7 .1 : PROI plotted with respect to adjacent planes of a ROI.
A significant number of regions were found not to fit this criteria, which was 
also confirmed when the more time consuming visual checks were done. Even though, 
results were similar to the hemispherical differences observed before the removal of the 
‘bad’ data points, errors and significances had been reduced.
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Fortunately both SPM techniques preserved the general trends observed over all 
regions of the brain, this was determined by a number of methods. Re-examination of 
metabolic ratios were found to be similar in both cases although significances between 
hemispheres again differed. Importantly, correlations of rCMRGlu for both hemispheres 
of a lobe resulted in the same significances observed in section 6.3.1. A more in depth 
way of examining these correlations is hierarchical cluster analysis which led to each 
subject’s scan normalised with both techniques being clustered together within the same 
subgroup, shown in figure 7.2). Thus showing that all ROI from both normalisation 
methods still uniquely define a subjects rCMRGlu over the whole brain.
O o J o o . O O O o , o o o . ( > a i p . O o . O P < o . a . O B i O l o . O o . O O o . O o . o . o o l o . p .
Figure 7. 2: Hierarchical clustering for both SPM ‘classic’ (P) and 
SPM 96 (G) subjects with AD.
In conclusion, great care and a certain degree of caution has to be used when 
quoting hemispherical differences in the brain using ROI analysis as this can clearly 
depend on the method used to obtain data. If comparison between hemispheres has to be 
performed it clearly needs to be kept consistent, that is to say, the same method must be
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applied to all data sets used in group analysis where only relative changes between 
groups should be quoted. The type for normalisation used will also change the outcome 
of the final images. Many researches use non-linear fitting which in itself can introduce 
many enors in brain morphing. Clearly one subject’s data set could result in many 
different brain permutations and hence results. For this reason analysis in this chapter 
uses only SPM 96 for linear normalisation. Additionally SPM 96 was used in preference 
to SPM ‘classic’ as it is now more widely used throughout the PET community.
7.4. rCMRGlu with age.
With increasing age, the brain generally suffers from the effects of 
morphological and metabolic rate changes. It is generally accepted that the brain 
undergoes atrophy with regions being affected to varying degrees [Aki97, Dou96] with 
gender also influencing the rate of decline [Sal99], metabolic rates are also generally 
assumed to decrease [Mur96]. Though these features of ageing are generally accepted 
the pattern of changes in regional cerebral glucose metabolism are unclear. In ageing 
there is a progressively decreasing amount of oxygen and glucose consumption which 
subsequently results in a reduction of cerebral blood flow [Bar92]. This decrease may 
be responsible for some age related changes in cognitive function. Advances in imaging 
techniques, such as improved resolution in PET and MRI allow for more precise 
regional measurement to examine these changes. A typical high resolution MRI scan of 
a young ‘normal’ 25 year old subject is shown in figure 7.3. Murphy [Mur96] has 
shown significant age related increased in atrophy in the cerebellum, main cortical 
regions and subcortical nuclei using MRI. Blesa revealed that a linear association 
existed between increasing age and a declining rCMRGlu [Ble97]. An 8% decrease was 
observed per decade measured between the ages of 20 to 74 for the whole brain with 
changes most pronounced in limbic structures^ an area implicated in age-associated 
memory loss. Most researches quote changes in the frontal lobe of the brain during 
ageing. Mielke [Mie98] remarks upon the ‘normal’ ageing brain being predominantly 
characterised by metabolic changes in the prefrontal cortex with hypermetabolism in 
middle age but decreasing thereafter. Hazlett [Haz98] examined metabolic rate in
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ageing using a verbal memory task where frontal activity showed a significant age 
related decline. Further analyses of young and old subjects who performed equally well 
in tasks revealed that the young activated frontal regions whereas the old relied on 
occipital regions. As such any age related functional change may reflect a ‘ré­
allocation’ of brain function to another brain region and not necessarily an anatomically 
fixed neuronal loss or diminished capacity to perform.
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Figure 7. 3: MRI scan of a 25 year old ‘gifted’ student.
Male and female brains have been found to change in a different way with age. 
Yoshida [YosOO] observed that the way in which the brain changes in normal ageing 
differed between males and females with respect to certain cerebral receptors. These 
were shown to decline in density at a greater rate in females than males which in turn 
would affect glucose uptake in the region examined. Wong [Won97] showed that 
dopamine receptor density also declined in normal ageing, dopamine being associated 
with Parkinson’s disease. In terms of rCMRGlu and the age, sex relationship, Murphy 
determined that the thalamus and temporal regions declined at a greater rate in females. 
Hemispherical differences were also noted in the temporal and parietal lobes.
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7.4.1. rCMRGlu in brain regions.
To examine the change in rCMRGlu the seventy two subjects were sorted into 
seventeen age groups spread between 20 and 82 years. By taking the mean in this way 
would reduce any fluctuations that may have been caused by a subject having an 
abnormally high or low metabolic rate for a given brain region. As work by Blesa 
[Ble97] had determined an 8% linear decline every ten years, a linear least squares fit 
was applied to all 36 ROI to examine this trend.
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Figure 7. 4: Mean rCMRGlu values with age for the frontolateral and temprolateral regions.
The regions CAU, FRL, FRM, CGA, CGP, INS, MOT, PAR, PUT, SMS, TEL, 
TEM, TEP and THA all had correlation with age of r<0.7 (p<0.001) for both 
hemispheres. There were no significant differences in correlations or rate of decrease 
between hemispheres. The OCL, OCM and WHM had low correlations (0.45<r<0.65, 
p<0.01) but gradients were still negative. The CER had no significant correlation 
(r=0.31 left, r=0.37 right) only displaying a noticeable decrease in rCMRGlu about the 
age of 75 years. Figure 7.4 shows the decrease for the frontolateral and temporolateral 
regions with age with the linear gradient equal to the rate of change in rCMRGlu per 
year. Table 7. 3 shows the region and the percentage change in rCMRGlu per decade for 
all regions. Though linear fitting provided high correlations for twenty eight regions and
D. A Cutts 181
Investigation into Brain Function; 7. Age variation of rCMRGlu in control subjects:
low correlations for another six, a general trend could still be seen in the data of an 
increased rate of decrease with age. A second order polynomial fit showed that all 
regions had their correlation coefficients improved or either not changed if this trend 
was assumed. All regions did in fact show an increased rate of decrease with age though 
due to the error on rCMRGlu values the linear fit is equally valid in the majority of 
cases. Only in the regions TEL, TEM, CER and WHM was the second order polynomial 
fit the only appropriate fit. To examine the trend of increasing rate of decrease with age 
further each rCMRGlu value was normalised for each region to give each region equal 
weighting. Then the average normalised rCMRGlu values over all brain regions was 
plotted with respect to the seventeen age groups shown in figure 7.5.
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Figure 7. 5: Mean normalised rCMRGlu values for all control brain regions with age.
Figure 7.5 shows that the rate of change of rCMRGlu with age can be comprised 
of two linear fits between the two age limits 20 to 60 and 60 to 80 years. Between the 
ages of 20 to approximately 60 years of age, the rCMRGlu decreases at a rate of 2.2% 
per decade over the whole brain with a correlation coefficient of r=0.65 (p<0.01 ). At the
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age range between of 60 to 65 (retirement age!) a sudden decrease in metabolic rate is 
seen. The decrease is highly correlated (r=0.94, p<0.001) and equates to a 11% decrease 
in rCMRGlu per decade. Relating this back to the water content of the ageing brain 
discussed in chapter 5 it was observed that after the age of 57 the brain becomes more 
saturated with water; could a correlation exist here? Looking back to figure 7.4 the 
temporolateral region clearly shows this change as does the medial region of the same 
lobe. The change can only just be noticed in the frontolateral region. Table 7. 3 
additionally shows percentage decreases in rCMRGlu determined by lineai* fitting 
between the two age groups 20-60 and 60 to 80 years.
Between ages 20 and 60 years the percentage decrease per decade varies from 
approximately 1% in the right hemisphere PUT and CAU to a maximum of around 
5.5% in the INS and CGA. The hemispherical rates of change were not significantly 
different between left and right regions of the brain. The rates of change were more 
severe in the 60 to 80 age group with rates of decrease ranging from 3% to a massive 
30% per decade. The low rate of 3% belonged to the SMS region of which the decrease 
remained constant through age groups. The both hemispheres white matter, which 
remained pretty much constant over the 40 years between 20 and 60, exhibited the 
extreme decrease of 30±6% per decade over the last 20 years. All regions except the 
SMS showed an increased rate of decrease in ages above 60 years old.
Separating sexes resulted in six regions (twelve left and right) having different 
rates of decrease from each other (Table 7 .4 ). The cerebellum, putamen and temporal 
pole all decreased in rCMRGlu by a higher rate in the males for the age group 61-82. 
The cerebellum having an average decrease of 32+7% per decade in males but only 
20+5% in females, similarly the temporal pole with 35+7% in males and 14±4% in 
females, while the putamen displayed a 11±3% decrease in males and no change in 
females from the overall decrease observed. The remaining three regions had higher 
rates of decrease in the females with both regions of the occipital lobe (lateral/medial) 
both retaining their constant decrease over all years in males while a 8+2% (OCL) and 
11±3% (OCM) were seen in the 61-82 year old female group. Finally the insula had a 
17±4% decrease in the older female group but only an 8+3% decrease in the males. In
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general the decreases detemiined for the 20-60 yeai' age groups did not differ 
significantly between sex.
Cleaily tliese results» have implications in analysis concerning subject groups. 
Subject data must be age matched as any significant differences detennined with respect 
to disease duration may simply be the effect of normal ageing.
Table 7.3: Percentage decreases in rCMRGlu per decade for the age groups 20-82,20-
60 and 61-82.
Left
Regions
Decreas
decade
20-82 (y)
e in rCMR 
%) for ag«
20-60 (y)
GIu per 
; groups
61-82 (y)
CAU 5.2±0.9 2.1±0.4 14.7+2.7 :
CER 2.1+0.4 -2.6+1.3 20.1+3.7
I  FRL 4.0+0.7 4.0±0.7 9.3±1.7
FRM 4.0+0.7 3.4+0.6 8.8+1.6
CGA 4.1±0.8 5.2+1.0 9.4±L7 ;
CGP 5.1+0.9 2.6+0.5 9.8+1.8
Î INS 5.2±1.0 4.1±0.7 12.612.3 ;
! MOT 3.2+0.6 2.4+0.4 1.9+0.4
OCL 1.9+0.3 2.4+0.5 7.2+1.3
OCM 2.5+0.5 3.0+0.5 5.511.0
FAR 4.8+0.9 3.3+0.6 9.811.8
PUT 3.9+0.7 2.3+0.4 10.211.9
SMS 3.4±0.6 2.6+0.5 1.610.3
TEL 4.1+0.8 1.8±0.3 9.511.8
TEM 3.3+0.6 1.0+0.2 10.912.0
TEP 3.4+0.6 4.4+0.8 14.912.8
TIIA 5.7+1.1 3.3+0.6 14.8+2.8
WHM 6.8+1.3 -2.1+1.8 30.815.7
Right 
1 Regions
Decreas 
decade(
20-82 (y)
e in rCMR 
%) for ag<
20-60 (y)
GIu per 1 
i groups
61-82 (y) i
CAU 4.410.8 0.910.2 14.712.7 ;
CER 1.910.4 -2.411.9 22.114.1 1
FRL 3.710.7 3.110.6 9.311.7 i
FRM 3.710.7 4.210.8 7.011.3 i
CGA 4.010.7 5.411.0 10.211.8 !
CGP 4.410.8 2.210.4 13.912.6 :
INS 5.611.0 5.511.0 11.712.2 =
MOT 3.310.6 1.910.4 6.611.2
OCL 1.910.3 2.510.5 7.711.4 Î
1 OCM 2.710.5 1.310.2 8,911.7 :
PAR 4.210.8 2.410.4 11.012.0 :
PUT 3.110.6 1.110.2 10.411.9 i
SMS 3.410.6 1.910.4 3.110.6 g
TEL 4.210.8 1.410,3 10.612.0 !
1 TEM 3.010.6 2.210.4 12.812.4
TEP 3.910.7 3.410.6 16.9+3.1
THA 4.210.8 1.410.3 13.812.6 I
WHM 4.910.9 -2.211.7 28.415.2
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Table 7.4: Percentage decrease in rCMRGlu per decade for male and female age
groups 20-82,20-60 and 61-82.
: Left 
Î Regions
Decreas
decat
20-82 (y)
e in rCMR 
e (%) for
20-60 (y)
GIu per 
males
61-82 (y)
Right
Regions
Decreas
decat
20-82 (y)
B in rCMR 
e (%) for
20-60 (y)
Glu per 
nales
61-82 (y)
CAU 6.2+1.1 1.710.3 11.512.1 CAU 6.311.2 1.110.2 18.313.4
CER 2.710.5 -3.712.2 35.116.5 CER 2.610.5 -3.912.2 28.715.3
1 FRL 4.910.9 4.310.8 5.811.1 FRL 4.710.9 3.410.6 7.611.4
FRM 4.710.9 3.710.7 6.611.2 FRM 4.410.8 4.210.8 3.410.6
CGA 4.810.9 6.011.1 9.411.7 CGA 4.910.9 6.611.2 7.911.5
CGP 6.011.1 4.110.8 13.012.4 CGP 5.311.0 1.210.2 16.013.0
INS 5.711.1 3.010.6 7.311.3 INS 5.711.0 5.110.2 8.011.5
MOT 3.810.7 1.710.3 3.810.7 MOT 3.710.7 1.710.9 5.311.0
OCL 3.110.6 2.410.4 1.610.3 OCL 3.210.6 4.010.3 2.710.5
OCM 2.710.5 2.610.5 1.410.2 OCM 3.010.6 0.610.7 3.710.7
PAR 5.81.1.1 4.210.8 7.711.4 PAR 5.311.0 2.210.5 8.511.6
1  PUT 4.810.9 1.410.3 12.712.4 PUT 4.110.8 0.710.4 10.411.9
1 SMS 4.710.9 1.110.2 0.310.4 Q SMS 3.710.7 0.510.3 1.410.3
TEL 4.410.8 1.610.3 6.911.3 1 TEL 4.310.8 0.310.3 9.211.7
; TEM 3.210.6 -0.310.4 7.411.4 1 TEM 3.710.7 2.210.4 13.312.5
1 TEP 7.311.3 5.211.0 36.716.8 TEP 6.711.2 2.810.5 34.716.4
i  THA 5.611.0 4.810.9 14.012.6 THA 4.310.8 0.510.2 14.312.7
1 WHM 7.011.3 8.111.5 29.6+5.5 WHM 5.211.0 8.111.4 27.315.1
Left females \  Right Females
1 Regions 20-82 (y) 20-60 (y) 61-82 (y) Regions 20-82 (y) 20-60 (y) 61-82 (y) 1
i CAU 4.010.7 1.410.3 10.411.9 CAU 1.910.3 0.010.5 -0.810.7 1
CER 2.510.5 -2.611.3 17.713.3 CER 1.810.3 -1.911.7 22.014.1 I
FRL 2.610.5 2.910.5 8.311.5 FRL 2.010.4 2.610.5 6.011.1 1
FRM 2.810.5 3.010.6 5.411.0 FRM 2.810.5 3.410.6 4.110.8 1
CGA 2.810.5 5.211.0 7.311.4 CGA 2.510.5 3.510.7 6.811.3 1
1  CGP 4.210.8 1.910.3 8.212.1 CGP 3.110.6 3.110.6 7.511.4
I  INS 3.910.7 4.210.8 17.213.2 INS 5.010.9 5.211.0 16.013.0 1
1 MOT 2.410.4 2.310.4 3.110.6 MOT 2.310.4 1.610.3 5.911.1 1
!  OCL 1.810.3 3.610.7 9.611.8 OCL 1.310.2 2.010.4 5.611.0 1
I  OCM 3.010.6 4.410.8 11.912.2 OCM 2.710.5 3.010.5 11.112.1 !
I  PAR 3.310.6 2.510.5 6.911.3 PAR 3.110.6 2.410.4 8.111.5 i
1 PUT 2.810.5 2.310.4 -0.811.0 PUT 1.710,3 0.510.2 3.110.6 1
1 SMS 1.710.3 3.110.6 -0.911.8 SMS 2.810.5 2.810.5 0.310.2 i
?  TEL 3.010.6 1.910.4 9.711.8 TEL 3.610.7 2.510.5 9.511.7 Î
TEM 3.010.6 2.410.4 11.612.1 TEM 1.710.3 2.110.4 9.311.7 ■
TEP 2.010.4 3.210.6 11.512.1 TEP 3.210.6 5.111.0 16.713.1 1
I THA 5.311.0 2.110.4 13.612.5 THA 3.610.7 1.910.3 6.611.2 1
1 WHM 5.511.0 4.810.9 35.016.5 WHM 3.310.6 0.410.1 25.514.7
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7.4,2. rCMRGlu distributions.
Distributions of rCMRGlu were examined using probit plots [Kir88] which 
compares known frequency distributions relative to the probit model to determine 
whether normal or non-normal distributions exist. This was performed on all 72 subjects 
and all 398 PROI (28,656 PROI in total) created using MNI template normalisation. 
The subjects were also separated into distinct age groups and distributions examined 
over these three time periods. The rCMRGlu for each of the subjects were calculated 
using both the Rhodes and Patlak method of analysis. The PROI from the same main 
regions of the brain were grouped into the 36 major brain regions and the frequency 
examined again. Because of the limitation inherent with Patlak analysis only 7 planes 
are used in reconstruction of rCMRGlu data this reduces the number of ROI determined 
to approximately 20-25.
PUTFRL
100%250 100%70 -
60 -
>, 50 - gg 40 -
- 75% - 75%
S 150 - -- 50% -- 50%30 - 20 - 10 -- 25% -- 25%50 -0 4-4-1 0% 0%
"J>‘
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R :.  0.9975
iC M R Q Iu rCMRGlu
Figure 7. 6: Histograms showing distributions for the frontolateral and putamen with 
associated probit plots for control subjects.
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As glucose is essential to the noiTnal functioning of the brain it would be 
expected that all regions would follow noimal distributions. Examination of the 36 left 
and right hemisphere ROI for all subjects led to just one region, the PUT exhibiting 
non-nonnal distributions in both hemispheres of the brain. Figure 7.6 shows a typical 
normal distribution and that of the PUT, with the relevant probit plots. Separating out 
sex led to the same results. When examining the three age groups separately the same 
results were found.
The difference observed in the PUT may be due to problems aligning the ROI 
template exactly to the reconstructed images. The PUT as described in an earlier chapter 
lies in the centre of the brain where problems occur in localisation of region for an 
individual image.
7.4.3. rCMRGlu between hemispheres.
Significance testing performed on the hemispheres of AD subjects resulted in 
differences in rCMRGlu between left and right areas of certain regions. As AD affects 
the functioning of the brain these observed variations may be expected to differ in the 
‘normal’ brain. The previous section also described how rCMRGlu was seen to decrease 
in a lobe with age which may affect the hemispherical differences within the brain. 
Three groups of controls were compiled with respect to distinct age ranges with the 
older age group age-matched with the AD subjects. The youngest group had twenty 
eight subjects average age 26.4±2.6 (15 male 26.3±2.8, 13 female 26.4±2.4), the middle 
age group consisted of twenty six subjects, average age 35.7+3.0 (17 male 36.2+3.2, 9 
female 34.9±2.2). Finally the AD age matched group had an average age 61.5+11.0 (8 
male 61.3±13.6, 10 female 61.7±8.8).
For the young age group the majority of regions had higher rCMRGlu values in 
the left hemisphere than those in the right. These were the FRL, FRM, CGA, CGP 
OCM, PAR, SMS, THA and WHM (all with p<0.0001), CAU (p<0.0002), MOT 
(0.002), PUT (p<0.006) and TEM (p<0.02). The four regions CER (p<0.03), OCL 
(0.04), TEL (p=0.0001) and TEP (p<0.06) had higher rCMRGlu values in the right
D. A. Cutts 187
Investigation into Brain Function: 7. Age variation of rCMRGlu in control subjects:
hemisphere. The ten year age gap between the young and middle age groups was 
expected to result in a decrease in metabolic rates between the two categories as 
observed in section 7.4.1. Significance testing between the groups showed this to be 
true as all regions except for the cerebellum having significantly lower metabolic rates 
in the middle age group. The lack of change in the cerebellum‘for the grouped subjects 
mirrors that observed in the ageing study whereby this region appears to be relatively 
preserved. For the middle age group the variation between hemispheres was the same as 
witnessed in the younger age group apart from the white matter region which now no 
longer exhibited any dissimilarity between hemispheres.
It may be expected that the old age group may be significantly different to the 
young and middle age groups as an increased rate of decline of rCMRGlu was observed 
over the latter years of the ageing brain. But figure 7.5 shows the sudden decrease to 
occur at the age of about 60 to 65 years, the age of the old group used for analysis here 
is well within these limits and additionally suffers a large standard deviation in age 
range. Unfortunately this latter obstacle will decrease observed significances which may 
have been seen if all subjects in the group were over the age of 60. Even though, 
significant decreases were again seen in absolute rCMRGlu values between the middle 
and old age group with the exception of the CER and WHM. Hemispherical differences 
were observed to vary slightly from those in the younger subject groups. There was a 
decrease in the number of regions, which in the lower age groups, had previously 
displayed significant differences between hemispheres. Six regions had significantly 
higher rCMRGlu values in the left hemisphere compared to those in the right. These 
were the FRM, CGA, CGP, OCM (all with p<0.0001), INS (p<0.04) and PAR (p<0.08). 
Eight regions seen to have higher rCMRGlu values in the right hemisphere, four of the 
regions being the CER (p<0.005), OCL (p<0.02), TEL (p<0.0003) and TEP (p<0.0002) 
as seen before. The remaining four regions had all previously had their rCMRGlu 
values higher in the left in the younger subjects, these were the FRL (p<0.04), THA 
(p<0.0002), CAU (p<0.04), PUT (p<0.005). Table 7. 5 shows the significant differences 
found between hemispheres in all, female and male control subjects for the ‘old’ AD 
age matched group.
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Variation from the general trends of the group data were observed when 
examining the sexes separately. The majority of regions in the young male subjects had 
higher rCMRGlu values in the left hemisphere than those in the right. These were the 
same as those observed in the grouped young age group with the addition of the INS 
and the exclusion of the TEM. Only two regions had significantly a higher rCMRGlu in 
the right hemisphere, namely the regions CER and TEL. For the middle age male group, 
the variation between hemispheres was similar to that observed in the younger males 
with the exception of the regions INS, MOT, TEP and WHM which were now no longer 
significantly different between hemispheres. For the control ‘AD age-matched’ subjects 
there was, as seen in the grouped data, a decrease in the number of significant 
differences between left and right regions. Six regions had higher rCMRGlu values in 
the left hemisphere compared to those in the right and were the FRM, CGA, CGP, 
OCM, INS and PAR. Four regions were significantly higher in rCMRGlu for the right 
hemisphere, four of the regions being the TEL TEP, THA and CAU. The males in 
general followed similar trends as the grouped data although with p-values increased, 
i.e. less significant.
The female subjects again followed the same trends as those observed in the 
male and grouped sex data. That is to say, where significances existed in the grouped 
data, they either still existed in the female data with respect to a left or right region of a 
lobe having a higher rCMRGlu value, or variation between the two hemispheres was 
not significant. Regions with metabolic rates significantly higher in the left for the 
young female group were the CAU, FRM, CGA, CGP, MOT, OCM, PAR, TEM, THA 
and WHM, again the majority of regions. Lower metabolic rates were observed in the 
left hemisphere for the regions OCL, PAR and TEL. Again the middle age group 
followed the same trend. The AD age-matched group again exhibited the general trend 
of a switch in left and right hemisphere rCMRGlu with the right hemisphere generally 
having greater metabolic rates. FRM, CGA, CGP, INS and the OCM had rCMRGlu 
significantly greater in the left hemisphere while CER, FRL, OCL, PUT, TEL, TEP and 
THA were all significantly greater in the right regions.
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There appears to be a general trend of higher rCMRGlu in the left hemisphere of 
the brain at younger ages which for a particular reason switches to right side dominance 
at increased ages. This trend was observed in both male and female subjects separately. 
To examine this trend further each metabolic rate was normalised over all subjects for 
individual regions to give each region equal importance, then a significance test 
performed by grouping the data for each hemisphere. The change in normalised 
metabolic rate can be seen in figure 7.7 as a percentage. A positive percentage denotes a 
greater metabolic ratein the left hemisphere compared to that of the right. A negative 
value shows higheimetabolic rates in the right hemisphere of the brain.
Trend in rCM RGIu for all regions
Male 
Female
Middle Old
Figure 7. 7: Difference in the metabolic rates between right and left hemisphere 
normalised values across all control subjects and brain regions.
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Figure 7.7 claiifies what is evidently happening to the hemispheres with respect 
to metabolic rates. Clearly in the ‘young’ age group metabolic rates are significantly 
higher in the left hemisphere (p<0.0001) for both genders while in the ‘middle age’ 
group the left hemisphere is still highly significant though with a smaller difference. 
Finally in the older age group the grouped data shown a overall higher rCMRGlu in the 
right hemisphere as does the female group although these are not significant. The left 
hemisphere of the male group remains higher in tenais of metabolic rate but the 
difference is no longer significant.
So far differences between regions within gender have been examined but 
variations between gender have previously been observed in the AD study. As such 
variations were expected within the control subject group. For all three age groups 
metabolic rates observed between gender, for either hemisphere, were all greater in the 
females with the majority significantly so. For all three age groups eleven regions were 
significantly higher in females these were the CER, FRL, FRM, CGA, OCL, OCM, 
PUT, TEM, TEP and THA. The lack of change between age groups was expected as no 
significant variation between gender was noted with respect to rCMRGlu decreases with 
increased age, section 7.4.1. Table 7. 6 shows the variations between hemispheres for 
the AD age matched controls.
Many people may expect a higher metabolic rate in the frontal lobe of the female 
brain as this region is associated with worrying, planning, thinking, judgement and 
personality, traits which many believe are lacking in males. Research has shown that 
cognitive function differences do occur between genders in the frontal lobe [GolOO]. 
The occipital region is associated with vision while the temporal areas act primarily as 
auditory processing regions.
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Table 7.5: Difference in rCMRGlu between hemispheres in tlie ‘old age’ group
controls.
Region rCMRGlu in all subjects
IK.. .^--.iiasnrsaaanaa'ifetn,.- ...-îrrafJu^ .TiiaKMiu
Variation between hemispheres
of
Brain Left Right
Difference
L-R Sig’p-value
CAU 35.68+7.23 36.0416.31 -0.3610.29 <0.04 ^
CER 36.46+6.39 37.5916.25 -1.13+1.01 <0.005 ;
FRL 39.75±6.26 40.1316.04 -0.3710.29 <0.004 i
FRM 37.4115.96 35.6515.82 1.7711.10 <0.0001
CGA 35.3315.55 31.7416.02 3.5910.56 <0.0001
CGP 40.1018.52 37.3617.12 2.7311.67 <0.0001
INS 40.1417.06 39.3616.48 0.7910.31 <0.03 :
MOT 34.2514.26 34.2014.39 0.0411.77 NS ;
OCL 35.0915.49 35.9515.60 -0.8710.53 <0.02 1
OCM 39.9816.30 37.5015.76 2.4910.09 <0.0001 i
PAR 38.3916.69 37.9116.64 0.481.0.42 <0.07 1
PUT 32.9119.00 33.5919.56 -0.6810.59 <0.004
SMS 35.6214.97 35.4714.81 0.1510.85 NS
TEL 36.6815.84 37.3516.03 -0.6710,41 <0.0002
TEM 29.0814.41 29.4914.54 -0.4110.40 <0.12 ;
TEP 28.0415.82 29.5515.66 -1.5111.25 <0.0001 ;
THA 34.9417.86 35.8017.46 -0,8610.43 <0.0002 i
WHM 16.2213.75 16.2813.57 -0.0610.57 NS
Î Region 
of 
Brain
rCMRGlu in f  
Left
emale subjects 
Right
Variation betwc
Difference
L-R
:en hemispheres
Sig’
£-vahie ^
CAU 36.1515.46 36.62+4.35 -0.4710.96 NS Ï
CER 36.1614.79 38.1115.64 -1.9611.84 <0.01 ;
FRL 40.6814.27 41.4713.92 -0.7810.52 <0.0001 1
i FRM 38.5914.73 36.8614.74 1.7311.16 <0.0001 s
1 CGA 35.9414.20 32.7714.92 3.1710.56 <0.0001 Ï
CGP 41.5118.02 38.2515.38 3.2612.97 <0.0001 1
! INS 40.3415.16 39.3714.26 0.9710.38 <0.02
1 MOT 34.6112.76 34.7113.34 -0.1112.28 NS
1 OCL 37.1913.96 38.3312.91 -1.1410.22 <0.02
1 OCM 40.9514.81 39.1713.82 1.7810.53 <0.002 i
I p a r 40.1014.59 39.8313.90 0.2710.93 NS
1 PUT 33.0017.93 34.8518.34 -1.8411.32 <0.0001 I
i SMS 36.2313.13 35.8712.92 0.3511.36 NS
I TEL 37.0213.72 37.7513.61 -0.7310.40 <0.003 !
I t e m 29.9513.54 30.3213.13 -0.3810.23 <0.15 1
TEP 30.4013.49 31.7713.85 -1.3811.09 <0.003 ;
THA 35.5616.46 36.3915.57 -0.8310.78 <0.05 s
I WHM 16.1814.10 16.7113.41 -0.5210.76 NS i
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Table 7.5 (continued).
I Region 
of 
1 Brain
RCMRGlu in 
Left
male subjects 
Right
Variation betwc
Difference
L-R
en hemispheres
Sig’ ' p-value
iCAU 35.0319.07 35.2818.17 -0.2510.23 <0.11 ;I CER 36.8818.07 36.8716.95 0.0112.5 NS
fFRL 38.5917.94 38.4617.61 0.1410.57 NS :
FRM 35.9416.95 34.1316.64 1.8111.24 <0.0001 j
CGA 34.5616.80 30.4516.97 4.1111.27 <0.0001 1
CGP 38.3318.80 36.2518.71 2.0811.33 <0.0003 ;
INS 39.9018.89 39.3518.48 0.5510.62 NS ■
MOT 33.7815,61 33.5615.37 0.2211.13 NS 1
I OCL 32.4616.00 32.9816.66 -0.5210.93 NS
OCM 38.7817.61 35.4016.97 3.3810.47 <0.0001
PAR 36.2718.12 35.5118.36 0.7710.61 <0.03 ;
PUT 32.78110.19 32.01110.71 0.7710.67 <0.09 :
SMS 34.8616.50 34.9516.43 -0.0910.25 NS !
TEL 36.2517.69 36.8518.08 -0.5910.40 <0.03
TEM 27.9415.13 28.3515.77 -0.4111.00 NS
TEP 24.5216.76 25.9816.27 -1.4610.77 <0.02
THA_____ 34.1319.33 35.0419.28 -0.9110.20 <0.0009 s
1 WHM 16.2713.21 15.7113.70 0.5510.30 NS
Table 7.6: rCMRGlu differences between male and female ‘old age’ control subjects.
I Region Left female and male. Right female and male
of 
1 Brain Difference M-F SD
Significance
p-value
Difference 
M-F SD
Significance : 
p-value
1 CAU -1.12 0.97 NS -1.34 111 NS
1 CÉR 0.73 0.67 NS -1.24 0.88 NS i
1 FRL -2.09 1.32 <0.001 -3.01 1.02 <0.0001
FRM -2.65 0.92 <0.0001 -2.73 0.85 <0.0001
CGA -1.38 1.04 <0.08 -2.32 0.68 <0.007 ;
CGP -3.18 0.72 <0.009 -2.00 1.14 <0.05 ^
INS -0.44 0.78 NS -0.02 0.87 NS
MOT -0.83 1.12 NS -1.15 1.53 NS
OCL -4.73 1.06 <0.0002 -5.36 1.24 <0.0001 :
1 OCM -2.18 1.91 0.14 -3.77 1.77 <0.005
I p a r -3.82 0.92 <0.0006 -4.32 0.97 <0.0001 i
1 TUT -0.22 0.53 NS -2.83 1.66 <0.05
I sm s -1.37 1.45 NS -0.92 0.89 NSI TEL -0.77 0.64 NS -0.90 0.97 NS
I t e m -2.01 1.10 <0.01 -1.97 0.61 <0.02 g
I TEP -5.88 0.61 <0.0003 -5.79 0.72 <0.0004
i THA -1.43 1.32 NS -1.35 1.35 NS
j WHM 0.08 0.04 NS -0.99 0.57 NS
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7.4.4. rCMRGlu between brain regions.
When investigating the metabolic rates in the AD brain with disease duration 
absolute rCMRGlu values were observed to decrease with an increased rate. The rate at 
which the metabolic rates decreased in AD patients affected the MR with increasing 
disease duration. It may be expected that the MR may change with the normal ageing 
brain as many researches suggest some dementias are an advanced foiTn of ageing 
[Pol97]. All 306 possible MR were examined with reference to the three age groups. 
The MR values for the three distinct age group controls are listed in Table 7. 7 for both 
left and right hemisphere ratios with the frontal, occipital, parietal and cerebellum.
7.4.4.I. Ratios of the fr onto medial/lateral regions (FRM7L).
Between the first two age groups (average 26 and 36 years) no significant 
changes were detected for ratios with both the FRL and FRM. This pattern may be 
expected as changes in rCMRGlu in lobes of the brain over this time period did not vary 
drastically. Over the last two time periods however metabolic ratios did vary for both 
hemispheres of the FRM and FRL. The ratios decreased in the TEM, OCM, OCL, and 
CER and so signifying that the rCMRGlu in the both hemispheres of both frontal 
regions are decreasing at a faster rate relative to the four regions in normal ageing. 
Interestingly though the TEM varied during the final two ages groups the TEL did not. 
This pattern of TEM and TEL having different properties has been a constant factor 
during analysis and shows the distinct nature of the two regions. The remaining regions 
remained approximately the same within the final age group. As noted in the study of 
ageing on individual lobes, it is thus important to distinguish between age groups when 
using any group statistics. Results here suggest that it is valid to group control subjects 
of age greater than 20 years but less than 60 together. Over the age of 60 careful 
separation has to be perfoimed as the ageing brain appears to be affected by increased 
deterioration which needs to be accounted for in an analysis. Additionally the results 
here reiterate the problems discussed in section 7.3 with respect to the differences 
between SPM ‘classic’ and SPM 96. Table 6.6 shows Vollenweider’s work [Vol97] 
using control subjects and SPM ‘classic’. Whereas Vollenweider observed a ratio of one
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between the FRM and FRL the ratio is significantly different to the one here (Table 7. 
7). Though as we are concerned with relative changes this is of no consequence as long 
as one method of normalisation is used throughout analysis. The FRM/FRL ratio, 
though different to Vollenweider’s study, did remain constant over the three distinct age 
groups.
7.4.4.2. Ratios of the occipitomedlal/lateral regions (OCM/L).
Generally for both the OCM and OCL little change in ratio was observed 
between young and middle age groups but the ratios of OCM and OCL to PAR, THA, 
FRL and FRM increased with respect to the old age group in the left hemisphere. This 
increase denotes that the OCL and OCM regions decrease at a slower rate in ageing 
compared to the region to which it is in ratio. The ratios for both occipital regions with 
the CER both decreased. For the right hand regions the only change in ratio was the 
decrease observed in the CER. In both hemispheres the MR OCM/OCL remained 
constant throughout the group studies though clearly the way in which both regions vary 
with respect to opposing hemispheres is distinct.
7.4.4.3. Ratios of the parietal lobe (PAR).
Again the general trend of no variation in the first two younger age groups was 
observed with changes in ratio occurring in old the age group. The ratios of PAR with 
the TEM, PUT and CER all decreased in both hemispheres indicating a higher rate of 
decrease in the parietal with respect to these regions. Of note is the difference between 
the TEM and TEL, where again the TEL displayed no variation.
T.4.4.4. Ratios with cerebellum (CER),
All regions, where ratios were examined with respect to the CER, rose in the 
elderly subjects. This shows that the cerebellum is relatively unaffected in ageing with 
respect to other regions of the brain. This was also observed in the ageing study of
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section 7.4.1. The cerebellum has also been shown to be relatively unaffected by a 
number of diseases such as AD [Pic99] and vascular dementia [Reu98]. The reason for 
this immunity to forms of degeneration is not known but the cerebellum is involved 
with balance and motor co-ordination within the brain, functions relatively preserved in 
AD. In relation to the MR for both female and male subjects groups with age, the ratios 
exhibit the same trends as observed in the grouped data for all regions.
7.5. Conclusions.
It is clear that metabolic rates within the brain vary with increased age of a 
subject group, moreover two distinct trends were observed with respect to the rate of 
decrease observed. Between that ages of approximately 20 to 60 years a steady decline 
of 2.2% per decade in rCMRGlu was observed over the whole normalised brain, while 
between 60 and 80 years a massive 11% decrease per decade was seen. This clearly has 
implications with regards to subject selection in any group study. It is not enough to 
match groups on mean age alone when ages are around the 60 year old limit as, if the 
majority of subjects are below 60 within a study whilst a few are above 60, these latter 
subjects will have a disproportionate effect. This would result in a lower mean 
metabolic rate than would be expected. The significances in rCMRGlu between 
hemispheres of a particular brain region also varied with increased age. At the relatively 
young mean age of 26, the left hemisphere regions were dominant with regards to 
metabolic rate, this dominance declined with increasing age until no significant 
difference was observed in the mean age 61 year old group. Metabolic ratios between 
regions varied with age showing the cerebellum to be relatively preserved with 
increased age. The changes also imply that brain function may alter slightly with age 
with the frontal lobe being particularly affected.
These factors along with gender differences also determined within this chapter 
impose crucial constraints upon any analysis concerning metabolic rates from subject 
data. As such it is critical that the study of the change in rCMRGlu between AD and 
control subjects should be age and sex matched to as high a degree as possible.
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Table 7.7: Metabolic ratios for tlie yoimg, middle and old age control groups.
Brain
Regions
Young Ç 
Left
16 years) 
Right
Mid (3( 
Left
> years) 
Right
Old (61 
Left
years)
Right
1 FRM/FRL 0.94+0,06 0.91+0.05 0.93T0.04 0.9210.03 0.9410.03 0.8910.05
; FRM/TEM 1.34±0.10 1.30+0.09 1.33+0.09 1.3010.10 1.2810.08 1.2110.10
FRM/TEL 1.03±0.06 0.96+0.07 1.0310.05 0.9610,06 1.0210.05 0.9610.08 :
FRM/OCM 0.9710.09 1.0010.13 1.0110.11 1.0410.10 0.94+0.08 0.9610.08 1
FRM/OCL 1.13+0.11 1.06+0.08 1.13+0.10 1.09+0.09 1.0710.10 1.0010.08 !
j FRM/PAR 0.94+0.07 0.94+0.08 0.9510.06 0.93+0.07 0.98+0.07 0.95+0.06 ;
1 FRM/CAU 1.05+0.13 1.0310.07 1.0210.08 1.0110.05 1.0710.11 1.0010.11 i
i FRM/CER 1.14+0.12 1.0510.10 1.1010.13 1.0210.10 1.0210.14 0.9310.14 Î
1 FRM/PUT 1.16+0.11 1.1310.11 1.1510.10 1.1410.07 1.1510.11 1.0710.08 !
I  FRM/THA 1.0510.11 1.0610.08 1.0610.12 1.0410.07 1.10+0.13 1.01+0.12 g
i FRM/TEP 1.2710.08 1.1910.11 1.2810.12 1.2010.08 1.2810.12 1.15+0.10 ;
; FRL/FRM 1.0710.06 1.1110.07 1.0810.05 1.0910.04 1.0610.03 1.1210.06 :
I FRL/TEM 1.4310.13 1.4310.14 1.4310.10 1.4110.09 1.3610.08 1.36+0.08 1
!  FRL/TEL 1.10+0.09 1.0610.09 1.1110.05 1.0510.06 1.0910.05 1.0810.06 ;
i  FRL/OCM 1.0410.13 1.1010.16 1.0810.12 1.1310.11 1.0010.08 1.0810.09I FRL/OCL 1.2110.14 1.1810.12 1.2210.11 1.1910.10 1.1410.10 1.1310.10 i
1  FRL/PAR 1.0010.07 1.03+0.10 1.0210.07 1.0210.08 1.0410.08 1.0710.07 !
! FRL/CAU 1.1210.11 1.1410.10 1.1010.08 1.1110.06 1.1410.12 1.1310.09 :
1 FRL/CER 1.2110.14 1.16+0.13 1.1710.14 1.1110.09 1.08+0.13 1.05+0.14 '
i FRL/PUT 1.2310.09 1.2510.15 1.2310.09 1.2410.11 1.2210.11 1.2010.06 i
1 FRL/THA 1.1210.11 1.1810.14 1.1310.10 1.1310.09 1.1710.14 1.14+0.12 :
I FRL/TEP 1.3510.11 1.3010.14 1.3610.12 1.3010.12 1.35+0.12 1.3010.08 1
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Table 7.7; (continued)
Brain
Regions
Young Ç  
Left
16  years) 
Right
Mid (3( 
Left
)  years) 
Right
Old (61 
Left
■HIM 1 ;
years)
Right
Î OCM/TEM 1.3810.13 1.3210.19 1.3310.15 1.2610.10 1.3710.14 1.2710.14 i
1 OCM/TEL 1.0710.11 0.9810.13 1.0310.11 0.9410.09 1.0910.10 1.0110.09 !
1 OCM/OCL 1.1710.11 1.0810.12 1.1310.09 1.0610.10 1.1410.09 1.0510.07 1
i  OCM/PAR 0.9710.13 0.9610.17 0.9410.09 0.9110.11 1.0510.10 0.9910.07 1
OCM/CAU 1.1010.19 1.0610.24 1.0310.13 0.9910.10 1.1510.17 1.0610.15 1
OCM/CER 1.1910.17 1.0610.17 1.0810.14 0.9710.13 1.0710.11 0.9610.15 i
OCM/PUT 1.2110.19 1.1610.21 1.1510.15 1.1110.12 1.2310.18 1.1210.11 !
OCM/THA 1.0910.15 1.0910.19 1.0610.16 1.0110.13 1.1810.21 1.0710.17 I
OCM/TEP 1.3010.14 1.2010.17 1.2810.13 1.1610.12 1.3610.16 1.2010.11 !
OCL/TEM 1.1910.11 1.2210.11 1.1810.11 1.1910.11 1.2110.15 1.2210.13 !
OCL/TEL 0.9210.09 0.9110.08 0.9210.08 0.8910.07 0.9610.11 0.9710.10 !
OCL/OCM 0.8610.08 0.9410.10 0.8910.07 0.9510.09 0.8810.07 0.9610.06 i
OCL/PAR 0.8310.11 0.8910.13 0.8310.07 0.8510.08 0.9210.11 0.9510.07 '
OCL/CAU 0.9410.17 0.9810.19 0.9110.10 0.9310.10 1.0110.15 1.0110.14 i
OCL/CER 1.0110.16 1.0010.13 0.9710.14 0.9410.11 0.9510.16 0.9310.16 ;
OCL/PUT 1.0410.18 1.0810.17 1.0210.12 1.0510.12 1.0810.16 1.0710.10 i
OCL/THA 0.9310.13 1.0110.15 0.9410.14 0.9610.13 1.0410.20 1.0210.17 ^
OCL/TEP 1.1210.10 1.1210.12 1.1310.11 1.0910.11 1.1810.15 1.1610.12 :
PAR/TEM 1.4410.15 1.4010.19 1.4210.10 1.4010.12 1.3110.08 1.2810.10 ;
PAR/TEL 1.1110.10 1.0310.12 1.0910.07 1.0410.06 1.0510.06 1.0110.06 !
PAR/PUT 1.2410.14 1.2210.18 1.2210.12 1.2310.15 1.1710.14 1.1310.06 :
PAR/CAU 1.1310.14 1.1110.14 1.0810.10 1.0910.11 1.1010.14 1.0610.11 i
PAR/CER 1.2310.15 1.1310.14 1.1410.12 1.1010.14 1.0210.13 0.9810.13 !
I PAR/THA 1.1210.12 1.1510.16 1.1210.15 1.1210.14 1.1310.14 1.0710.13 1
1 PAR/TEP 1.3710.10 1.2910.17 1.3410.12 1.2810.15 1.3010.15 1.2210.07 ;
i  CER/TEM 1.1710.11 1.2310.14 1.2410.13 1.2810.13 1.2810.11 1.3210.14 ,
1 CER/TEL 0.9110.11 0.9110.11 0.9510.11 0.9510.09 1.0210.11 1.0410.13 !
1 CER/PUT 1.0310.13 1.0910.12 1.0710.15 1.1410.14 1.1010.10 1.1510.15 ‘
1 CER/CAU 0.9410.13 0.9910.15 0.9310.12 1.0010.10 1.0410.11 1.0510.14 i
1 CER/THA 0.9310.09 1.0210.13 0.9810.18 1.0210.11 1.0910.13 1.0810.14 !
! CER/TEP 1.1110.11 1.1110.13 1.1710.16 1.1710.11 1.2410.16 1.2610.13 i
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8. Comparison of rCMRGlu between control and 
Alzheimer subjects.
8.1. Introduction.
The study into the effect that disease duration has on AD in chapter 6, has 
shown that the metabolic rate within regions of the brain decreases rapidly during 
disease progression. Chapter 7 additionally showed the need to make sure subjects were 
age-matched as the global rate of decline of rCMRGlu after the age of 60 years 
increases dramatically. As such the AD subject group containing eighteen subjects, 
average age 66.5 ±8.1 (9 female, 69.8 ± 6.2, 9 males, 63.2 ± 8.5), were compared with 
eighteen control subjects with average age 61.5±11.0 (10 female 61.7±8.8, 8 male 
61.3±13.6), the closest possible match to produce good quality statistics. Subject 
information for the AD group is given in table 6.1 while table 7.2 shows the control 
subject information. Four statistical methods were used to determine whether 
differences existed between the AD and control rCMRGlu these were standard t-tests or 
Wilcoxon (depending on normal or non-noimal distributions respectively), statistical 
parametric mapping (SPM), hierarchical clustering and subprofile scalar modeling 
(SSM). The latter two routines used to uniquely identify subjects as being within a 
distinct AD or control subject group.
8.2. rCMRGlu distributions.
In the control brain only the PUT was observed to have a non-normal 
distribution with respect to rCMRGlu within regions of the brain, figure 7.6. However, 
in the AD brain significant deviations from a normal distribution were seen for the 
majority of regions, figure 6.4. This result in itself introduces difficulties in the 
statistical testing of these two data sets as a non-normal distribution dictates that
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parametric testing should not be performed. EiTors may be introduced if data with non­
normal distribution are compared with those which do in packages such as SPM.
The disruption caused to the rCMRGlu distributions in regions of the brain 
shows that in AD the uptake of glucose and hence metabolic rate in those regions is 
unsystematic relating to a disruption of brain function. This would be expected as 
clearly by definition, dementia gradually inhibits brain function. Figure 8.1 shows 
rCMRGlu histogram, frequency distributions and probits plots [Kir88] of the regions 
OCL and OCM for the left hemisphere. The probit plot being linear if the data is 
normally distributed or curved if not. Determination of how far* the probit plot differs 
from linearity was performed on a statistical/visual basis.
In both AD and controls the PUT did not show a normal rCMRGlu distribution, 
but this ROI in paiticular is small and problems do occur with localisation of this area. 
Of the remaining regions seven, the CAU, INS, OCL, OCM, PAR, THA, and WHM, 
were seen to have non-noimal distributions in both hemispheres of the brain. Gender 
was also seen to affect rCMRGlu distributions in AD with females displaying 
significantly more deviations from normality than the males. Twenty six out of the total 
thirty six regions were affected in females while just fifteen had non-noimal 
distributions in the male subject group. The change from normal distribution to non­
normal distribution between control and AD subjects show clear similaiities for left and 
right hemispherical area of a region of interest. This may be expected as primarily each 
region or lobe is specific in its function though the right hemisphere is generally 
concerned with non-verbal skills while the left hemisphere verbal skills [Tho85].
Both of the affected occipital regions are associated with the sense of vision and 
have been associated with apraxia in AD [Nie96], an ailment usually associated with the 
parietal and frontal regions [Oxf96]. More recently visual hallucinations in AD have 
been assigned to atrophy in this region of the brain [HolOO]. Along with apraxia as 
already mentioned the parietal lobe processes somatosensory information such as 
kinesthesis and spatial awareness [Kne96] but is also accredited with verbal working 
memory [Jon98]. The thalamus receives sensory information except for taste and smell 
and distributes it to the required areas. The caudate is associated with cognitive function 
whilst the use of the insular region is less well defined. Uses for this region range from
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emotional expression [Can90], impaired speech [Shu93] and general cognitive 
difficulties [Fou96], to taste perception [Pri99]. The insula is like many other regions of 
the brain where many functions have been attributed to one region making it difficult to 
interpret results.
OCL left control OCM left control
iCMROlu
OCL left AD OCM left AD
rCMRGlu rCMRGlu
OCM leftOCL left
Figure 8.1: Plots showing histograms, cumulative frequency and probits for rCMRGlu in
AD and control subjects
D. A. Cutts 201
Investigation into Brain Function; 8. Comparison of rCMRGlu between control and
AD subjects:
8.3. rCMRGlu between hemispheres.
In the ‘normal’ ageing brain significant differences in metabolic rates between 
hemispheres were observed. Initially metabolic rateswere generally higher in the left 
hemisphere but then as subjects increased in age this dominance gradually declined 
imtil no difference was seen. Table 8. I shows the differences between hemispheres in 
both AD and the age matched controls. Hemispherical differences follow similar trends 
in both mental states with the regions CAU, CER and TEL significantly higher in the 
right hemisphere while the FRM, CGA, CGP, OCM, PAR and THA were higher in the 
left. The regions INS, SMS, OCL, TEP and PUT all had significant differences in 
rCMRGlu in either controls or AD but not both. When looking at female and male 
subject groups separately the trends observed between hemispheres adhere to the 
grouped subjects trend though the male subject set exhibited fewer regions with 
significances. From Table 8. 2 it is seen that the male subjects include eiglit regions 
(both hemispheres) of no significance in controls while in females (Table 8. 3) there are 
six. In the AD brain ten regions were not significant in the males while the female 
subjects contained seven. Figure 8.2 shows the global trend between hemispheres for 
young, middle, old control and AD subjects for all regions of the brain. Clearly age 
appears to be a greater factor in terms of hemispherical differences rather than disease 
state.
T re n d  in rC M R G lu  fo r  all r e g io n s
1
Female
Middle
Figure 8. 2: Difference in the metabolic rates between right and left 
hemisphere normalised values across all subjects and brain regions.
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The differences between the hemispheres in , AD are again at odds with the 
previous SPM ‘classic’ normalised data which exhibited a distinctly higher rGMRGlu in 
the majority of right hand regions, table 6.2. If this had been the case in analysis here it 
would have continued the general trend of the right hemisphere gradually superseding 
metabolic rate in the left as seen in the ageing study and so may have implied AD is a 
form of advanced ageing. This theory of AD being an advancement of the ageing 
process has been discussed [Mor97]. Unfortunately results here, obtained using SPM 96 
do not confirm this but neither do they contradict it. The use of SPM ‘classic’, as 
discussed in chapter 7, may have lead to different results.
Tables 8.1 to 8.3 additionally show the percentage decrease in rCMRGlu from 
the control to the AD brain for both hemispheres, for all subjects, male subjects and 
female subjects’ respectively. As expected with the onset of dementia significant 
decreases in rCMRGlu were observed between control subjects and those with AD. All 
regions of the brain exhibited a statistically significant decrease ranging from 4% 
(p<0.1) in the SMS to 25% (p<0.0001) in the PAR. Both the SMS and MOT only 
suffered reductions of 7% or less, not surprising as these regions are associated with 
skin sensation (such as touch) and motor co-ordination, respectively, which are 
functions not seriously affected in AD. The cortical regions FRM, FRL, OCL and OCM 
suffered a moderate decline of the order of 10-16%, as did the regions CER, CGA, 
CGP, INS, PUT, THA and WHM. The regions that experience the greatest deviation in 
rCMRGlu from control to AD subjects are the cortical regions, CAU, TEL, TEM, TEP 
and PAR all with a decline in the range 17-25%. These results correlate well with 
histopathological hallmarks found in the brain of AD sufferers with the moderately 
affected frontal region affected by senile plaques. But the more severely affected 
temporal and parietal regions containing large amounts of senile neuritic plaques and 
neurofibrillary tangles [Gia95]. The CAU and CGP were also severely affected with the 
caudate nucleus connected with cognitive function [Holt97] and the lack of activity in 
the cingulate region associated with depression [E1197]. Though in the later case there 
were marked differences between the CGP and CGA. The anterior cingulate has been 
attributed to planning [E1197] whilst dysfunction of the posterior cingulate has been 
linked to impairment of learning abilities and memories [Min97].
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The gender of the subject was again significant with respect to changes in the 
brain between control and AD states. Females exhibited significant decreases between 
subject groups in all regions of the brain whereas the male subjects had notable 
exceptions. The rCMRGlu of the CER, MOT, SMS, OCM, PUT, TEP and right 
hemisphere FRM were not significantly lower in the male AD subjects. The cerebellum 
is linked with balance and motor co-ordination and clearly so is the motor cortex as has 
been reported to not significantly change with the onset of AD [Pic99]. Of the 
remaining regions the percentage decline from control to AD varied from 5% (p<0.05) 
to a highly significant 20%. The higher values found in the PAR and TEL, as previously 
mentioned, are regions associated with plaques and tangles. Additionally to all of the 
female regions exhibiting significant differences, their decreases were also greater than 
those of the male subjects ranging from 10% to 28%. The largest decrease again seen in 
the PAR (-28%) with the TEL, TEM and TEP also displaying large reductions (-24%). 
This implies, as with earlier results that the female brain is affected more severely than 
the male. But before this can be suggested the ages of the two subject groups have to be 
examined.
The male control subjects had a mean age of 61.3+13.6 while male AD 63.2 ± 
8.5 a difference of less than 2 years. The females however consisted of a control group 
of mean age 61.7+8.8 while the AD subjects had age 69.8 ± 6.2, a gap of over seven 
years. Even though not statistically significant with respect to the standard deviation of 
age of the two groups, the seven year difference may affect any significance observed. 
In chapter 7 an increasing rate of decline in rCMRGlu was observed after the age of 
60-65, figure 7.5. This suggests that for a minimum of 5 years the decreases have to be 
adjusted according to figures in table 7.4. This correction resulted in all regions apart 
from the CER, TEP and WHM still exhibiting significant differences. The CER and 
TEP now matched the results seen in the male study, though significant decreases in 
rCMRGlu in the female group were still greater than those of the males. This correction 
confirms that the female brain in AD does in fact endure a greater change than the male 
counterpart.
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When performing significance testing on rCMRGlu between genders rather than 
comparing results obtained while investigating male and female groups separately, the 
control subjects showed females to have a generally higher rCMRGlu across brain 
regions, table 7.6. In AD this trend has been significantly reversed with all regions 
which are significantly different between female and males now having higher 
metabolic rates in the male brain. This equates well to the higher rates of decrease in 
metabolism observed between control and AD states in the female subject group. Table 
8. 4 displays the significant differences. The frontal and temporal areas were amongst 
the regions which in control subjects had higher metabolic rates in females but in AD 
were now significantly higher in male subjects. Other regions such as the parietal and 
occipital areas which were metabolically more active in the female were now not 
significant in either. Figure 8.3 shows this trend observed between female and male AD 
and control subjects with respect to normalised metabolic rates. In the control group the 
female subjects had a global normalised metabolic rate of 4.9% higher than males in the 
left hemisphere and 6.6% in the right. In the AD subjects group figure 8.2 presents a 
5.3% higher global normalised metabolic rate in the left while 3.8% was observed in the 
right. Figure 8.4 shows the decrease normalised rCMRGlu over the whole brain in 
female (15%±3%) and male (7%±2%) subjects between disease states. The female 
group wasclearly observed to have a greater decrease.
T rend  in rCM RGlu for b e tw e e n  g e n d e r  for a ll r e g io n s
Figure 8. 3: Difference in normalised 
metabolic rates between gender across 
all brain regions
7% decrease
15% decrease
Figure 8. 4: Difference in normalised 
metabolic rates between control and AD 
subjects.
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Table 8,1; rCMRGlu between hemispheres in the AD and age-matched controls.
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Table 8.2; rCMRGlu between hemispheres in male AD and Controls,
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Table 8.3: rCMRGIit between hemispheres in the female AD and Contiols.
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Table 8.4: rCMRGlii differences between male and female AD subjects.
Region 
1 of 
Brain
r .m . w u  iM mwM. " W
Left femal
Difference 
M-F SD
e and male.
Significance
p-value
Right fern:
Difference 
M-F SD
lie and male
Significance
p-value
i CAU 1.20 0.92 NS 0.29 0.34 NS
CER 1.57 1.47 NS 4.11 1.07 <0.008
FRL 4.28 1.26 <0.0001 2.97 0.92 <0.0001
FRM 2.79 0.87 <0.0002 3.48 0.82 <0.0001 g
CGA 1.68 1.08 <0.07 2.17 0.85 <0.005
CGP -1.02 0.96 NS -0.54 0.67 NS
flN S 2.52 1.98 NS 0.63 0.79 NS
MOT 2.10 1.24 <0.11 1.01 1.23 NS
OCL 1.04 1.05 NS -1.53 1.33 NS
OCM 0.00 0.89 NS -0.99 1.03 NS
PAR 0.11 0.58 NS -0.11 0.38 NS
PUT 1.88 0.58 NS 1.44 1.64 NS
SMS 4.76 2.01 <0.01 3.15 0.85 <0.06
TEL 1.83 1.04 <0.03 0.11 0.46 NS
! TEM 1.98 1.13 <0.02 1.73 0.73 <0.08
1 TEP 1.73 0.73 <0.01 1.65 0.68 <0.05
i THA 1.11 1.22 NS 0.72 0.83 NS
WHM -0.77 0.85 NS
I... J . . 1 I .........
0.28 0.32 NS
8.3.1 Fatlak results.
So far results have been deteimined with respect to tlie Rliodes method of 
analysis. This method results in all brain regions being described in terms of rCMRGlu 
wiüi Üie maxiniiun number of ROI available. The Patlak method however is limited to 
whichever half of the brain dynamic scanning was perfonned on during tlie PET 
imaging procedure. As a results not all ROI are measured and tliose winch are can suffer 
from a low number of PROI of which it is constructed. In control subjects the regions 
SMS and MOT were not detected at all while PAR WHM and CGP were measured in 
just two subjects. Neveitlieless, the Patlak method utilises rate constants between tissue 
and plasma compartments whereas the Rliodes method relies on a general uptake model. 
The dynamic scanning procedine determining tlie rate constants and so exploiting all 
infoimation available on glucose uptake over the scanning period ratlier tlian a total 
uptake ‘mean’ image.
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The differences observed between tlie Palalc and Rhodes metliod of analysis are 
outlined in Table 8. 5 witli respect to differences between hemispheres. Witli reference 
to absolute values of rCMRGlu obtained using tlie Rliodes metliod also listed in Table 
8. 5, Patlalc values are observed to be between 6% and 7.5% lower. Generally all 
regions exliibited tlie similar differences between hemisphere altliough these were, on 
the whole, larger and more significant than those seen witli tlie Rhodes metliod. The 
only exceptions to tliis were die regions FRL and TEL in the AD subjects which were 
still both displayed significant differences between hemispheres but die variation was 
reversed, mai'ked widi in Table 8.5. The FRL now matched the difference observed 
in rCMRGlu between left and right hemispheres in control subjects. The TEL region 
only consisted of 4 subjects in die AD group so statistical fluctuation may account for 
tliis discrepancy.
Table 8. 5; Difference in observed significances 
AD and contiol subjects using die Rhodes
between left and right hemispheres for 
and Patlalc methods of analysis.
Region All Conti ol Subjects All Alzheimer Subjects
of Patlak Rliodes Patlak Rhodes :Brain Left Right P P Left Right P P
1 CAU 31.00±7.41 31.25+6.81 <0.22 <0.04 20.82+10.40 22.64+10.30 <0.0001 <0.0001 i
1 CER 30.04±6.23 31.00+6.24 <0.0006 <0.005 30.35+12.70 32.90+16.55 <0.03 <0.07 :
i FRL 35.78±5.99 36.12+5.61 <0.001 <0.004 28.53+5.97 29.27+7.02 <0.0001* <0.02
1 FRM 33.49+6,05 31.77+5.46 <0.0001 <0.0001 29.24+6.70 27.60+6.27 <0.0001 <0.0006 ^
i CGA 30.64+5.12 29.50+5.76 <0.04 <0.0001 28.29+5.88 27.47+7.98 <0.007 <0.0001 i
CGP 43.29+3.91 35.63+4.95 <0.002 <0.0001 28.60+8.35 27.96+7.89 <0.001 <0.0001 •
INS 35.55+7.06 34.85+6.50 <0.02 <0.03 27.73+7.25 27.27+6.22 NS NS :
! MOT NA NA NA NS 30.65+4.96 30.65+6.64 NS <0.05 ;
i OCL 29.43+4.87 30.27+4.29 <0.001 <0.02 27.44+5.70 29,40+6.84 <0.0001 NS !
I OCM 38.06+5.62 35.27+4.99 <0.0001 <0.0001 33.08+6.68 32.65+5.97 NS <0.01
PAR 44.90+0.68 39.73+0.86 <0.004 <0.07 26.93+8.93 26.15+9.67 <0.0001 <0.0001 ;
1 PUT 30.09+8.11 30.92+8.52 <0.0002 <0.004 23.65+8.67 24.02+9.20 <0.02 NS [
! SMS NA NA NA NS 32.15+8.54 31.37+9.72 <0.015 <0.0006 ;
! TEL 31.66+5.99 32.27+5.59 <0.0001 <0.0002 26.77+8.10 26.29+8.19 <0.03* <0.0008 ;
i  TEM 23.57+3.71 24.15+3.76 <0.0005 NS 18.53+4.47 18.05+5.50 NS NS i
1 TEP 22.76+4.96 24.15+5.17 <0.0001 <0.0001 16.92+4.81 16.79+4.95 NS NS ;
; THA 29.75+7.09 29.91+7.33 <0.09 <0.0002 20.78+9.89 22.30+10.48 <0.0001 <0.0001 ;
WHM 15.93+0.84 13.23+1.68 <0.009 NS 11.95+2.24 11.79+3.14 NS NS
* = Regions where left or right hemisphere dominance was switched when using the Patlak method.
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Between control and AD subjects the observed decreases in rCMRGlu were 
greater in the CAU, PAR, TEP and THA though in general decreases were of the same 
order of magnitude to those obtained with the Rhodes method. The change described in 
the PAR and TEP regions can be explained by the limited number of subjects where 
these region were available, this resulted in a change in the mean age of the ROI group 
and so rCMRGlu values as described in chapter 7. This is the main drawback of the 
Patlak approach used here as there was a sizeable difference in the number of subjects 
in each study possessing a particular ROI. In the case of the TEM region all eighteen 
controls had rCMRGlu values while the AD group had just four which has an adverse 
effect on statistics.
Overall, in areas of the brain where the vast majority of PROI were available, 
and so good quality ROI infoimation, the Patlak method showed an increased 
significance between brain regions compared to the Rhodes method. The difference 
between the two methods originated from the use of the glucose uptake method. Both 
methods are generally accepted in the PET field though it is cleai* that although results 
are similar there is a certain degree of disparity. As the Patlak method relies on rate 
constants, and in particular rate constant "ki\ the rate constant across the blood brain 
barrier (figure 3.16) this would be the preferred method of analysis concerning data 
here. But due to the limitations of the scanner used the dynamic scanning area was 
reduced resulting in many regions not been measured and so increasing errors. 
Furthermore, to categorise subjects into AD and control groups using hierarchical 
clustering and subprofile scalar modelling, the largest number of regions possible would 
be required. As such the Rhodes method of analysis was best suited.
8.4. Correlations between brain regions.
Primaiily, the left and right hemispheres of a lobe within the brain perform tasks 
based upon one main function although the left side is connected more with the verbal 
skills associated with that function while the right, the non-verbal. Therefore with 
‘normal’ brain functioning it may be thought that glucose uptake and metabolism in the 
either hemisphere of a particular lobe would relate to one another. In the control group
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all eighteen regions of the left hemisphere normal brain correlated well with its right 
counterpart all with coirelations greater than r = 0.85 (p<0.0001 for all). However in the 
case of the AD subjects the TEL and TEP regions suffered poor coiTelation with 
coefficients of r = 0.65 (p<0.001) and r = 0.63 (p<0.003) respectively. Both male and 
female subject groups displayed the same non-correlation. The correlations for the 
temporolateral and temporal pole for both AD and control are shown in figure 8.5. Why 
the TEL and TEP do not correlate in AD subjects is not cuirently known, moreover why 
the TEM region of the brain correlates well while its other two associated regions do 
not, is more puzzling. Although, much research in AD has found left temporal region 
vulnerability associated with disease onset [MizOO], this would account for the 
breakdown in correlation.
Additionally to the use of correlations to examine differences between disease 
states metabolic ratios (MR) are used explore how the relationship between two 
particular regions of the brain alters during a neurological disorder. Even if the absolute 
rCMRGlu values decrease in both regions the ratio will remain the same as long as both 
regions decrease at the same rate. However, if the ratio increases from control to AD 
then the numerator region will have decreased at a slower rate than the denominator 
region between disease states. A decrease implies the opposite scenario of the 
numerator decreasing at a quicker rate relative to its denominator. Table 8. 6 shows the 
MR for control and AD subjects. Concurrent to this, correlations were also examined 
between the regions in ratio. In ‘normal’ brain function, regions of the brain have a 
particular pattern of glucose uptake expected as regions will require a fixed amount of 
glucose to perform their paiticular task. In the AD brain this relationship between brain 
function and glucose uptake may be broken in such a way that the MR alter and 
coiTelations aie destroyed suggesting a complete breakdown in any functional 
relationship between the two regions. Or the MR change but correlations still exist 
implying the association survives between the two regions although the functional 
relationship may have changed.
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Figure 8. 5: Correlation between hemispheres in AD and control subjects for the 
temporolateral and temporal pole.
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The way in which regions of the brain interact is a massive and confusing field. 
For example, the relationship between the frontal and temporal lobe of the brain has 
been discussed in terms of recall and recognition memory [Kop89], verbal fluency 
[Tro98] and hyperactivity [Oad98]. The way in which left and right hemispheres 
interact with respect to the frontal lobe has also been shown to vary [Kel98]. Examining 
the relationships between other regions result in the same conclusions. As such 
correlations may be found to change with the onset of AD but the interpretation of such 
variation will be difficult.
8.4.1. Ratios of the frontomedial/lateral regions (FRM/L).
Chapter 7 examined how MR for FRM and FRL regions varied with the age of 
three control subject groups. In both FRM and FRL the ratios were seen to decrease 
with increasing age in control subjects for the regions TEM, OCM, OCL and CER listed 
in Table 8. 6. With the onset of AD the TEM was the only one of these regions to 
display (p<0.03) significance but with an increasing ratio, as did the TEL, PAR and 
CAU. This indicates that these regions suffer hypometabolism with reference to the 
FRM. Interestingly the FRM/FRL ratio, which remained at approximately 0.94 
throughout the three groups in the ageing study, now exhibited no significance from 
unity showing the lateral region to be no longer dominant. As a result, the MR with the 
FRM region demonstrated more changes between brain states with the addition of areas 
OCL, OCM and PUT, which significantly decreased in ratio. The relative 
hypermetabolism in these regions with respect to the FRM associates well with 
histopathalogical hallmarks in the brain in which the occipital region is only moderately 
affected compared to the frontal lobe [Gia95]. A decrease in ratio was also seen in the 
ageing brain with regards to the OCM and OCL. The relative lack of decrease in these 
regions seen with the onset of AD may be in respect to their primary functions. The 
PUT is associated with the motor perfonnance [Holt97] while the occipital regions are 
linked with vision, both functions not severely affected in AD.
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In both control and AD subjects high correlations existed between all of the 
regions paired for MR. For the FRL left and right regions all regional correlations had 
r>0.85 (p<0.0001) for both hemispheres in controls with the exception of the CER 
(r<0.7, p<0.0001). Similarly in AD all had correlations with r>0.7 (p<0.0001) again 
with the exception of the CER which had a lower coefficient r<0.6. The FRM region 
also displayed the same trends. This suggests that although the ratios with TEM, TEL, 
PAR CAU, OCM and OCL for the regions FRM and FRL changed with onset of AD 
their primary relationship in terms of rCMRGlu remained the same though with slightly 
lower correlations (approximately O.I lower in AD for each pairing). However the 
con elation coefficient of =0.6 with the CER in AD may suggest a breakdown in 
functional relationship.
8.4.2. Ratios of the occipitomedial/Iateral regions (OCM/L).
For all MR examined, which had significant differences from the control group, 
ratios were higher in AD subjects for both the OCM and OCL. The regions TEL, FRL, 
PAR, CAU and TEP all experience hypometabolism compared to both the OCL and 
OCM regions with the added areas of TEM and FRM. As seen in the previous section, 
the occipital region of the brain appears to be relatively well preserved in AD. In the 
normal ageing brain ratios with PAR, THA, FRL and FRM increased with increasing 
age. This could suggest rapid continuation of the ageing process occurs in AD.
Correlations were again high between all regions examined in both AD and 
controls although coefficients were on average r=0.1 lower in the OCM of AD subjects. 
In the control subject group correlations for the OCM and OCL left hemisphere all had 
coefficients of r>0.8 (p<0.0001) with the exception of the PUT, THA, CER and CAU 
(r<0.7, p<0.0001). Generally correlations in the right hemisphere for both AD and 
control subjects were higher than the left but followed the same trends.
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8.4.3. Ratios of the parietal lobe (PAR).
Every single ratio examined with respect to the PAR decreased although not all 
did significantly so. MR with the regions CER, OCL, OCM, FRL, FRM, PUT, and 
THA were significantly lower in AD subjects. This indicates that the PAR lobe 
experiences a greater decline in AD, which again is backed up by histopathological 
findings of high proportions of neuritic plaques and neurofibrillary tangles in this area 
[Gia95].
For the left hemisphere PAR all correlations had coefficients r>0.75 (p<0.0001) 
in the control subjects while in AD all were greater than 1-0.7 (p<0.001) with the 
exception of the TEM, TEL, OCM, CAU, THA and TEP (r<0.6, p<0.0001). Again a 
similar pattern was observed in the right hemisphere with all coefficients greater than 
r=0.8 (p<0.0001) and AD subjects with all pairs r>0.7 (P<0.0001) except TEM (r<0.6, 
p<0.0001). Again as seen in the previous lobes, correlations were on average higher in 
the right hemisphere for both AD and controls.
8.4.4. Ratios of the cerebellum (CER).
The function of the cerebellum is thought to be relatively unharmed by the 
effects of AD and as such the MR with other regions of the brain would not be expected 
to decrease. In the ageing brain the CER was seen to be relatively unaffected with 
respect to other regions of the brain with ratios increasing with age. The relative 
preservation of the CER was also discovered to be the case in the AD brain as all 
regions either exhibited an increase in ratio or no significant difference. The regions 
connected with the ratios which increased were the TEL, CAU, PAR and TEP. The ratio 
of CER/PUT remained the same as may be expected as both are linked by means of 
motor function.
Correlations with the CER in both controls and AD subjects were generally 
lower than for the previous regions examined with all left hemisphere coiTelations all 
with r>0.7 (p<0.0001) with the exclusion of OCL (r<0.6, p<0.0001). However more 
significant results were observed in the AD subjects with the regions TEL, OCL, OCM,
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FRL, FRM, CAU, and TEP not having coefficients above r=0.6 and so low coiTelation. 
Once more the right hemisphere displayed a similar relationship with controls having 
coefficients r>0.7 (0.0001) for all region but the OCL and OCM r<0.6 (p<0.0001). And 
again in AD the right hemisphere was severely affected with the regions TEM, TEL, 
OCL, OCM, FRL, PUT CAU, THA and TEP with coefficients r<0.6 (p<0.0001). The 
lack of correlation seen in the AD subject group with respect to the control group again 
suggests functional relationships with the CER are destroyed with the onset of the 
disease.
When separating gender, differences in MR between disease states followed 
similar trends of hypo- and hypermetabolism observed in the grouped gender study 
although the MR values did vary between sex as discussed in section 7.4.4. 
Furthermore, correlations between regions also followed the same trends of higher 
coefficients in the right hemisphere.
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Table 8. 6: Significances between metabolic ratios for tire control and AD brain.
Brain
Regions
Control
All left
AD
Metaboli
p
c Ratios.
Control
All right
AD P
i FRM/FRL 0.94±0.03 0.9910.07 <0.01 0.8910.05 0.97+0.05 <0.0001 ;
FRM/TEM 1.28+0.08 1.3310.18 NS 1.21+0.10 1.33+0.20 <0.03 j
FRM/TEL 1.02±0.05 1.1510.16 <0.004 0.9610.08 1.10+0.17 <0.004 ■
FRM/OCM 0.94+0.08 0.90+0.11 NS 0.9610.08 0.9010.07 <0.06 1
FRM/OCL 1.07±0.10 1.0510.11 NS 1.0010.08 1.0310.11 NS i
FRM/PAR 0.98+0.07 1.1310.16 <0.002 0.9510.06 1.1710.16 <0.0001 ;
FRM/CAU 1.07+0.11 1.1910.17 <0.03 1.0010.11 1.1210.19 <0.03 ■
FRM/CER 1.02±0.14 1.0010.12 NS 0.9310.14 0.9810.13 NS i
FRM/PUT 1.15±0.11 1.09+0.08 <0.07 1.0710.08 1.0710.09 NS
FRM/THA 1.10+0.13 1.1410.21 NS 1.0110.12 1.00+0.14 NS !
FRM/TEP 1.28±0.12 1.37+0.20 NS 1.1510.10 1.3510.12 <0.0003 i
FRL/FRM 1.06+0.03 1.0210.07 <0.01 1.1210.06 1.0310.06 <0.0001 1
FRL/TEM 1.3610.08 1.3410.17 NS 1.3610.08 1.3810.23 NS i
FRL/TEL 1.09+0.05 1.1610.12 <0.04 1.0810.06 1.1310.14 NS i
I FRL/OCM 1.0010,08 0.91+0.11 <0.02 1.0810.09 0.9310.07 <0.0001 *I FRL/OCL 1.1410.10 1.07+0.12 <0.07 1.1310.10 1.0610.11 <0.09
i FRL/PAR 1.0410.08 1.1410.18 <0.05 1.0710.07 1.20+0.16 <0.004 ■
FRL/CAU 1.1410.12 1.20+0.14 NS 1.1310.09 1.1510.19 NS
FRL/CER 1.0810.13 1.0210.12 NS 1.0510.14 1.0210.14 NS :
! FRL/PUT 1.2210.11 1.10+0.08 <0.001 1.2010.06 1.1110.08 <0.001 1
! FRL/THA 1.1710.14 1.15+0.19 NS 1.1410.12 1.0410.14 <0.03 !
! FRL/TEP 1.3510.12 1.3810.15 NS 1.3010.08 1.4010.15 <0.06 i
i OCM/TEM 1.3710.14 1.4910.24 <0.09 1.2710.14 1.4710.23 <0.004 S
OCM/TEL 1.0910.10 1.2910.23 <0.004 1.01+0.09 1.22+0.19 <0.0002 Ï
OCM/OCL 1.14+0.09 1.17+0.12 NS 1.0510.07 1.1410.09 <0.003 i
OCM/FRL 1.0110.08 1.1110.13 <0.01 0.9310.07 1.08+0.09 <0.0001 I
OCM/FRM 1.1110.09 1.1810.12 <0.08 1.07+0.08 1.1610.07 <0.001 ,
! OCM/PAR 1.05+0.10 1.27+0.22 <0.001 0.9910.07 1.2810.16 <0.0001 !
j OCM/CAU 1.1510.17 1.3310.21 <0.01 1.0610.15 1.22+0.19 <0.01 ■
I OCM/CER 1.0710.11 1.1310.17 NS 0.9610.15 1.08+0.15 <0.06
I OCM/PUT 1.23+0.18 1.21+0.14 NS 1.1210.11 1.1910.09 <0.08 I
OCM/THA 1.1810.21 1.27+0.21 NS 1.0710.17 1.1010.15 NS i
1 OCM/TEP 1.3610.16 1.5310.27 <0.05 1.20+0.11 1.4910.17 <0.0001 i
1
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Table 8. 6; Significances between metabolic ratios for die control and AD brain
(continued)
Brain 
. Regions
1 Control
All left
AD
Metaboli
p
c Ratios.
Control
All right
AD P
OCL/TEM 1.2110.15 1,2810.21 NS 1.2210.13 1.30+0.21 NS 1
OCL/TEL 0.9610.11 1.1010.19 <0.01 0.97+0.10 1.0810.16 <0.04
OCL/OCM 0.8810.07 0.86+0.09 NS 0.96+0.06 0.8810.07 <0.002 I
OCL/FRL 0.8910.08 0.9510.11 <0.06 0.9010.08 0.9510.10 <0.08 I
OCL/FRM 0.9710.09 1.0110.10 NS 1.0310.08 1.0310.08 NS 1
OCL/PAR 0.9210.11 1.0910.14 <0.001 0.9510.07 1.1310.13 <0.0001 1
I OCL/CAU 1.0110.15 1.1410.20 <0.03 1.0110.14 1.09+0.18 0.14 ;
OCL/CER 0.9510.16 0.9610.13 NS 0.9310.16 0.9710.16 NS '
OCL/PUT 1.0810.16 1.0410.12 NS 1.0710.10 1.05+0.10 NS i
OCL/THA 1.0410.20 1.1010.23 NS 1.0210.17 0.98+0.15 NS I
OCL/TEP 1.1810.15 1.32+0.24 <0.09 1.1610.12 1.32+0.14 <0.005 i
PAR/TEM 1.3110.08 1.2110.25 NS 1.2810.10 1.2010.24 NS !
PAR/TEL 1.0510.06 1.04+0.16 NS 1.0110.06 0.9610.12 <0.12 s
PAR/OCL 1.1010.11 0.94+0.12 <0.0006 1.0610.07 0.9010.11 <0.0001 g
PAR/OCM 0.9610.09 0.8110.14 <0.001 1.01+0.08 0.8010.10 <0.0001
PAR/FRL 0.9610.07 0.9010.13 <0.07 0.94+0.06 0.8510.11 <0.003 1
PAR/FRM 1.0610.06 0.95+0.11 <0.002 1.0810.05 0.93+0.10 <0.0001 !
PAR/PUT 1.1710.14 1.0010.15 <0.002 1.1310.06 0.9410.10 <0.0001 :
PAR/CAU 1.1010.14 1.0910.22 NS 1.0610.11 1.0010.16 NS
PAR/CER 1.0210.13 0.9010.14 <0.04 0.9810.13 0.8510.14 <0.02 I
PAR/THA 1.1310.14 1.0310.23 0.1733 1.0710.13 0.8710.13 <0.0001 '
1 PAR/TEP 1.3010.15 1.2510.24 NS 1.2210.07 1.1910.16 NS 1I
j CER/TEM 1.2810.11 1.34+0.15 NS 1.3210.14 1.4010.23 NS 1
CER/TEL 1.0210.11 1.14+0.14 <0.03 1.0410.13 1.12+0.20 0.25 i
CER/OCL 1.0910.18 1.07+0.16 NS 1.10+0.20 1.07+0.22 NS i
CER/OCM 0.9410.09 0.9110.15 NS 1.0710.17 0.95+0.13 <0.05 I
CER/FRL 0.9410.10 1.00+0.13 NS 0.97+0.13 1.00+0.15 NS
CER/FRM 1.0310.11 1.0610.12 NS 1.11+0.13 1.1010.13 NS 1
CER/PUT 1.1010.10 1.1010.12 NS 1.1510.15 1.12+0.16 NS I
CER/CAU 1.0410.11 1.20+0.20 <0.02 1.05+0.14 1.1710.20 <0.09 i
CER/PAR 0.9910.12 1.1310.16 <0.03 1.04+0.16 1.2110.20 <0.03 ;
1 CER/THA 1.0910.13 1.1210.19 NS 1.0810.14 1.0410.16 NS '
1 CER/TEP 1.2410.16 1.3610.21 <0.14 1.26+0.13 1.40+0.20 <0.07 1
I m h  i i i 'W f m r - »  I"
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8.5. Statistical parametric mapping.
So fai' the method of predetermined ROI has been used in significance testing 
between subject groups. Rather than determining specific ROI, analysis of rCMRGlu 
reconstructed images can be examined on a voxel by voxel basis using Statistical 
Parametric Mapping (SPM). The SPM parametric method is discussed in section 
3.5.3.1. SPM does make one basic assumption on the data, that is distribution 
approximations, which are used across voxels, assume that the data sets aie from 
stationary homogeneous discrete Gaussian random fields. As shown in chapter 7, 
distributions across subjects for the selected ROI did conform to the t-distribution 
(Gaussian z-distribution approximation) in control subjects but across AD subjects this 
was not the case. Even in regions which were t-distributed in both subjects groups, 
differences still exist in variances which can also affect statistics.
Comparison between the eighteen age-matched controls and eighteen AD 
subjects led to significances at the p<0.005 level for the right hemisphere cerebellum 
and parietal postcentral gyrus with the cingulate gyrus in the left hemisphere. In both 
right and left hemispheres the occipital lingual gyrus, frontal lobe precentral gyrus, 
frontal lobe medial gyrus and anterior cingulate had observed differences. These 
significances are shown in figure 8.6. At a lower level of significance (p<0.05) the left 
and right insula and thalamus regions were added along with the right cingulate gyrus. 
But areas in the mid brain regions were prone to inaccurate significances due to poor 
distributions of rCMRGlu across subjects determined using f-tests so care has to be 
taken when interpreting results. Interestingly a similar test using control subjects of all 
ages with those with AD resulted in the left temporomedial region being significant 
between disease states also with the left parietal region (figure 8.7). The former region 
is well documented to display signs of early deterioration with the onset of AD [MizOO, 
ConvOO] but here this was not found with age matched subjects possibly pointing to 
errors induced by incorrect age-matching.
As seen in the age-matched groups the frontomedial region of the brain 
displayed a significance between disease states using SPM which when using standard 
t-tests on ROI data was not observed to deviate more so than the majority of other 
regions in the brain. However in terms of metabolic ratios, the frontomedial region was
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determined to be hypermetabolic compared to the frontolateral in AD which may 
explain the lack of a significant difference observed in the frontolateral regions using 
SPM. The parietal region did show a significant decrease in the left hemisphere which 
was also activated within SPM although none was seen in the right hemisphere.
Figure 8. 6: Statistical parametric maps of differences between age matched 
control and Alzheimer subjects at a significance of p<0.005.
2 - ---------1
(-> r
Figure 8. 7: Statistical parametric maps o f ‘activation’ between all ages of control 
and Alzheimer subjects at a significance of p<0.01.
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8.6. Hierarchical cluster analysis.
Hierarchical clustering of absolute rCMRGlu values determines whether the 
degree of association or correlation between subjects is weak then how distinct the 
clusters are with respect to each other. As a result each cluster will represent a distinct 
grouping of subjects which are then hierarchically grouped according to their similarity 
on a dendrogram. This method has been described in section 3.5.3.3. Figure 8.8 shows 
how regions of the brain are clustered together using the AD age matched control 
subjects as variables. It can be seen that over all subjects the similarity between brain 
hemispheres of a same lobe/region is greater than that of others. This was expected as 
each left and right regions of a lobe primarily have the same ftinction. From figure 8.8 it 
can be seen that the SMS and MOT regions are grouped within the same subcluster. 
These two adjacent brain regions have been shown to be associated in terms of median 
nerve stimulation [Spi99]. The lateral and medial regions of the occipital and temporal 
lobes can be seen to be grouped in different clusters, this evidence adds to previous 
results indicating a need to separate these regions in future research.
Figure 8. 8: Clustering into brain regions across all control subjects.
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Using clustering to divide male and female control subjects led to a low, but 
noticeable, level of separation shown in figure 8.9. Five males and three females were 
grouped within one cluster and seven females with three males in the other. In female 
controls metabolic rates were generally higher than those in males which may accoimt 
for the separation observed. Examining the AD subject group no clear separation was 
seen between gender.
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Figure 8. 9: Clustering of male and female subjects using the control brain.
Hierarchical clustering was performed on the absolute rCMRGlu values for the 
eighteen AD and eighteen age-matched control subjects to determine whether any 
significant group separation existed between the two states. All 36 ROI per subject were 
initially used to cluster control and AD subjects but this led to a low level of clear 
separation between the two states, as such a selection of brain regions was made which 
would improve and so best characterise the subjects. The main cortical regions of the 
brain are known to be severely affected with distinct pathological hallmarks clearly 
present in AD. In order to improve separation the FRL, FRM, OCL, OCM, TEL, TEM, 
TEP and PAR regions were used alone.
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Between control and AD subject groups significant (p<0.001) clustering was 
observed, shown in figure 8.10 with 12 control and 2 AD in one cluster and 16 AD and 
6 controls in the second cluster. Subject reference numbers which are underlined relate 
to exemplai's within the cluster group, that is those subjects who best describe the 
cluster. Figure 8.11 shows the cluster profile of the two groups with respect to the mean 
rCMRGlu for each region within the cluster. Separating left and right hemispheres 
resulted in similar groupings being observed. The left hemisphere resulted with one 
cluster having 15 AD and 6 controls with the other 12 control and 3 AD (p<0.001). 
While in the right hemisphere a slight improvement in separation was seen with 15 AD 
and 4 controls in one cluster and 14 controls and 3 AD in the other. Out of the subjects 
who did not group with the majority of members of the same genus, two male subjects 
( ‘outliers’ marked with a in figure 8.10), one control patient grouped in the AD 
cluster and one AD grouped into the control group were consistently different. The AD 
‘outlier’ had rCMRGlu similar to that expected of a control subject while the control 
‘outlier’ had an unusually low rCMRGlu expected of someone with a degenerative 
brain disorder. The remaining ‘outliers’ were of a lower level of dissimilarity, possibly 
due to the short disease duration in AD cases and the increased age of the control 
subjects. On examining the ‘outliers’ further, all but two of the subjects were male. 
When separating genders’ females exhibited a clear and significant sepaiation (p<0.001) 
between the two genus states, 8 controls in one cluster, 9 AD, 2 controls in the second, 
figure 8.12. The three scans performed on the one AD subject aie cleaidy ^ ''observed to 
shift from the AD cluster 2 to AD cluster 1, clusters with decreasing mean rCMRGlu. 
Isolating the males led to poor separation and little grouping within clusters mainly due 
to the two aforementioned ‘outliers’, figure 8.12. To examine whether it was possible to 
separate male AD and control subjects with greater confidence, clustering of the left and 
right hemispheres alone was perfoimed. This resulted in a more distinct two group 
separation in the right with 6 AD, 2 ‘normal’ in cluster one and 6 ‘noimal’ 3 AD in 
cluster two though some mixing still occurred, in part due to the two ‘outliers’ 
discovered earlier. The left hemisphere had little separation, figure 8.13. Figure 8.14 
shows the separation obtained using female subjects.
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Figure 8.10; Hierarchical clustering of rCMRGlu for AD and control female and male subjects
using the regions: FRM, FRL, OCM, OCL, TEM, TEL, TEP and PAR from both hemispheres.
Cluster profile
O) 40
■  Control c lu s te r
■  AD c lu s te r
1, ", “i ", ", ", ", ", ",
_ Î  i  ^ ^
Region
Figure 8.11: Cluster profile of the predominantly AD and control subject groups.
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Figure 8.12: Dendrograms and cluster profiles of rCMRGlu for AD and control subjects using the 
regions: FRM, FRL, OCM, OCL, TEM, TEL, TEP and PAR fi'om both hemispheres.
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Figure 8.13: Hierarchical clustering of rCMRGlu for AD and control male subjects using the 
regions: FRM, FRL, OCM, OCL, TEM, TEL, TEP and PAR from both hemispheres.
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Figure 8.14: Hierarchical clustering of rCMRGlu for AD and control female subjects using 
the regions: FRM, FRL, OCM, OCL, TEM, TEL, TEP and PAR from both hemispheres.
8.6.1. Comparison with elemental clustering.
In section 5.2.6 it was seen that with hierarchical cluster analysis of certain 
elemental concentrations it is possible to separate the majority of control and AD 
subjects using tissue samples from the frontal, occipital and parietal lobes of the brain. 
Elements S, Cl and Ca were seen to produce the best separation in the frontal lobe while 
separating hemispheres improved grouping further. Hierarchical Clustering of the 
elements Na, Mg, Cl, K and A1 in the occipital lobe again showed separation for all 
elements examined. As seen in the frontal lobe, removing K again did not significantly 
change the results of the clustering model. The parietal lobe displayed poor separation 
when clustering was applied to the concentrations of all elements, this was only 
improved with the removal of K. Clearly the results for the elemental concentrations 
show that using hierarchical clustering of certain elemental concentrations from a 
particular lobe of the brain leads to significant group separation of AD and control 
subjects.
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Hierarchical clustering of rCMRGlu in the main lobes of the cerebrum again led 
to significant separation between AD and control subjects especially if the two ‘outlier’ 
subjects were removed. Similar clustering was seen when examining left and right 
hemispheres separately, which may be explained by the similar tasks performed by each 
hemisphere. Additionally the clustering of female subjects into ‘normal’ and AD and 
groups was superior to males, the main problem with the male subjects caused by the 
two aforementioned ‘outliers’. Clearly hierarchical cluster analysis used on rCMRGlu 
may aid in the diagnosis of AD. Moreover, with an improvement in the clustering 
procedure by examining other regions of the brain which aie affected significantly in 
AD, such as the hippocampus, greater significance in clustering should be seen.
Ideally, it would have been desirable to obtain elemental concentrations for all 
three regions of the brain for all patients using the same techniques, which may have 
resulted in an improved sepaiation between the control and AD subjects. Additionally to 
determine whether any relationship exists between the clustering of trace elements in 
the lobes and rCMRGlu in the same regions it would clearly be desirable to obtain 
tissue samples and PET data from the same subjects. Unfortunately this is almost 
impossible at present to achieve as PET studies of patients who have donated brain 
tissue samples would have to be performed shortly before death so as to make sure no 
drastic change in rCMRGlu occurs during the remaining time the patient is alive. Even 
though, it is clear that certain elements in the brain cluster differently between genus 
and so correlations between these elements and their implications need to be rigorously 
examined. Moreover, it is also clear that clustering analysis of rCMRGlu may help in 
determining the onset of AD, though comparison with other dementia’s or disease states 
would have to be performed. This would detennine whether cluster analysis can 
distinguish between diseased states.
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8.7. Subprofile scalar modelling.
The Subprofile Scaling Model (SSM) was used to identify networks of regions 
associated with AD. The method of SSM [Moe91] is discussed in section 3.5.3.2 and 
uses the assumption that information about the regional ratios in the brain can be 
obtained from the SSM regional covariance patterns. Residuals from SSM are entered 
into principal component analysis (PCA) in which correlations between variables, 
principal components, Eigenvector and Eigenvalues are determined [Eve9i]. These 
principles can then be extended to disease specific covariance patterns. Unlike previous 
analysis all 72 control and 18 AD subjects scans were used in the SSM technique. As 
subject scaling factors (SSF) are determined for each subject independently age 
grouping is not essential.
From figure 8.15 clearly the first four principal components (PC) account for a 
large proportion of the deviation observed. In fact the first four PC relate to 32% of the 
total variation with the first PC 11%, second with 8%, third 7% and finally the fourth 
with 6%. The first PC unquestionably accounts for much of the variation of the original 
subject data and as such was expected to lead to the most significant information and 
best describe the differences in cases searched for [Col80].
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Figure 8. 15: Scree plot of Eigenvalue against associated principal 
component (factor number) using principal component analysis.
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The SSF values from the first four PC are seen plotted in figure 8.16 where the 
vertical line denotes the separation between AD and control subjects. Subjects 1 to 18 
have AD, 19 to 90 are control where reference numbers are given in Table 6.1 and 
Table 7.2 respectively. SSF values for the first PC noticeably display differences 
between AD and control subjects those with AD generally having higher Eigenvectors 
than controls. Note the control subjects grouping around the Eigenvector equal to zero 
and so minimum variance from the group profiles. The second PC shows a change in 
pattern for the 18 AD subjects with respect to the control subjects but is less clearly 
defined. The variances associated with the second PC will be dependent on different 
relationships between regions of the brain than those of the first PC. This is due to the 
mathematical constraints applied during PC analysis. Both PC 3 and 4 have less distinct 
variation between groups although the fourth PC shows a slight deviation with respect
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Figure 8. 16: SSF plotted against subjects for principal components one to four. The vertical 
line in each plot referring to the separate disease states (AD<18<Control).
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to the AD group. Figure 8.17 shows ‘block’ plots of the SSF values for the control and 
AD subjects. Each plot shows the average for all subjects within a subject group (white 
dash), the blocks show the mean for subjects above and below the group average. The 
bars show the complete range of subjects within each mental state while the points show 
subjects who are statistically different to the main subject group, ‘outliers’.
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Figure 8.17: ‘Block’ plots of mean SSF scores for control and AD subjects for principal
components 1 to 4.
Clearly from figure 8.17 PC 1 exhibits statistically different mean SSF scores 
between control and AD subjects. PC 2 also shows variation for SSF though of less 
significance. The SSF values for PC 3 and PC 4 can be seen to exhibit no significance 
from between AD and control mental states. It is clear that both PC 1 and PC 2 best 
describe variations between region of the brain concerning both control and AD 
subjects. Finally plots of the group invariant subprofile (GIS) for each region of the 
brain can be made, this shows the pattern of regional covariation with SSF. The plots of 
GIS scores against region of the brain for both significant PC shows which regions best 
separate disease states. The regions with GIS scores whose deviation in greatest from 
zero being more predominant. Figure 8.18 shows the GIS independent brain region 
covariance pattern indexed over regions, common to all subjects for the PC 1, and PC2.
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It can be seen from figure 8.18 that thirteen regions of the brain showed 
significant variation with respect to the disease state of the subjects for the first PC. All 
except one of the regions, THA (25) where paired with its hemispherical partner. The 
regions were the MOT, SMS, PAR, CAU, OCL and OCM. As PC 1 relates to the linear 
combination of variables whose sample variance is greatest, the results show that the 
covariance between disease states for these regions is high (high variation). This 
implying possible neuronal damage and connectivity changes in and between these 
regions with the onset of AD. The second PC whose total sample variance is 
uncorrelated with PCI, displayed less significant group variation in SSF so any regions 
with high GIS scores will only lead to a low order of separation between AD and 
control subjects. From figure 8.18, eleven regions account for the less significant 
variation of the second PC. The regions are both hemispheres of the SMS, PAR, WHM 
and THA, the right regions of the CGA TEL and CER.
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Figure 8.18: Group invariant subprofile for each region of the first and second
principal component.
D A. Cutts 2 3 2
Investigation into Brain Function: 8. Comparison of rCMRGIu between control and
AD subjects:
From figures 8.16 and 8.17 it is seen that the first PC leads to a significant 
difference between control and AD subjects groups in terms of SSF scores. Even though 
there are a total of four ‘outliers’ in this data set three of which have SSF values 
equivalent to the opposite mental state. AD subjects 3 (A803M68) and 4 (A873M54) 
had scores associated with control subjects while the control subject 19 (N219M82) had 
an AD associated SSF score. Subject 15 (A2438M60) however had an extremely high 
SSF score though this was still associated with the AD group. Interestingly subject 15 
using hierarchical cluster analysis was grouped significantly with the control subjects 
(figure 8.10) which may point to a limitation in the clustering technique. This was 
noticed more significantly when all control subjects were used in cluster analysis, a 
number of young controls were grouped with the AD subject group. SSM covariance 
patterns clearly lead to a well defined separation with no young controls being mis- 
grouped. This being said neither technique was able to place subjects 19 and 4 into the 
correct category.
Using the second PC resulted in AD subjects 3 and 4 being clearly separated 
from the control group with regards to SSF score, as was control subject 19 with respect 
to the AD group. This suggests that rather than relying on the first PC alone to diagnose 
AD, an examination of both should be performed. Results here show that all AD 
subjects are identified in this way with just one erroneous control subject. The mis- 
categorised control (subject 19) being the oldest control subject in the study at 82 years.
8.8. Conclusions and comparisons with elemental concentrations.
Distinct variations in metabolic rates have been observed between control and 
AD mental states. In the control group frequency distributions were ‘normal’ in shape 
for all regions with the exception of the putamen while in AD the majority had non­
normal distributions. Significantly more deviations from normal distribution were 
observed in the female group suggesting that the onset of AD has a greater effect on the 
female population. This was also supported by the overall metabolic rate in females 
which decreased at a significantly greater rate between disease states than that seen in
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the male group. With respect to relationships between regions of the brain and 
metabolic ratios, the temporal and parietal regions suffered hypometabolism compared 
to the frontal lobe of AD subjects. All three of these regions also experienced 
hypometabolism compared to the two occipital regions a result which is well correlated 
with histopathological hallmarks in terms of the order of regions affected. The parietal 
and temporal being severely affected while the frontal is marginally affected and the 
occipital relatively unharmed. The parietal suffered the greatest number of 
hypometabolic ratios compar'ed to other regions again confirming the correlation 
between plaques and tangles in AD brain tissue. Histopathologically the cerebellum is 
least affected in AD and similarly this was found with metabolic rates with this region 
displaying general hypermetabolism in AD. Unfortunately as different techniques and 
samples were used to detect elemental concentrations in different regions is was not 
possible to examine whether ratios of elements varied in the same way.
With respect to the trace element study, the frontal lobe of the control subjects 
was determined to have significantly higher concentrations of P and Fe in the right 
hemisphere. For the remaining elements a general trend of higher concentrations in the 
right hemisphere compared to the left was observed. For AD subjects P and Fe again 
differed but with concentrations higher in the left hemisphere again with a general trend j
of higher concentrations in the left hemisphere for the remaining elements. With respect '
to glucose metabolism in the frontal lobe the control subjects had an overall metabolic 
rate which was higher in the left hemisphere compared to the right; the same was 
observed for the AD subjects. As no difference was observed with respect to rCMRGlu 
between hemispheres, it is not possible to draw any conclusions. This being said, 
contrary to these results determined using SPM 96, analysis relying on SPM ‘classic’ 
did suggest a possible connection between elemental concentrations and metabolic rates 
[CutOO]. The AD study showed the metabolic rate of glucose to be higher in the right 
hemisphere while control subjects had greater left hemisphere metabolism. As such the 
higher elemental concentrations in the right hemisphere of control subjects appears to be 
related to a lower metabolic rate, while the lower elemental concentrations in the left 
hemisphere seem to be related to higher rates of metabolism. The same argument could
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be said of the control group although with hemispheres reversed. In terms of 
metabolism phosphorous is involved in the production of biological energy within the 
brain. The energy in the form of adenosine triphosphate (ATP) can only be produced by 
neurons from the phosphorylisation of glucose. As such the result of the higher 
concentration of P in the right hemisphere of the normal brain may explain the lower 
rCMRGlu in the same hemisphere. The lower rate of rCMRGlu which requires less P 
therefore results in a higher concentration of the element in this particular hemisphere. 
The converse can be said about the left hemisphere in the ‘normal’ brain, with a lower 
concentration of P and higher rCMRGlu. A higher rCMRGlu results in more P being 
utilised thus leaving less P in the tissue sample. Again this same hypothesis can be 
applied to the AD subjects but why there should be an inversion in the concentration of 
P and Fe and the rCMRGlu between left and right hemispheres cannot at present be 
explained. Iron followed the same trend as phosphorous which may be expected as iron 
is also involved in metabolism within the brain. As plausible as this link may be it is 
now seen to be tenuous by the results obtained from SPM 96.
Changes in elemental concentrations between disease states were seen for Cl in 
the left hemisphere which increased in AD brain tissue. The right hemisphere displayed 
more significances differences with Cl and Ca increasing in concentration with the onset 
of AD and P, S, K and Fe decreasing in the AD group. A general trend of lower 
concentrations in AD tissue was observed for all elements apait from Cl. The metabolic 
rates between control and AD decreased by an average of 12% in all frontal regions 
along with the concentrations above, although an equal rate of decrease was determined 
in both hemispheres. Interestingly the female AD tissue samples displayed a greater 
general decrease than the males while metabolic rates also decreased at a greater rate in 
females; a mean of 20% in the females opposed to just 7% in males. This may suggest a 
correlation exists between one are all of the elements listed with metabolic rate. It has 
been suggested that an elements which have a relatively small ionic radii are able to 
pass easily through the blood brain barrier whereas elements of larger ionic radii cannot 
[Ehm86]. So if an element such as calcium is increased in AD (which was found to be 
the case) then a possible reason for the change could be due to alterations in the blood 
brain barrier which would in turn affect metabolism.
D. A. Cutts 235
Investigation into Brain Function: 8. Comparison of rCMRGlu between control and
AD subjects:
For the occipital and parietal lobes no difference between hemispheres in terms 
of elemental concentrations was determined, possibly due to the small sample size 
available. However, between disease states, both Na and Cl had significantly lower 
concentrations in AD while K and Mg were significantly higher in both brain regions. 
Metabolic rates in these regions were significantly lower (10% occipital, 20% parietal) 
in AD subjects, the female subjects being affected more.
With SSM clear separation between disease states was found with respect to the 
first Principal component. This implied a breakdown or reorganisation had occurred 
with relationships between the motor cortex, somatosensory cortex, caudate, parietal 
and occipitomedial and lateral regions. The motor and somatosensory cortex’s have 
been linked in terms of nerve stimulation [Spi99] with the parietal [Kne96] and occipital 
lobes also linked to the somatorsensory system. The caudate had been connected with 
motor function [Jue97]. With regards to the occipital regions, metabolic rates have been 
shown to deviate only slightly between disease states in terms of metabolic ratios and 
absolute values. Clearly the occipital lobe and its relationships with other regions of the 
brain are more complicated than simple correlations and t-tests and clustering can 
determine, hence the multivariate nature of SSM is ideally suited to determine these 
functional differences.
This method of SSM may also be ideal for separating between different mental 
illness such as AD and frontal lobe dementia which show similarities in terms of 
metabolic decline [Har97]. In work, performed though not presented here, seventeen 
subjects with various dementias were compared to both control and AD groups to 
determine whether subjects could be separated using hierarchical cluster analysis. 
Though separation was observed between control and the general dementia groups inter 
dementia separation was not observed. SSM was not used to distinguish between groups 
as this procedure, unlike clustering, requires two distinct states. But the ‘functional 
connectivity’ SSM discovers suggests it may be able to distinguish between two mental 
closely related mental states.
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9. Conclusions and suggestions for further work.
Applying the in-vitro techniques of PIXE and DMA analyses and the in-vivo 
method of PET to the AD and ‘normal’ control brain has determined a large degree of 
heterogeneity within the brain in terms of elemental concentrations and metabolic rates. 
Variations were found to exist in elemental concentrations and metabolic rates between 
lobes, hemispheres, gender and the age of the subjects. As a result literature which 
states such information as elemental concentrations over the whole brain must be 
viewed with an air of caution as these mean values will cancel out any significant 
variation there may otherwise have been.
With respect to elemental concentrations it would have been desirable to obtain 
results for the three regions of the brain examined using the same techniques. This 
would have enabled comparisons of concentrations between lobes which in turn could 
have been used to compare with information on metabolic rates. Additionally the added 
information may have improved significances between brain hemispheres and disease 
state clustering. In the frontal lobe, differences were observed between hemispheres for 
both phosphorus and iron which had higher concentrations in the right hemisphere in 
the ‘normal’ brain and lower concentrations in the right hemisphere of AD subjects. For 
the remaining elements examined a general trend of higher concentrations in the right 
hemisphere was seen in ‘normal’ and lower in the right of AD subjects, these trends 
following that of phosphorus and iron. These variations did not imply that these 
concentrations increased in the left hemisphere or decreased in the right with the onset 
of AD as in fact concentrations were significantly lower in the right hemisphere of AD 
subjects. In the left hemisphere no significant variation was observed for iron or 
phosphorus. Both iron and phosphorus are involved in metabolism within the brain and 
so changes observed in concentrations of these elements may have implications on the 
metabolic rates within the brain. Phosphorous in the form of adenosine triphosphate is 
involved in biological energy and can only be produced by neurons from the
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metabolism and phosphorylisation of glucose. For all of the elements detected in the 
frontal lobe there was a general trend of decreasing concentrations with the exception of 
chlorine and calcium which increased. Calcium is thought to be involved with 13- 
amyloid is present in senile plaques in the AD brain. |3-amyloid forms small channels in 
nerve cell membranes which then allow calcium to enter the nerve cell which then kill 
the cell the excess calcium leading to increased measurements in AD. This suggests AD j
affects the right hemisphere of the frontal lobe more so than the left where the right I
hemispheres is primarily associated with non-verbal skills, such as spatial awareness.
Many of the conelations observed between elemental concentrations within a 
lobe were expected as many are present in intracellular and extracellular' fluid and have 
roles in cell exchange mechanisms. Cori'elations between sodium and potassium were 
expected as their ions work together to make the sodium pump which controls the flow 
of fluids across cell membranes. One element of interest was zinc where no other 
element had correlations with it for the ‘normal’ subject group but in AD five pairs were 
significantly correlated. Notably three of the elements, phosphorus, sulphur and iron 
had significant correlation coefficients with cadmium in the ‘normal’ brain but not in 
AD an important discovery as cadmium and zinc have known antagonism towards each 
other. Moreover zinc and cadmium displayed no correlation in the ‘normal’ subjects but 
did so in AD so implying a substitutive effect. Within the brain zinc has been 
determined to protect against cadmium toxicity and as such some form of correlation 
may be expected in AD [Und77]. Both cadmium and zinc are bound to the free radical 
absorber protein metallothionein (MT) as is sulphur [Mar'95] which was found to be 
highly correlated with cadmium in ‘normal’ but poorly in AD subjects. As the 
substitution of cadmium for zinc binding is thought to act to detoxify the effects of 
cadmium a reduction in MT would expose the brain to a greater amount of cadmium 
without the level needing to increase.
Hierarchical clustering was used to determine whether clusters and correlations 
of certain eler'nent concentrations for a given brain region would lead to distinct 
grouping between ‘normal’ an AD brain states. In the frontal lobe the elements sulphur, 
chlorine and calcium lead to best clustering, implying that the relationship between 
these elements in uniquely different in the AD and ‘normal’ brain states. In the occipital
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and parietal regions magnesium, chlorine and potassium were the best selection though 
in these regions the available list of elements was different to that of the frontal lobe. 
Sulphur is contained within cystine, cysteine and cysteamine which ar e all considered to 
be natural scavengers of oxygen derived free radicals [Nya96], calcium as already 
discussed is also important in the free radial absorber MT. To improve clustering it 
would be have been beneficial to have been able to obtain brain tissue samples from all 
regions of the brain for all subjects and to analyse them with the same techniques. These 
results suggest that this would improve cluster separation between subject groups and 
help determine influential elemental changes between ‘normal’ and AD subjects.
Turning our attention to metabolism in the brain, subjects with AD were 
expected to have metabolic rates that decreased linearly with disease duration [Her99]. 
The study into the effects of AD with disease duration on one female subject showed an 
increasing rate of decline with increased years in the majority of the regions examined. 
A decrease far greater than that expected in the normal ageing brain. A reason for the 
trend observed not being seen to be anything but a linear relationship in other studies 
may possibly be due to the grouping of subjects together in terms of disease duration. 
Only approximate disease durations are known as it is impossible to accurately 
determine the start of the disease and so averaging will remove any small deviations 
from linearity. The cerebellum and temporomedial regions displayed a completely 
different pattern to what was expected with the metabolic rate increasing over the first 
year followed by a decrease thereafter. The temporomedial region has been shown by 
many researches to be affected early in AD [MizOO, ConvOO] and Kennedy [Ken94] 
discovered hypometabolism in the left temporal lobe seen at a relatively short disease 
duration. Again results here give credence to this finding as metabolic rates in the 
temporomedial region were initially significantly lower than the temporalateral region.
Comparing elemental concentrations with rCMRGlu data led to a number of 
possible variables which may be connected. Zinc concentrations have been determined 
to be at increased in the temporal lobe of AD subjects [Ste96] where it has been 
suggested that the protective mechanism of CuZn-SOD against free radicals could
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explain the increase. These results give a clear* indication for the need to separate 
between medial and lateral regions of the temporal lobe. The variation seen with 
metabolic rates may be a cause or effect of elemental concentrations but as yet biopsy 
samples have not been separated as such. In brain tissue an increasing amount of fluid 
was observed with duration of AD while metabolic rates were found to decrease in the 
lobes which were involved in elemental analysis. Whether the increased fluid quite 
literally dilutes glucose within the brain and so decreases metabolic rate cannot be 
remarked upon here but fluid within the brain could cause an undesired effect due to a 
change in osmotic regulation [Go97]. With the duration of the disease the metabolic 
ratios were seen to vary and so describe how different regions of the brain are affected 
to varying degrees with respect to each other. The parietal region suffered a high rate of 
hypometabolism compared to frontal regions this compares well with atrophy in the 
parietal which is severely affected [Ken94]. Histopathologically the parietal is also more I
affected than the frontal lobe with an increased amount of tangles and plaques within |
the brain which prevent neuronal processes and so metabolism.
The PET investigation into metabolic rates across all AD subjects also showed 
that there is a need to study both genders and hemispheres of the brain separately.
Additionally AD subjects were seen to have significantly different rCMRGlu in the left 
and right regions of the frontal, occipital and parietal lobes. Although by changing the 
normalisation technique used to fit subjects scans to a standardised template it was 
found that these variations no longer existed. This generates problems with any form of 
research as the same raw data can give statistically different results depending on 
methods used to prepare data. Both the Talairach and MNI stereotaxic volumes are 
derived from different procedures, the Talairach from brain dissection while the MNI 
from a mean of 152 MRI scans. Both result in slightly different image volumes which 
can cause the brain to be morphed differently during normalisation. Additionally to this 
the SPM ‘classic’ normalisation routine converts to a 26 plane template while the SPM 
‘96’ routine used converted to a 68 plane. This increase in planes would in turn increase 
the probability of introducing enor in selecting ROI. As well as keeping to the same 
normalisation technique, data reconstruction in terms of rCMRGlu has to remain 
consistent. The two routines used here to interpret PET data were the Rhodes and Patlak
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methods which again resulted in significantly different absolute rCMRGlu values. As a 
result of this it is clear that the same method of nonnalisation has to be used throughout 
analysis of any two subject groups, using two different subject groups with images 
reconstructed with two different routines may lead to false significances being observed.
To examine whether differences occuned between the AD and ‘normal’ brain a 
control data set was collected. From this set it was cleai* that metabolic rates within the 
brain decreased with increased age of a subject group; this was expected as this trend 
had previously been reported [Mur96, Ble97]. What wasn’t expected were the two 
distinct trends found between the ages of approximately 20 to 60 years, where a steady 
decline of rCMRGlu was observed of 2.2% per decade, for the noimalised whole brain. 
While between 60 and 80 years a considerable decrease of 11% per decade was seen 
which clearly has implications with regards subject selection in any future group study. 
If a subject group were to have a mean age of around 60 years with the majority of 
subjects below 60 whilst a few are above 60, the younger subjects will have a 
disproportionate effect which would result in higher mean metabolic rates than 
otherwise may be expected. Differences in the rate of decline were observed between 
gender with rCMRGlu in the cerebellum, putamen and temporal pole all decreasing by a 
higher rate in the males for the age group 61-82. The occipitolateral, medial and insula 
were observed to have a higher rate of decrease in the 61-82 years female group. Clearly 
these results have implications in analysis concerning subject groups. Subject data must 
be age matched as any significant differences deteiTnined with respect to disease 
duration may simply be the effect of noiTnal ageing.
Between hemispheres of a particular brain region significances in rCMRGlu 
were also observed to vary with increased age. In the subject group with a mean age of 
26 years the left hemisphere regions had higher metabolic rates while this dominace 
deteriorated with increasing age until no significant difference was observed in the 61 
year mean age group. This adds to the need to age match subjects as false differences 
may be found if groups differ greatly in age. The relationships between regions in terms 
of metabolic ratios varied with age showing both frontal and parietal lobe metabolism to 
decline greater than other regions. However, metabolism in the cerebellum was seen to
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be relatively preserved with increasing age. The changes in rCMRGlu also imply that 
brain function may alter slightly with increasing age of subject again imposing 
demanding but crucial constraints upon any analysis concerning metabolic rates. It is 
critical that in any future study, rCMRGlu between AD and control subjects should be 
age and gender matched to as high a degree as possible.
Between control and AD mental states frequency distributions of rCMRGlu 
were destroyed in the majority of regions of the AD brain with female subjects being 
affected more so than the male group suggesting that the onset of AD causes greater 
damage to the female brain. This discovery was also supported by the overall metabolic 
rate in females which was significantly higher in female controls compared to males but 
significantly lower in females with AD. So females appear to have a greater rate of 
decline between control and AD states than that seen in male group. Metabolic ratios 
were again used to determine relationships between regions of the brain where it was 
found that the temporal and parietal regions suffered hypometabolism compared to the 
frontal lobe in AD subjects. All three of these regions experienced hypometabolism 
compared to the two occipital regions, a result which conelates well with 
histopathological hallmarks in terms of the order of regions affected. Both the parietal 
and temporal are known to be severely affected in AD and the frontal is only marginally 
affected with the occipital lobe relatively unharmed. The parietal also experienced the 
greatest number of hypometabolic ratios with other regions so again suggesting a 
correlation between plaques and tangles in AD brain. The cerebellum is relatively least 
affected in AD with respect to characteristic hallmarks and similarly this was found 
with metabolic rates with this region displaying general hypermetabolism in AD 
subjects. Unfortunately as samples from different regions of the brain were analysed 
using different techniques it was not possible to determine whether ratios of element 
concentrations varied in the same way as metabolic rates and so suggest any 
correlations between the two.
Comparing these glucose rates with respect to elemental concentrations initially 
resulted in possible correlations being determined between frontal lobe phosphorus, iron 
and metabolic rate between hemispheres of the brain [CutOO]. But these results relied
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upon SPM ‘classic’ for normalisation of scans of the brain whereas using SPM 96 
results were less conclusive with no strong connections being drawn from the 
information available.
Between disease states chlorine was observed to be at a higher concentration in 
the left hemisphere of AD brain tissue while in the right both chlorine and calcium were 
at increased levels. Phosphorus, sulphur, potassium and iron were seen to be at 
decreased levels in the right hemisphere of the AD group. Metabolic rates between 
control and AD decreased by an average of 12% in right hemisphere frontal regions 
with elemental concentrations of calcium rising by 11% while decreased amounts were 
found in phosphorus (9%), sulphur (8%), iron (14%) and potassium (12%). The order of 
magnitude of these decreases and increases implying possible association between 
metabolic rate and elemental changes. Interestingly tissue samples from female AD 
subjects displayed a greater general decrease in concentrations than the males while 
metabolic rates also decreased at a greater rate in females. A mean of 20% in the 
females opposed to just 7% in males in the frontal lobe. This again may suggest that a 
coiTelation exists between elemental concentrations and metabolic rate. Both the 
occipital and paiietal lobes displayed no difference between hemispheres in terms of 
elemental concentrations possibly due to the small number of samples available. Even 
though, between disease states Na and Cl had significantly lower concentrations while 
K and Mg were significantly higher in AD. The metabolic rate in the occipital was 
lower in AD by 10% and 20 % in the parietal, the female subjects being affected more.
Interpretation of metabolic data can be confusing as a number of different 
statistical techniques can be applied which all may imply different results. As such care 
has to be taken when inteipreting results with different tests. SSM is a multivariative 
technique which indicates as to which regions of the brain neuronal and hence 
functional connectivity has altered. The use of SSM led to clear separation between 
control and AD subjects employing the first principal component. This suggested a 
breakdown or even reorganisation between the motor cortex, somatosensory cortex, 
caudate, parietal and occipitomedial and lateral regions. These regions are all connected 
to at least one other in tenns of function. The motor and somatosensory cortexes with
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nerve stimulation [Spi99], paiietal and occipital lobes also linked to the somatorsensory 
system [Kne96] and the caudate again being linked with motor function [Jue97]. The 
relationships between these regions are complicated as even today the way in which 
different regions of the brain interact is not fully understood. It is cleai* that simple 
conelations, t-tests and clustering cannot determine fully these complex interactions and 
so the multivariate nature of SSM is ideally suited to deteimine these functional 
differences.
There are many possibilities with respect to future analysis of elemental 
concentrations within brain tissue. Work needs to be conducted on more tissue samples 
from the regions of the brains examined in the PET study although this will be difficult 
due to limitations on the availability of brain tissue samples and the areas from which 
samples can be taken. Clear differences in metabolic rates were observed between 
medial and lateral regions of the frontal, temporal and occipital regions. This suggests 
more care is needed in dissecting these regions as elemental concentration may also 
vary between these areas. A complete analysis of regions should only be undertaken 
using the same method of analysis throughout. This would result in a similar' ‘shopping 
list’ of elements for each region which then can be extensively examined similarly to 
the glucose data. In addition to this it is proposed that brain tissue samples, as well as 
being homogenised, are examined in their ‘normal’ unhomogenised state. Analysis now 
becoming available at the University of Surrey’s ion beam facility will allow the 
acquisition of trace element maps of a particular element at the micron level. This tool 
will allow the determination of local distributions for a sample when using PIXE 
analysis. It makes the possibility of determining trace element distributions in the 
neurofibrillary tangles and senile neuritic plaques a reality. This in turn will allow the 
determination of whether a redistribution of trace elements occurs on a localised level 
rather than just in a particular lobe.
Future interpretation and development of the SSM method may also be ideal for 
separating mental states using element concentration profiles. This would imply 
functional changes of elemental concentrations between region rather than simple
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correlations which aie the limit of analysis here. To determine whether conelations 
between elemental concentrations and metabolic rates exist ideally it would be 
beneficial to obtain PET information and brain tissue samples from the same subjects. 
Metabolic rates and elemental concentrations could then be directly compared within a 
subject. This apart from being a fairly long term project is clearly hard to achieve as 
both are difficult to obtain due to limited resources and high demand. With regards to 
PET scans alone there is a real need to follow subjects with AD during their disease 
lifetime although the ethics behind this would be immense. Variations have been 
observed in one female subject which may be destroyed if a group study was
performed due to the different rates of decline and inaccuracies in exact disease start
dates.
These ideas for future research may be hard to pursue but results found within 
this thesis suggest they will also be beneficial leading to a better understanding and
earlier diagnosis of the disease, if not treatment.
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Glossary.
Useful definitions.
Acetylcholine:
Allele:
Amyloid:
Aspartate:
Astrocytes:
Axons:
The acetic acid ester o f tlie organic base choline; the neurotransmitter released at die synapses of 
parasympathetic nerves and at neuromuscular junctions, involved in learning and memory. After 
relaying a nerve impulse, acetylcholine is rapidly broken down by the enzyme cholinesterase. 
Acetylcholine is severely diminished in Alzheimer’s disease.
One of two or more alternative forms o f a gene, only one o f which can be present in the chromosome.
A glycoprotein resembling starch, that is deposited in the internal organs in amyloidosis. B-amyloid 
protein has been found in the brains o f Alzheimer’s patients.
A neurotransmitter; aspartate can be an excitotoxin.
Type of cell with numerous sheet-like processes extending from its cell body, found tliroughout the 
central nervous system. It is one of the several different types of cell that make up the glia. The cells 
have been ascribed the function o f providing nutrients for neurons and possibly of taking part in 
information storage processes.
The “arm” of a nerve cell that normally transmits outgoing signals. Each nerve cell has one axon, 
which can be over a foot long. A nerve cell communicates with another nerve cell by transmitting 
signals from the branches at the end of its axon. In large nerves the axon has a sheath made of 
myelin.
Calcium channel blocker: a  drug that blocks the entry o f calcium into cells, thereby preventing cell death and loss of
function caused by excess calcium. Calcium channel blocker’s are used primarily in the 
treatment o f certain heart conditions and stroke, but are being studied as potential treatments for 
Alzheimer’s disease.
Calcium:
Cell:
Cell body;
Cell membrane:
An element taken in through the diet that is essential for a variety o f bodily functions, such as 
neurotransmission, muscle contraction, and proper heart function. Imbalances o f calcium can lead to 
many health problems, and excess calcium in nerve cells can cause their death.
The fundamental unit o f all organisms; the smallest structural unit tliat is capable of independent 
functioning.
In nerve cells, tliis is the central portion containing the cell nucleus, from wliich axons and dendrites 
sprout. The cell body is primarily concerned with carrying out the life- sustaining functions of a cell.
The outer boundary of the cell; the cell membrane helps control what substances enter or exit the cell.
Central nervous system (CNS): One of the two major divisions o f the nervous system. Composed o f the brain and spinal
cord, the CNS is the control centre for the entire body.
Cerebral cortex: The outer portion o f the brain, consisting o f layers of nerve cells and the pathways that connect them.
The cerebral cortex is the part o f the brain in which thought processes take place. In Alzheimer’s 
disease, nerve cells in the cerebral cortex die.
Cerebrospinal fluid (CSF): The clear watery fluid that surrounds the brain and spinal cord. It is contained in the
subarachnoid space and circulates in the ventricles o f the brain and in the central canal of the 
spinal cord.
Cbelation:
Cboline:
The process of binding and removing metal ions from the body. Chelation is used to treat metal 
poisoning, such as lead poisoning.
A natural substance required by the body that is obtained from various foods, such as eggs; one 
essential component of acetylcholine.
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Choline acetyltransferase (CAT); An enzyme that controls the production of acetylcholine; appears to be depleted in the 
brains of Alzheimer patients.
Cholinergic: 
Cholinergic system:
Cholinesterase:
Chromosome:
Cytoplasm:
Cytoplasmic:
Dendric:
Dendrite:
Dendrites:
Dopamine:
Dopaminergic system: 
Enzyme:
Gene:
Glial (neuroglia): 
Glutamate:
Glutathione
Glycoprotein:
Hippocampus:
Lipid:
Lipofuscin:
Membranes:
Meninges:
Describing nerve fibres that release aceylcholine as a neurotransmitter.
The system of nerve cells that uses acetylcholine as its neurotransmitter; nerve cells in the cholinergic 
system are damaged in the brains of Alzheimer patients.
An enzyme that breaks down a choline ester, to stop its action, into its choline and acid components. 
The term usually refers to acetylcholinesterase  which breaks down the neurotransmitter acetylcholine 
into choline and acetic acid. It if  found in all cholinergic nerve junctions, where it rapidly destroys 
the acetylcholine released during the transmission o f a nerve impulse so that subsequent impulses 
may pass.
One of the thread like structures in a cell nucleus that carry genetic information in the form of genes 
It is coiled into a helix together with associated proteins, with the genes arranged in a linear manner 
along its length. The nucleus of each human somatic cell contains 46 chromosomes, 23 of which are 
of maternal and 23 paternal origin.
See Cytoplasmic.
The jelly-like substance that surrounds the nucleus of a cell.
See Dendrite.
One of the shorter branching processes o f the cell body of a nerve, which makes contact with other 
neurons at synapses and carries nerve impulses from them into the cell body.
Branched extensions of the nerve cell body which receives signals from other nerve cells. Each nerve 
cell usually has many dendrites.
A neurotransmitter that is essential for normal movement, such as walking. The brains of Parkinson’s 
disease patients are deficient in dopamine.
The system of nerve cells that uses dopamine as its neurotransmitter.
Protein that, in small amounts, speeds up the rate of a biological reaction without itself being used up 
in the reaction. An enzyme acts by binding with the substance involved in the reaction (the substrate) 
and converting it into anotlrer substance (the product o f the reaction). An enzyme is relatively 
specific in the type o f reaction it catalyses; hence there are many different enzymes for the various 
chemical reactions. Failure in the production of an enzyme my result in metabolic disorders.
The basic unit o f genetic material, which is carried at a particular place on a chromosome.
The special connective tissue o f the central nervous system, composed of different cells with various 
supportive and nutritive functions.
A neurotransmitter that is normally involved in learning and memory. Under certain circumstances it 
can be an excitotoxin, and appears to cause the death o f nerve cells in a variety of neurodegenerative 
disorders. Early research has shown that glutamate may cause nerve cell death in AD, and further 
research is being performed to learn more about its possible role in AD.
Peptide containing the amino acids glutamic acid, glycine and cysteine. It functions in oxidation- 
reduction reactions.
One of a group of compounds consisting o f a protein combined with a carbohydrate. Examples are 
certain enzymes, hormones, and antigens.
A part o f the brain that is important for learning and memory.
One of a group of naturally occurring compounds that are soluble in solvents but insoluble in water. 
Lipids are important dietary constituents, not only because o f there high energy value but also 
because o f certain vitamins and essential fatty acids are associated with them.
A brownish pigment staining witli certain fat stains.
The lipoprotein envelope surrounding a cell.
The three connective tissue membranes that line the skull and vertebral canal and enclose the brain 
and spinal cord.
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Metabolism: The complex chemical and physical processes of living organisms that promote growth, sustain life,
and enable all other bodily functions to take place.
Mitochondria structure in the cytoplasm of every cell and is the site of energy production, they contain ATP.
biological energy, and enzymes involed in producing energy.
Monoamine oxidase (MAO): An enzyme that breaks down certain neurotransmitters, including dopamine, serotonin, and
noradrenaline.
Monoamine oxidase inhibitor (MAGI): A drug that interferes with the action of monoamine oxidase, slowing the
breakdown of certain neurotransmitters. Used in the treatment of depression.
Myelin:
Nerve:
Nerve cell: 
Neuritic plaque:
Neurofibril:
A complex material formed of protein and phospholipid tliat is laid down as a sheath around tire 
axons o f certain neurons, known as myelinated nerve Fibres. Myelinated nerves conduct impulses 
more rapidly than nonmyelinated nerves.
A bundle of conducting nerve fibres tliat transmit impulses from the brain or spinal cord to the 
muscles and glands or inwards from the sense organs to the brain and spinal cord.
See neuron
Abnormal cluster o f dead and dying nerve cells, other brain cells, and protein. Neuritic plaques are 
one of tlie characteristic structural abnormalities found in the brains o f Alzheimer patients. Upon 
autopsy, the presence o f neuritic plaques and neurofibrillary tangles is used to positively diagnose 
AD.
One of the microscopic threads of cytoplasm found in the cell body of a neuron and also in the 
axoplasm o f peripheral nerves.
Neurofibrillary tangle: Accumulation of twisted protein fragments inside nerve cells. Neurofibrillary tangles are one of the 
characteristic structural abnormalities found in the brains of Alzheimer patients. Upon autopsy, the 
presence of neuritic plaques and neurofibrillary tangles is used to positively diagnose AD.
Neuron (nerve cell):
Neuropeptide Y: 
Neuropil
Neurotransmitter :
Noradrenaline:
Nucleus: 
Olfactory bulb 
Organelles:
One of the basic functional units of tlie nervous system; a cell specialised to transmit electrical nerve 
impulses and so carry information from one part of the body to another. Each neuron has an enlarged 
portion, the ‘cell body’, containing the nucleus, several short branches (dendrites), and one long arm 
(the axon) with short branches along its lengtli and at its end. The point o f contact o f one neuron witli 
another is known as a synapse.
A substance that sometimes functions as a neurotransmitter. Some research shows that neuropeptide 
Y may be involved in Alzheimer’s disease.
Nerve tissue, interconnected mass rather than ordered structure.
Specialised chemical messenger (e.g., acetylcholine, dopamine, norepinephrine, serotonin) produced 
and secreted by nerve cells that sends a message from one nerve cell to another across synapses.
Neurotransmitters play different roles throughout tlie body, many o f which are not yet fully
understood.
A neurotransmitter, also called norepinephrine, that plays a role in mood, pain, and possibly learning 
and memory. Noradrenaline may be involved in AD.
A large body within cells that contains DNA, the genetic material.
Sensory nerve o f smell. Receptors lead straight to brain.
Structures within a cell that is specialised for a particular function. An example is the golgi apparatus.
Parasympathetic nervous system: One of the two divisions of the autonomic nervous system (the other being the 
sympathetic nervous system), having fibres that leave the central nervous system 
from the brain and the lower portion of the spinal cord and are distributed to blood 
vessels, glands, and the majority o f internal organs.
Peripheral nervous system (PNS): One of the two major divisions of the nervous system. Nerves in the PNS connect the
central nervous system (CNS) witli sensory organs, other organs, muscles, blood 
vessels, and glands.
Phospholipid:
Plaques and tangles: See neuritic plaque and neurofibrillary tangle.
Lipid containing a phosphate group as part o f the molecule. Found in the brain, synthesised in the 
liver and small intestine.
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Processes:
Receptor:
Serotonergic system:
Serotonin:
Somatostatin:
Subarachnoid space:
Supramodal
Synapse:
Synaptic vesicles:
Synaptic:
Unmyelinated:
A thin prominence or proturberance.
In the nervous system, a site on a nerve cell that receives a specific neurotransmitler; the “message 
receiver.”
The system of nerve cells that uses serotonin as their neurotransmitter.
A neurotransmitter that plays a role in mood, sleep, and pain. Serotonin may be involved in sleep.
A substance that sometimes functions as a neurotransmitter. Some research indicates that 
somatostatin may be involved in Alzheimer’s disease.
The space between the arachnoid and the pia meninges of the brain and spinal cord containing 
circulating cerebrospinal fluid and large blood vessels.
The minute gap across which nerve impulses pass from one neuron to tlie next, at the end of a nerve 
fibre, from the axon of one nerve cell to the dendrite o f another. Reaching a synapse an impulse 
causes the release of a neurotransmitter, wliich diffuses across the gap and triggers an electrical 
impulse in the next neuron. Some brain cells contain more than 15,000 synapses.
Small sac located in the area of nerve cell axons that contain neurotransmitters. During activity the 
vesicles release their contents at the synapse, and tlie neurotransmitter stimulate receptors on otlier 
cells.
See Synapse.
See Myelin.
Ventricle (of the brain): One of four fluid-filled cavities within the brain, fluid cerebrospinal circulates through all of the 
cavities.
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Appendix.
Folstein’s Mini-Mental Status Exam (MMSE).
A perfect score is 30 with each coiTect answer given one point. 
Five areas of mental status are tested:
Orientation
I. What is the: 2. Where are we?
Year? ________
Season? ________
Date? ________
Day? ________
Month? ________
State?
County?
Town or City?
Hospital?
Floor?
Registration
3. Name three objects, taking one second to say each. Then ask the patient to repeat all three after you 
have said them. Give one point for each correct answer. Repeat the answers until patient learns all three.
  3 Trails = ______
Attention and Calculation
4. Serial sevens. Give one point for each correct answer. Stop after five answers. Alternatively: Spell 
WORLD backwards.
Recall
5. Ask for names of objects learned in question 3. Give one point for each correct answer
  3
Language
6. Point to a pencil and a watch. Have the patient name them as you point.   2
7. Have the patient repeat “No ifs, ands, or buts.”   1
8. Have the patient follow a three-staged command: “Take a paper In your right hand. Fold the paper in 
half. Put the paper on the floor.”   3
9. Have the patient read and obey the following: “CLOSE YOUR EYES.”   1
10. Have the patient write a sentence of his or her choice. (The sentence should contain a subject and an 
object and should make sense. Ignore spelling errors when scoring.)   1
11. Have the patient copy a design (e.g. two overlapping squares.)   1
Scores of 23 or less = High likelihood of dementia.
Scores of 25 to 30 = Normal ageing or borderline.
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